US20030120338A1 - Advanced endovascular graft - Google Patents

Advanced endovascular graft Download PDF

Info

Publication number
US20030120338A1
US20030120338A1 US10/091,641 US9164102A US2003120338A1 US 20030120338 A1 US20030120338 A1 US 20030120338A1 US 9164102 A US9164102 A US 9164102A US 2003120338 A1 US2003120338 A1 US 2003120338A1
Authority
US
United States
Prior art keywords
graft
inflatable
proximal
stent
distal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/091,641
Inventor
Michael Chobotov
Brian Glynn
Stuart Kari
Maurice Marthaler
Robert Whirley
Isaac Zacharias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Corp
TriVascular Inc
Endologix LLC
Original Assignee
Chobotov Michael V.
Brian Glynn
Stuart Kari
Maurice Marthaler
Robert Whirley
Isaac Zacharias
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chobotov Michael V., Brian Glynn, Stuart Kari, Maurice Marthaler, Robert Whirley, Isaac Zacharias filed Critical Chobotov Michael V.
Priority to US10/091,641 priority Critical patent/US20030120338A1/en
Priority to US10/327,711 priority patent/US7147660B2/en
Priority to AT09009090T priority patent/ATE553721T1/en
Priority to CA002468951A priority patent/CA2468951A1/en
Priority to AU2002360765A priority patent/AU2002360765C1/en
Priority to PCT/US2002/041338 priority patent/WO2003053288A1/en
Priority to EP02796047.5A priority patent/EP1467679B1/en
Priority to EP09009090A priority patent/EP2135583B1/en
Priority to EP10180726.1A priority patent/EP2277474A3/en
Priority to JP2003554049A priority patent/JP4331610B2/en
Priority to ES09009090T priority patent/ES2384133T3/en
Publication of US20030120338A1 publication Critical patent/US20030120338A1/en
Assigned to BOSTON SCIENTIFIC CORPORATION reassignment BOSTON SCIENTIFIC CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TRIVASCULAR, INC.
Assigned to TRIVASCULAR, INC. reassignment TRIVASCULAR, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WHIRLEY, ROBERT G., CHOBOTOV, MICHAEL V.
Assigned to BOSTON SCIENTIFIC SANTA ROSA CORP. reassignment BOSTON SCIENTIFIC SANTA ROSA CORP. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: TRIVASCULAR, INC.
Priority to US11/333,595 priority patent/US7766954B2/en
Priority to JP2008303094A priority patent/JP2009039581A/en
Priority to AU2009201682A priority patent/AU2009201682B2/en
Priority to US12/491,336 priority patent/US8709065B2/en
Priority to US12/566,104 priority patent/US8900288B2/en
Priority to US12/566,808 priority patent/US20100016943A1/en
Priority to AU2009230748A priority patent/AU2009230748B2/en
Priority to JP2010041226A priority patent/JP5432003B2/en
Assigned to TRIVASCULAR, INC. reassignment TRIVASCULAR, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BOSTON SCIENTIFIC CORPORATION
Priority to US13/245,652 priority patent/US20120016457A1/en
Priority to US13/245,661 priority patent/US8167927B2/en
Priority to US13/246,651 priority patent/US8864814B2/en
Priority to US13/246,643 priority patent/US8241346B2/en
Priority to JP2011256571A priority patent/JP2012035139A/en
Priority to US14/799,656 priority patent/US9788934B2/en
Priority to US15/686,218 priority patent/US10470871B2/en
Assigned to DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT reassignment DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ENDOLOGIX, INC., NELLIX, INC., TRIVASCULAR, INC.
Assigned to DEERFIELD ELGX REVOLVER, LLC, AS AGENT reassignment DEERFIELD ELGX REVOLVER, LLC, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ENDOLOGIX, INC., NELLIX, INC., TRIVASCULAR, INC.
Priority to US16/680,779 priority patent/US11439497B2/en
Assigned to ENDOLOGIX LLC reassignment ENDOLOGIX LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ENDOLOGIX, INC.
Assigned to DEERFIELD PRIVATE DESIGN FUND IV, L.P. reassignment DEERFIELD PRIVATE DESIGN FUND IV, L.P. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ENDOLOGIX LLC (F/K/A ENDOLOGIX, INC.), NELLIX, INC., TRIVASCULAR CANADA, LLC, TRIVASCULAR TECHNOLOGIES, INC., TRIVASCULAR, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/844Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents folded prior to deployment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/9517Instruments specially adapted for placement or removal of stents or stent-grafts handle assemblies therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/954Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/825Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having longitudinal struts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • A61F2002/8486Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs provided on at least one of the ends
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91508Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91516Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91583Adjacent bands being connected to each other by a bridge, whereby at least one of its ends is connected along the length of a strut between two consecutive apices within a band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • A61F2002/9511Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument the retaining means being filaments or wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0058Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0036Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M2025/0177Introducing, guiding, advancing, emplacing or holding catheters having external means for receiving guide wires, wires or stiffening members, e.g. loops, clamps or lateral tubes

Definitions

  • the present invention relates to a system for the treatment of disorders of the vasculature. More specifically, the invention relates to a system for the treatment of disease or injury that potentially compromises the integrity of a flow conduit in the body.
  • an embodiment of the invention is useful in treating indications in the digestive and reproductive systems as well as indications in the cardiovascular system, including thoracic and abdominal aortic aneurysms, arterial dissections (such as those caused by traumatic injury), etc. Such cardiovascular indications often require intervention due to the severity of the sequelae, which frequently is death.
  • Endovascular repair of aortic aneurysms represents a promising and attractive alternative to conventional surgical repair techniques.
  • the risk of medical complications is significantly reduced due to the less-invasive nature of the procedure.
  • Recovery times are significantly reduced as well, which concomitantly diminishes the length and expense of hospital stays.
  • open surgery requires an average six-day hospital stay and one or more days in the intensive care unit.
  • endovascular repair typically requires a two-to-three day hospital stay. Once out of the hospital, patients benefiting from endovascular repair may fully recover in two weeks while surgical patients require six to eight weeks.
  • endovascular-based systems have a number of shortcomings.
  • Present bifurcated stent-grafts require relatively large delivery catheters, often up to 24 French and greater in diameter. These catheters also tend to have a high bending stiffness.
  • Such limitations result in the need for a surgical cut-down to deliver the stent-graft and make delivery through the often narrow and irregular arteries of diseased vessels difficult and risky.
  • endovascular treatment of aortic aneurysmal disease is not available to many patients who could otherwise benefit from it. For instance, women statistically tend to have smaller vessels and therefore some are excluded from many current endovascular therapies simply due to this reason. There is therefore a need for an endovascular stent-graft capable of being delivered via a smaller and more flexible delivery catheter. Even greater advantages may be realized if such an endovascular stent-graft is capable of being delivered percutaneously.
  • an endovascular stent-graft must withstand tremendous pulsatile forces over a substantial period of time while remaining both seated and sealed within the vessel.
  • the device which may comprise component parts and/or materials, must remain intact.
  • the device must resist axial migration from the site of deployment while being subjected to significant pulsatile forces, and it should have sufficient radial compliance to conform to the vessel anatomy within which it is deployed so as to prevent blood leakage between the device and the vessel wall at both its proximal, or cephalic, end as well as at its distal, or caudal end or ends (where the net force may be retrograde).
  • Such a device should conform to the morphology of the treated vessel, without kinking or twisting, over the life of the patient.
  • the present invention generally is directed to a system for the endovascular treatment of body passageways that includes a medical device implantable within a body lumen such as a blood vessel.
  • a medical device implantable within a body lumen such as a blood vessel.
  • Some embodiments of this invention include an endovascular graft for treating vascular disease.
  • One embodiment includes a graft with a graft body section having a proximal end and a distal end, and, disposed or affixed on at least one end, a connector member having one or more connector member connector elements.
  • the connector member may be embedded within multiple layers of the graft body section.
  • a stent may be coupled or affixed to the one or more connector member connector elements via one or more stent connector elements.
  • the graft may include a proximal stent and connector member only, a distal stent and connector member only, or both proximal and distal stents and their respective connector members.
  • Both the connector member connector elements and the stent connector elements may have a proximal end and a distal end that comprise opposing shoulder portions.
  • the graft may further have one or more coupling members, such as a wire coil, configured to couple or connect the one or more connector member connector elements to the one or more stent connector elements.
  • Both the connector members and the stents may be formed of a serpentine ring having one or more apices.
  • One embodiment includes a graft having single stage distal and/or proximal stents in which the associated connector member may have twice as many apices as the stent.
  • the graft has two-stage distal and/or proximal stents with twice as many apices in a first region as in a second region while the associated connector member has the twice the number of apices as in the first region of the stent.
  • a useful embodiment is one in which a twelve-apex connector member is connected to a first six-apex or six-crown region of a proximal or distal stent and that stent has a second three-apex or three-crown region integral with or joined to the six-crown region.
  • grafts that include various combinations of single and multiple-stage proximal and distal stents with their associated connector members are possible.
  • the stents may also include one or more barbs.
  • the barbs on a proximal stent are oriented distally to engage the stent into the tissue wall in the proximal-to-distal flow field in which the graft is typically disposed.
  • the barbs on one or more distal stents are typically oriented proximally to engage the stent into the tissue wall to oppose the typically retrograde migration forces.
  • the barbs may range in length from about 1 to about 5 mm.
  • barbs will typically project radially outward from a longitudinal axis of their respective stent and form a barb radial angle from about 10 to about 45 degrees with respect to the graft proximal neck portion inlet axis when the stent is deployed in vivo.
  • the barbs may also be laterally biased in a plane that is orthogonal to a plane in which the barb radial angle is formed to form a barb kick angle.
  • the stent or stents (proximal and/or distal) comprise struts having one or more optional barb tuck pads integral to the struts such that when the proximal stent is in a reduced profile delivery configuration, each barb is retained by the stent strut. When the endovascular graft is in a deployed configuration, the one or more barbs are released.
  • the stent or stents may also comprise optional barb tuck slots configured to receive the barbs such that each barb is retained by a slot when the stent is in a delivery configuration. In a deployed configuration, the barbs are released from their corresponding barb tuck slots.
  • the stent may comprise grooves.
  • some type of belts or sutures may be used to help retain the endovascular graft in its compressed delivery configuration.
  • the grooves may accommodate these belts or sutures without increasing the small diameter delivery of the device.
  • the graft body section may also have one or more inflatable cuffs disposed on or near the graft body section proximal end, distal end, or both.
  • the inflatable cuffs provide a sufficiently stiff structure when inflated which help to support the graft body section and provide a conformable surface to seal the graft against the interior surface of the vessel in which it is deployed.
  • the graft body section may also include one or more inflatable channels.
  • the channel or channels typically may be disposed between and in fluid communication with either or both proximal and distal inflatable cuffs.
  • the channel or channels enhance the graft body section stiffness upon their inflation, help to prevent kinking of the graft body section, and may also facilitate deployment of the graft within a patient's body passageway.
  • the inflatable channel or channels can be in a longitudinal and/or linear configuration with respect to the graft body section, but alternatively may take on a helical or circumferential configuration. Other orientations such as interconnecting grids or rings may also be suitable alone or in combination with any of the other configurations.
  • a useful inflation medium includes the combination polyethylene glycol diacrylate, pentaerthyritol tetra 3(mercaptopropionate) and a buffer such as glycylglycine or triethanolamine in phosphate-buffered saline. Saline or another inert biocompatible liquid may be added to this three-component inflation medium in amounts up to about sixty percent of the total inflation medium volume. Radiopaque materials such as tantalum, iodinated contrast agents, barium sulfate, etc. may be added to this three-component medium, typically in the buffer, so to render the inflation medium visible under fluoroscopy.
  • the graft may comprise a main body portion and a first bifurcated portion forming a continuous lumen that is configured to confine a flow of fluid therethrough.
  • the graft may also include a second bifurcated portion in fluid communication with the main body portion.
  • At least one inflatable cuff may be disposed at either or both a proximal end of the main body portion and a distal end of the first bifurcated portion.
  • One or more inflatable channels may be disposed between the inflatable cuffs as previously described, and may extend over some or all of the main body portion.
  • the cuffs and channels may be filled with an inflation medium, optionally diluted with an inert biocompatible material such as saline or other liquid, as described above.
  • the graft may comprise a main body portion in fluid communication with a first and a second bifurcated portion forming a continuous bifurcated lumen, said lumen configured to confine a flow of fluid therethrough.
  • At least one inflatable cuff may be disposed at or near either or both a proximal end of the main body portion and a distal end of the first and second bifurcated portions.
  • One or more inflatable channels may be disposed between the inflatable cuffs as previously described, and may extend over some or all of the main body portion.
  • the proximal ends of the graft main body portion may have connector members comprising one or more connector elements, and a proximal stent coupled to the one or more connector elements.
  • One or both of the first and/or second bifurcated portions may likewise have first and/or second distal connector members comprising one or more connector elements disposed on their respective distal ends, and a distal stent coupled to the first and/or second distal connector members.
  • the present invention is also a system for implanting a tubular medical device within a body lumen having a wall, including a stent for affixing the medical device to the body lumen wall and a connector member for coupling the stent to the medical device, wherein the stent and the connector member are coupled to one another by at least one set of connector elements.
  • One or more barbs may also be included in this system.
  • one or more barb tuck pads may be included in which the one or more barbs are configured to be retained by the one or more barb tuck pads when the system is in a delivery configuration and released by the one or more barb tuck pads when the system moves to a deployed configuration.
  • the stent may further include optional slots configured to receive the barbs when the system is in a delivery configuration and wherein the barbs are configured to be released from the slots when the system is in a deployed configuration.
  • the invention also includes an endovascular graft comprising a graft body section with a proximal end and a distal end and a proximal connector member affixed to the proximal end of the graft body section.
  • the proximal connector member may have one or more connector elements.
  • the graft may also have a proximal stent comprising one or more distally oriented barbs and one or more proximal stent connector elements coupled to the one or more proximal connector member connector elements and a distal connector member affixed to the distal end of the graft body section.
  • the distal connector member may include one or more connector elements.
  • the graft of this embodiment further includes a distal stent comprising one or more proximally oriented barbs and comprising one or more distal stent connector elements coupled to the one or more distal connector member connector elements, one or more inflatable cuffs disposed at or near each of the proximal and distal ends of the graft body section, and wherein the graft body section comprises an inflatable channel in fluid communication with the proximal and distal cuffs.
  • proximal and distal connector member connector elements may each have opposing shoulder portions on their proximal and distal ends, as may the proximal and distal stent connector elements.
  • One or more coupling members may couple the proximal connector member connector elements to the proximal stent connector elements and likewise couple the one or more distal connector member connector elements to the one or more distal stent connector elements.
  • At least one of the inflatable channel, the distal inflatable cuff, and the proximal inflatable cuff may contain an inflation medium comprising the combination polyethylene glycol diacrylate, pentaerthyritol tetra 3(mercaptopropionate), and a buffer.
  • the proximal stent barbs or distal stent barbs of this embodiment may have a length from about 1 to about 5 mm, and the graft body section may comprise ePTFE.
  • the device includes a main body portion with a distal end and a proximal end with a connector member disposed on the proximal end.
  • the connector member may include one or more connector elements.
  • the proximal stent of this embodiment may comprise one or more distally oriented barbs and one or more proximal stent connector elements that are coupled to the connector member connector elements.
  • This embodiment further includes a first bifurcated portion and a second bifurcated portion forming a continuous lumen with the main body portion. This lumen is configured to confine a flow of fluid therethrough.
  • a distal connector member may be disposed on distal ends of each of the first and second bifurcated portions.
  • Each of these distal connector members includes one or more connector elements.
  • this embodiment has one or more distal stents with at least one proximally oriented barb and comprising one or more distal stent connector elements.
  • the distal stent connector elements are coupled to the distal connector member connector elements on one or both of the first and second bifurcated portions.
  • This embodiment also includes at least one inflatable channel extending from one or both of the first and second bifurcated portions to the main body portion, at least one inflatable cuff disposed at or near a proximal end of the main body portion in fluid communication with the at least one channel, and an inflatable cuff disposed at or near a distal end of each of the first and second bifurcated portions.
  • the proximal and distal connector member connector elements may each have opposing shoulder portions on their proximal and distal ends, as may the proximal and distal stent connector elements.
  • One or more coupling members may couple the proximal connector member connector elements to the proximal stent connector elements and likewise couple the one or more distal connector member connector elements to the one or more distal stent connector elements.
  • At least one of the inflatable channel, the first bifurcated portion distal inflatable cuff, the second bifurcated portion distal inflatable cuff, and the proximal inflatable cuff may contain an inflation medium comprising the combination polyethylene glycol diacrylate, pentaerthyritol tetra 3(mercaptopropionate), and a buffer.
  • the proximal and/or distal stent barbs may have a length from about 1 to about 5 mm.
  • the graft main body portion as well as the first and second bifurcated portions may comprise ePTFE.
  • FIG. 1 shows an endovascular graft according to an embodiment of the present invention.
  • FIGS. 1 A- 1 B detail two angles at which a stent barb may be oriented on the graft of an embodiment of the present invention.
  • FIG. 2 shows a second endovascular graft according to an embodiment of the present invention.
  • FIG. 3 shows a flat pattern of a component of the endovascular graft of FIG. 2.
  • FIG. 4 shows a flat pattern of another component of the endovascular graft of FIG. 2.
  • FIG. 5 shows a flat pattern of a portion of the endovascular graft of FIG. 2.
  • FIG. 5A is an enlarged side view of FIG. 5 at Detail A.
  • FIG. 6 is an enlarged view of a portion of an endovascular graft having features of an embodiment of the present invention.
  • FIG. 7 shows a bifurcated endovascular graft according to embodiments of the present invention.
  • FIG. 8 shows a flat pattern of yet another component of the endovascular graft of FIG. 2.
  • FIG. 9 shows a flat pattern of another component of the endovascular graft of FIG. 2.
  • FIG. 10 shows detail of a stent apex detail that comprises offset circular and elliptical radii.
  • FIG. 11 shows detail of a stent apex detail that comprises offset circular radii.
  • FIG. 12 shows detail of a stent section comprising a tapered strut section.
  • FIG. 13 shows detail of a stent section comprising another configuration for a tapered strut section.
  • FIG. 1 shows an endovascular graft 10 in its deployed configuration.
  • graft or “endovascular graft” is used herein to refer to a prosthesis capable of repairing and/or replacing diseased vessels or portions thereof, including generally tubular and bifurcated devices and any components attached or integral thereto.
  • the graft embodiments described below are assumed to be most useful in the endovascular treatment of abdominal aortic aneurysms (AAA).
  • AAA abdominal aortic aneurysms
  • proximal describes the end of the graft that will be oriented towards the oncoming flow of bodily fluid, typically shows a flat pattern blood, when the device is deployed within a body passageway.
  • distal therefore describes the graft end opposite the proximal end.
  • Graft 10 has a proximal end 11 and a distal end 12 and includes a generally tubular structure or graft body section 13 comprised of one or more layers of fusible material, such as expanded polytetrafluoroethylene (ePTFE).
  • a proximal inflatable cuff 16 is disposed at or near a proximal end 14 of graft body section 13 and an optional distal inflatable cuff 17 is disposed at or near a graft body section distal end 15 .
  • Graft body section 13 forms a longitudinal lumen 22 configured to confine a flow of fluid therethrough and may range in length from about 5 to about 30 cm; specifically from about 10 to about 20 cm.
  • cuffs 16 and 17 will cause them to assume a generally annular shape (especially when graft body section 13 is in an unconstrained state). Inflatable cuffs 16 and 17 will generally, however, conform to the shape of the vessel within which it is deployed. When fully inflated, cuffs 16 and 17 may have an outside diameter ranging from about 10 to about 45 mm; specifically from about 16 to about 32 mm.
  • At least one inflatable channel 18 may be disposed between and in fluid communication with proximal inflatable cuff 16 and distal inflatable cuff 17 .
  • Inflatable channel 18 provides structural support to graft body section 13 when inflated to contain an inflation medium. Inflatable channel 18 further prevents kinking and twisting of the tubular structure or graft body section when it is deployed within angled or tortuous anatomies as well as during remodeling of body passageways (such as the aorta and iliac arteries) within which graft 10 is deployed. Together with proximal and distal cuffs 16 and 17 , inflatable channel 18 forms a network of inflatable cuffs and channels in fluid communication with one other.
  • Inflatable channel 18 may be disposed helically as shown in FIG. 1, it may take on a more circumferential or annular rib and spine configuration as shown in the FIG. 2 embodiment, or otherwise.
  • the longitudinal and radial dimensions of inflatable channel 18 may vary as necessary both between different graft body sections and even within a single graft body section, depending on the indication for which graft 10 is intended to treat.
  • inflatable channel 18 may be oriented at various angles with respect to the longitudinal axis 25 of graft body section 13 , and the pitch (the distance between helical or parallel windings of channel 18 ) may vary as necessary.
  • the channel pitch, or distance between each helical inflatable channel 18 winding may range from about 2 to about 20 mm, depending on the overall size of graft body section 13 and the desired degree of kink resistance.
  • a pitch of between about 4 and about 10 mm is effective for tubular embodiments of the present invention and a pitch of between about 3 and about 10 mm to be useful in bifurcated graft embodiments.
  • the helix angle of each channel winding (measured with respect to a plane perpendicular to the graft body section longitudinal axis 25 ) may range from about 10 to about 45 degrees; more specifically, from about 20 to about 35 degrees in tubular and bifurcated graft embodiments.
  • the width of inflatable channel 18 typically ranges from about 1 to about 8 mm; more specifically, from about 2 to about 4 mm.
  • Graft body section or tubular structure 13 and its associated components may be made from a variety of suitable materials, including ultra high molecular weight polyethylene, polyesters, and the like. As previously discussed, we have found constructing graft body section 13 primarily from one or more layers of ePTFE to be particularly useful. Details of how graft 10 may be fabricated (as well as all of the other grafts discussed herein) are more fully described in parent U.S. patent application Ser. No. 10/029,559 and in copending U.S. patent application Ser. Nos. 10/029,570, 10/029,584, and 10/029,557, each to Chobotov et al. In addition, U.S. patent application Ser. No.
  • a proximal neck portion 23 is disposed in the vicinity of graft body section proximal end 14 and serves as an additional means to help seal the deployed graft against the inside of a body passageway.
  • Proximal neck portion 23 has an inlet axis 27 that forms an inlet axis angle ⁇ in relation to graft body section longitudinal axis 25 .
  • This angled inlet axis 27 allows the graft to better conform to the morphology of a patient's vasculature in patients who have an angled vessel morphology, such as is often the case in the neck region of abdominal aortic aneurysms.
  • the inlet axis angle ⁇ may range in any direction with respect to longitudinal axis 25 from about zero to about 90 degrees, preferably from about 20 to about 30 degrees.
  • Proximal neck portion 23 may be tapered or flared to a larger diameter in the proximal direction to facilitate this sealing function.
  • Proximal neck portion 23 also serves as a means of providing a smooth fluid flow transition into graft lumen 22 .
  • the network of inflatable cuffs 16 , 17 and channel 18 may be inflated, most usefully in vivo, by introduction or injection of a material or medium through an injection port 33 that is in fluid communication with cuff 17 and the associated cuff/channel network.
  • the material may comprise one or more of a solid, fluid (gas and/or liquid), gel or other medium.
  • the material may contain a contrast medium that facilitates imaging the device while it is being deployed within a patient's body.
  • radiopaque materials containing elements such as bismuth, barium, gold, iodine, platinum, tantalum or the like may be used in particulate, liquid, powder or other suitable form as part of the inflation medium.
  • Liquid iodinated contrast agents are a particularly suitable material to facilitate such imaging.
  • Radiopaque markers may also be disposed on or integrally formed into or on any portion of graft 10 for the same purpose, and may be made from any combination of biocompatible radiopaque materials.
  • a connector member 24 is affixed to or integrally formed in graft body section 13 , or as shown in FIG. 1, at or near graft body section proximal end 14 and proximal neck portion 23 .
  • Connector member 24 is a serpentine ring structure comprising apices 28 .
  • Connector member 24 may be made from any suitable material that permits expansion from a constrained state, most usefully a shape memory alloy having superelastic properties such as nickel titanium (NiTi).
  • Other suitable connector member 24 materials include stainless steel, nickel-cobalt alloys such as MP35N, tantalum and its alloys, polymeric materials, composites, and the like.
  • Connector member 24 (as well as all stents and connector members described herein) may be configured to self-expand from a radially constrained state or be configured to expand as a result of an applied force (such as from an inflated balloon), or, in the case of some shape memory materials, a temperature change.
  • connector member 24 shown in FIG. 1 comprises eight apices 28 (put more precisely, the FIG. 1 connector member 24 comprises eight proximal apices and eight distal apices; however, unless otherwise mentioned, the term “apices” refers in this context to either the proximal or distal set of apices in a single connector member, stent, or stent portion).
  • FIGS. 2 - 7 Another particularly useful configuration is one shown in FIGS. 2 - 7 in which the connector member comprises twelve apices. Any number of apices up to twenty-four or more may be used in connector member 24 . In general terms, as the number of apices 28 on connector member 24 increase, connector member 24 will exhibit a greater conformability to the vessel wall when it is expanded from a radially constrained state.
  • connector member 24 is to work in conjunction with proximal neck 23 in which it is typically embedded to help seal the deployed graft against the inside of a body passageway as previously described. It can also play a role in helping to keep graft 10 in place within the vessel wall and may also facilitate the opening of graft body section proximal end 14 during deployment.
  • Some apices 28 may also comprise a connector member connector element 30 , described more fully below with respect to the embodiment of FIG. 2.
  • a connector element 30 is distributed on every other apex 28 .
  • FIGS. 2 - 7 comprising six connector elements 30 distributed on every other apex 28 .
  • Other configurations in which, for example, connector elements are distributed on every apex, every third or fourth apex, or any other pattern are within the scope of the present invention.
  • Graft 10 further comprises a proximal stent 40 having a proximal end 42 and a distal end 44 .
  • proximal stent 40 in the FIG. 1 embodiment comprises a serpentine ring having four apices 46 , or half the number of apices 28 of connector member 24 .
  • proximal stent 40 in FIG. 1 takes on an optional tulip-shaped tapered profile in which the stent's diameter varies along its length.
  • Such a profile serves to present sufficient radial force upon radial expansion of stent 40 to reliably anchor graft 10 to the vessel or lumen wall within which it is deployed while, at its tapered distal end near graft body section 13 , refraining from interfering with the sealing function performed by proximal cuff 16 , proximal neck portion 23 , and connector member 24 .
  • This profile also accommodates any taper that may be present in the host vessel or lumen.
  • proximal stent 40 is disposed generally proximal to graft body section 13 and connector member 24 .
  • Proximal stent is typically, though not necessarily, made a part of graft 10 by being affixed or connected to connector member 24 via connector elements as described in detail below.
  • Proximal stent 40 may also be affixed or embedded directly to or in proximal neck portion 23 and/or other portions of graft body section 13 .
  • the present invention includes embodiments wherein the connector member and proximal stent are not mechanically or otherwise fastened to one another but rather unified, formed of a monolithic piece of material such as NiTi.
  • proximal stent 40 This configuration of proximal stent 40 , connector member 24 , proximal neck portion 23 , and proximal cuff 16 helps to separate the sealing function of proximal cuff 16 , which requires conformation and apposition to the vessel wall within which graft 10 is deployed without excessive radial force, from the anchoring function of proximal stent 40 (connector member 24 and proximal neck portion 23 play intermediate roles). This allows the sealing and anchoring functions each to be optimized without compromising the other.
  • proximal stent 40 , connector member 24 , and inflatable cuff 16 are longitudinally distributed along the graft body section longitudinal axis 25 , a smaller, more flexible delivery profile ranging from about 10 to about 16 French is possible; preferably below 12 French.
  • Proximal stent 40 may be manufactured from any of the materials suitable for connector member 24 . When manufactured from a shape memory alloy having superelastic properties such as NiTi, proximal stent 40 may be configured to self-expand upon release from a constrained state.
  • Proximal stent 40 further comprises proximal stent connector elements 48 that are affixed to connector member connector elements 30 via coupling members as described more fully below in relation to FIGS. 2 - 6 . Note that in the FIG. 1 embodiment, there is one proximal stent connector element 48 for every connector member connector element 30 .
  • Proximal stent 40 also comprises struts 41 and may also comprise one or more barbs 43 .
  • a barb can be any outwardly directed protuberance, typically terminating in a sharp point that is capable of at least partially penetrating a body passageway in which graft 10 is deployed (typically the intimal and medial layers of a blood vessel such as the abdominal aorta).
  • proximal stent 40 When proximal stent 40 is deployed in the abdominal aorta, for example, typically in a location proximal to the aneurysm and any diseased tissue, barbs 43 are designed to work in conjunction with the distally-oriented blood flow field in this location to penetrate tissue and prevent axial migration of graft 10 . This is why barbs 43 in the FIG. 1 embodiment are oriented distally with respect to graft body section 13 .
  • the length of barbs 43 in any of the embodiments of the present invention may range from about 1 to about 5 mm; more particularly, from about 2 to about 4 mm.
  • barbs 43 may be oriented in a distal direction and form an elevation angle ⁇ ranging from about 10 to about 45 degrees or higher with respect to a longitudinal axis 29 of strut 41 , projecting generally radially outward from graft lumen 22 away from proximal neck inlet axis 27 . Disposing barbs at angle ⁇ provides the necessary embedding force to anchor graft 10 into the vessel or lumen in which it is deployed.
  • the barb elevation may also be described when the graft 10 is deployed in vivo in a body lumen or vessel by a second angle ⁇ ′ measured relative to proximal neck inlet axis 27 .
  • This second barb elevation angle ⁇ ′ will typically range from about 5 to about 45 degrees.
  • similar orientations may be found with barbs in other embodiments of the present invention.
  • barbs 43 be oriented in a position generally parallel to the axis of the lumen in which they are deployed so that they are in a position to best resist the drag loads imposed by the flow field in vivo in certain applications.
  • one or more of barbs 43 to form an optional second barb azimuth or “kick” angle ⁇ with respect to strut longitudinal axis 29 as shown in FIG. 1B.
  • barb 43 is laterally biased in a plane that is tangent to an outside surface 37 of strut 41 and generally orthogonal to a plane in which angle ⁇ is formed.
  • strut outside surface 37 generally refers to that portion of the surface of strut 41 located opposite the proximal neck inlet axis 27 , or that portion of strut 41 that when deployed will be in direct contact with the vessel or lumen wall.
  • may range from between about 5 and about 70 degrees relative to strut axis 41 . Similar orientations may be found with barbs in other embodiments of the present invention.
  • the number of barbs, the length of each barb, each of the barb angles described above, and the barb orientation may vary from barb to barb within a single stent or between multiple stents within a single graft.
  • the various barbs (and tuck pads 45 discussed below) discussed herein may be attached to or fixed on the stent struts 41 , we have found it useful that, as shown in the various figures, they be integrally formed as part of the stent struts. In other words, they can be mere extensions of the struts in which no joint or other connection exists. Because there is no joint, we have found the strength of the barb/strut interface to be very high, as is the fatigue resistance of the barbs. With no mechanical connection to join the barbs to the struts, reliability of the barb/strut interface is higher. In addition, the lack of a heat-affected zone in which the mechanical properties of a welded or brazed joint may be deleteriously affected is another significant advantage to having the barbs and tuck pads be integral to the stent.
  • Struts 41 may also comprise optional integral tuck pads 45 disposed opposite each barb 43 . As is the case with the barbs, the number, dimensions, configuration and orientation of barb tuck pads 45 may vary significantly.
  • each barb 43 is placed behind a corresponding strut 41 (and optional tuck pad 45 , if present) so to thereby prevent that barb from contacting the inside of a delivery sheath or catheter during delivery of the device and from undesired contact with the inside of a vessel wall.
  • a release belt disposed in one or more grooves 35 disposed on struts 41 retain proximal stent 40 in this delivery configuration.
  • proximal stent 40 Upon deployment of graft 10 , and more particularly, proximal stent 40 , (typically accomplished in part by release of this and other belts), the radial expansion of stent 40 results in a displacement of struts 41 so that the distance between them increases. Eventually this displacement becomes large enough so to free the barbs from behind the adjacent strut (and optional tuck pad 45 , if present) and engage the wall of the lumen being treated.
  • an optional balloon may be used to expand stent 40 to free barbs 43 from their tuck pads 45 and to cause barbs 43 to engage tissue as desired. Even if a superelastic self-expanding proximal stent 40 is used in graft 10 , such a balloon may be used to help further implant barbs 43 into their desired position to ensure proper placement of graft 10 .
  • Graft 50 has a proximal end 51 and a distal end 52 and comprises a tubular structure or graft body section 53 with a proximal end 54 and distal end 55 .
  • graft body section 53 forms a longitudinal lumen 73 configured to confine a flow of fluid therethrough and may range in length from about 5 to about 30 cm; specifically from about 10 to about 20 cm.
  • Proximal inflatable cuff 56 and optional distal inflatable cuff 57 form a seal when inflated to help prevent transmission of pressure (hemodynamic pressure when the fluid is blood) to the lumen or vessel walls in the region between the proximal and distal cuffs.
  • the cuffs help to prevent flow of fluid such as blood around the outer surface of graft body section 53 .
  • Inflatable channel 58 comprises an inflatable longitudinal channel or spine in fluid communication with a series of approximately parallel inflatable circumferential channels or ribs. We have found this configuration to be particularly useful in providing effective kink resistance while allowing for rapid and relatively easy inflation of the cuffs and channels when using more viscous inflation materials.
  • Channel 58 is in fluid communication with proximal and distal cuffs 56 and 57 , forming a network of inflatable cuffs and channels in fluid communication with each other.
  • Fill port 59 is in fluid communication with distal cuff 57 , inflatable channel 58 , and proximal cuff 56 , adding to this network for the introduction of an inflation medium into graft body section 53 .
  • FIG. 1 embodiment not discussed herein may be present in the FIG. 2 device.
  • Graft 50 of FIG. 2 also comprises a twelve-crown or twelve-apex proximal connector member 60 , a two-stage six- and three-crown proximal stent 70 , distal neck portion 77 , distal connector member 124 , and distal stent 128 .
  • Distal connector member 124 and distal stent 128 are analogous to connector member 60 and proximal stent 70 except that the distal stent in the FIG. 2 embodiment is single-stage and its optional barbs face in the opposite, or proximal direction relative to the barbs 74 of proximal stent 70 .
  • Distal connector member 124 is affixed or attached to distal stent 128 , both of which are more fully described in relation to a bifurcated version of the present invention shown in FIGS. 8 and 9, respectively.
  • Distal connector member 124 and distal stent 128 may be manufactured from materials and according to methods that are suitable for connector member 60 and proximal stent 70 .
  • distal connector member 124 may be attached to, affixed to, formed integrally with tubular structure or graft body section 53 , or more typically, distal neck portion 77 .
  • Distal connector member 124 further comprises fill port bridge 132 .
  • FIG. 3 shows a detailed flat pattern view of the proximal connector member 60 shown in FIG. 2.
  • Proximal connector member 60 comprises a distal end 66 and a proximal end 64 having twelve crowns or apices 65 .
  • Alternate proximal apices 65 comprise proximal connector member connector elements 62 .
  • These connector elements 62 each in turn comprises a proximal end 61 , a distal end 63 , and optional ears 80 disposed near distal end 63 .
  • Ears 80 provide for increased surface area on connector elements 62 to aid in maximizing the strength of the bond between connector element and graft proximal neck portion and further comprises one or more optional apertures 82 to farther enhance such a bond as previously discussed.
  • shoulder portions 84 may have rounded corners so to minimize their potential to snag, tear, or otherwise interfere with other components of the graft or the lumen in which it is deployed. Shoulder portions 84 also have one or more optional shoulder holes 85 . These shoulder holes 85 are useful in helping to stabilize the proximal stent 70 and proximal connector member 60 device as they are coupled during assembly as discussed below in conjunction with FIG. 5A.
  • two-stage proximal stent 70 has a proximal end 76 and a distal end 77 with proximal stent connector elements 72 .
  • Proximal stent connector elements 72 have opposing shoulder portions 78 that may mirror opposing shoulder portions 84 of distal stent connector elements 62 .
  • Proximal stent 70 comprises struts 71 , any one of which may further comprise one or more barbs 74 .
  • Optional barb tuck pads 86 near each barb serve to shield barbs 74 when graft 50 is in its reduced diameter delivery configuration.
  • Struts 71 or tuck pads 86 may also contain an optional barb tuck slot 85 to help retain barbs 74 while graft 50 (and consequently proximal stent 70 ) is in its delivery configuration.
  • barbs 74 Upon deployment of graft 50 as previously described with respect to the FIG. 1 embodiment, barbs 74 are released from barb tuck slots 85 and are placed in their operational, or deployed configuration, as shown in FIGS. 2 and 6. When so deployed in a patient vessel, proximal stent 70 is expanded, forcing barbs 74 at least partially into the vessel wall to emplace graft 50 therein and to resist fluid flow forces that might otherwise dislodge graft 50 .
  • Proximal stent 70 also may comprise one or more sets of optional grooves 87 for housing device release bands as previously discussed.
  • proximal stent 70 is a two-stage component having a first, or six-crown region 90 and a second, or three-crown region 92 .
  • the first, or six-crown region 90 comprises a serpentine ring having six apices 94 (i.e., six distal and six proximal apices).
  • the second, or three-crown region 92 comprises a serpentine ring having three apices 93 , the distal apices of which connect to every other proximal apex 94 of six-crown region 90 .
  • proximal stent 70 is typically made from a single piece of material such that there are no joints or connections between each stage (such as a mechanical connection or a weld, etc.).
  • proximal stent 70 is typically made from a single piece of material such that there are no joints or connections between each stage (such as a mechanical connection or a weld, etc.).
  • other configurations in which two or more stages may be so joined or connected from separate parts or stents to form a single stent are possible; likewise, single-piece stents having more than two stages are also possible.
  • Proximal stent 70 may exhibit a greater outward radial force at three-crown region 92 than in six-crown region 90 . Such a design is particularly useful in a clinical setting in which it is desired that such outward radial force be applied within a healthier section of vessel, more remote from the site of disease. Proximal stent 70 may accordingly perform the anchoring function within a portion of vessel that can accommodate such radial force.
  • FIG. 5 is a flat pattern view of connector member 60 joined to proximal stent 70 .
  • apices 65 is denoted “n”, “n/2” then denotes the number of proximal stent 70 first or six-crown region 90 apices 94 and “n/4” as the number of proximal stent 70 second or three-crown region 92 apices 93 .
  • Other useful embodiments include those in which there are “n” connector member apices, “n” proximal stent first region apices, and “n/2” proximal stent second region apices. These ratios may vary as appropriate; these particular sets of ratios are merely illustrative.
  • connector member connector elements 62 are coupled to proximal stent connector elements 72 via coupling members 54 .
  • FIG. 5A is a side view of proximal stent connector element 72 , connector member connector element 62 , and coupling member 54 .
  • Coupling member 54 is a wire or similar element wrapped to form a coil around the overlapping connector member connector element 62 and proximal stent connector element 72 to mechanically join connector member 60 to proximal stent 70 .
  • any other suitable joining technique such as welding, brazing, soldering, mechanical means, adhesive, etc. may be used to join these components of the graft 50 .
  • coupling member 54 is most useful in that it avoids problems presented by techniques such as welding, etc., where possible heat-affected zones some distance from the joint may deleteriously affect the microstructure of the stent/connector element material, especially when that material is nickel titanium, thus having a negative impact on the joint strength, fatigue life, and ultimately the integrity of graft 50 .
  • any suitable member may be used for coupling member 54 although we have found a wire or wire-like member having a circular cross-sectional shape to be useful (although any shape may be used).
  • the wire coupling member 54 may be formed of a suitable metal such as nickel, stainless steel, nickel-titanium, etc.
  • the wire may have a diameter ranging from about 0.002 to about 0.006 inch; more specifically from about 0.003 to about 0.005 inch.
  • coupling member 54 may be wound around the matched connector elements one or more times. We have found that providing enough windings to present a single layer of wire in which the windings are immediately adjacent one another from shoulder 78 , 84 to shoulder 78 , 84 provides sufficient strength and stiffness to the joint thus created without detracting from the low delivery profile afforded by the novel design of graft 50 . Thus the number of optimal windings from graft to graft will vary but typically ranges from about 6 to about 18 windings in most applications. With coupling members 54 in place, connector member connector elements 62 and proximal stent connector elements 72 are securely coupled to one another. The features and advantages of coupling member 54 discussed herein may be utilized by any of the embodiments of the present invention herein discussed.
  • FIG. 6 is a perspective view of connector member 60 joined to proximal stent 70 in this way in their expanded, or deployed configuration. Graft body section 53 and other graft components are removed for clarity of illustration. Barbs 74 are shown in their deployed state, released from optional barb tuck pads 86 .
  • FIG. 7 illustrates another embodiment of the invention in the form of a bifurcated endovascular graft 100 .
  • a bifurcated device such as endovascular graft 100 may be utilized to repair a diseased lumen at or near a bifurcation within the vessel, such as, for example, in the case of an abdominal aortic aneurysm in which the aneurysm to be treated may extend into the anatomical bifurcation or even into one or both of the iliac arteries distal to the bifurcation.
  • the various features of the graft embodiments previously discussed may be used as necessary in the bifurcated graft 100 embodiment unless specifically mentioned otherwise.
  • Graft 100 comprises a first bifurcated portion 114 , a second bifurcated portion 115 and main body portion 116 .
  • the size and angular orientation of the bifurcated portions 114 and 115 may vary even between portion 114 and 115 —to accommodate graft delivery system requirements and various clinical demands. For instance, each bifurcated portion or leg is shown in FIG. 7 to have a different length, but this is not necessary.
  • First and second bifurcated portions 114 and 115 are generally configured to have an outer inflated diameter that is compatible with the inner diameter of a patient's iliac arteries.
  • First and second bifurcated portions 114 and 115 may also be formed in a curved shape to better accommodate curved and even tortuous anatomies in some applications.
  • main body portion 116 and first and second bifurcated portions 114 , 115 form a continuous bifurcated lumen, similar to lumens 22 and 73 , which is configured to confine a flow of fluid therethrough.
  • graft 100 does not have to have a second bifurcated portion 115 , in which case the bifurcated lumen is formed between main body portion 116 and first bifurcated portion 114 .
  • First and second bifurcated portions 114 and 115 each comprises a network of inflatable cuffs and channels as discussed with respect to the FIG. 2 embodiment, including inflatable channel 113 .
  • Channel 113 comprises one or more optional inflatable longitudinal channels 110 in fluid communication with one or more approximately parallel inflatable circumferential channels 144 , all of which are in fluid communication with optional distal inflatable cuffs 117 and 119 .
  • the number of inflatable circumferential channels 144 may vary with the specific configuration of the graft as adapted to a given indication. Generally, however, the number of inflatable circumferential channels 144 per bifurcated portion may range from 1 to about 30, preferably about 10 to about 20. Similarly, the dimensions, spacing, angular orientation, etc. of circumferential inflatable channels 144 may vary as well.
  • each circumferential inflatable channel 144 may vary along the length of the graft or may be constant.
  • the pitch or inter-ring distance may range from about 2 to about 20 mm; specifically, it may range from about 3 to about 10 mm.
  • Circumferential inflatable channels 144 are each typically between about 2 and about 4 mm wide, but may be from about 1 to about 8 mm wide.
  • Each longitudinal channel 110 is typically from about 2 to about 4 mm wide, but may vary, together or independently, to be from about 1 to about 8 mm wide.
  • channel 113 forms a continuous cuff and channel network extending from first bifurcated portion 114 to main body portion 116 to second bifurcated portion 115 .
  • inflatable channel 113 fluidly connects into a network with proximal inflatable cuff 111 , secondary proximal cuff 112 , circumferential inflatable channels 144 , optional distal inflatable cuff 117 and optional distal inflatable cuff 119 .
  • longitudinal channels 110 extend proximally along main body portion 116 to be in fluid communication with cuffs 111 and 112 .
  • inflatable channel and cuff configurations are possible.
  • the inflatable channel for instance may be disposed longitudinally, horizontally, in a helical fashion, or otherwise.
  • One or more additional cuffs may be disposed on either or both bifurcated portions 114 and 115 as well as main body portion 116 .
  • graft 100 may have compartmentalized channels and cuffs requiring multiple sites from which they are inflated and may use multiple inflation materials to optimize properties in each region.
  • Second bifurcated portion 115 may be of a similar construction to first bifurcated portion 114 .
  • second bifurcated portion 115 is of a unitary, continuous construction with first bifurcated portion 114 and main body portion 116 .
  • first and second bifurcated portion 114 and 115 respectively may be singly or jointly formed separately from a main body portion and may be joined to the main body portion before deployment in the body passageway or in vivo after such deployment.
  • First and second bifurcated portions 114 and 115 may be generally cylindrical in shape when deployed, and will generally conform to the shape of a vessel interior within which they are deployed. Their length as measured from main body portion 116 may range from about 1 to about 10 cm or more.
  • the nominal inflated outside diameter of the distal ends of the first and second bifurcated portions 114 and 115 at cuffs 117 and 119 may range from about 2 to about 30 mm, preferably from about 5 to about 20 mm.
  • Main body portion 116 comprises a proximal inflatable cuff 111 and an optional secondary proximal inflatable cuff 112 in fluid communication with one or more inflatable longitudinal channels 110 .
  • proximal cuff 111 serves primarily to seal graft 100 firmly against a lumen wall.
  • Secondary proximal inflatable cuff 112 has been found to confer additional kink resistance on graft 100 , particularly in those clinical applications in which the vessel in which the graft is deployed is highly angled or tortuous.
  • the nominal inflated outside diameter of secondary proximal inflatable cuff 112 may range from about 10 to about 45 mm, preferably from about 15 to about 30 mm, while the nominal inflated outside diameter of proximal cuff 111 may range from about 10 to about 45 mm, preferably from about 16 to about 32 mm.
  • Main body portion 116 may range in length from about 2 to about 10 cm; preferably from about 4 to about 8 cm.
  • Endovascular graft 100 further comprises a proximal connector member 118 , proximal stent 120 , and proximal neck portion 146 all of which may be similar to those components discussed above in reference to FIGS. 2 - 6 .
  • Coupling members (not shown) may join proximal stent 120 and proximal connector member 118 as discussed with respect to the embodiments of FIGS. 1 - 6 .
  • Proximal connector members and proximal stents as discussed in conjunction with the FIG. 1 embodiment are also possible for use in bifurcated graft 100 .
  • the direction of the bias or angulation can be important with regard to achieving a proper fit between the graft and the morphology of the deployment site.
  • the angular bias of the proximal end of the graft, proximal neck portion or proximal anchor can be in any direction.
  • the angular bias is in a direction and of a magnitude consistent with the mean angulation of the type of lesion (e.g. abdominal aortic aneurysm) intended for treatment with the graft.
  • proximal stent 120 comprises barbs 121 which are oriented in a distal direction for reliable anchoring against the direction of pulsatile forces in vivo when the device is implanted in the abdominal aorta, for instance, to treat an abdominal aortic aneurysm.
  • One or both bifurcated portions 114 and/or 115 may further comprise a distal connector member 124 and/or 150 , a distal stent 128 , and a distal neck portion 154 .
  • the embodiment of FIG. 7 has distal connector member 124 and distal stent 128 disposed at the distal ends of each of first and second bifurcated portions 114 and 115 , respectively.
  • Distal connector member 124 and distal stent 128 are shown in greater detail in FIGS. 8 and 9.
  • distal connector member 124 disposed at or near first bifurcated portion 114 comprises distal connector member connector elements 130 and an optional fill-port bridge 132 .
  • Fill-port bridge 132 serves to prevent interference by distal connector member 124 with the manufacture of graft 100 and with the injection of an inflation medium, while preserving the continuous ring structure of distal connector member 124 .
  • Inflatable channels 113 are in communication with a fill port 160 through distal inflatable cuff 117 .
  • Fill port 160 may be disposed alternatively on second bifurcated portion 115 or graft main body portion 116 , and more than one fill port may be used.
  • Fill port 160 is configured to accept a pressurized source of fluid (gas and/or liquid), particles, gel or combination thereof as previously discussed.
  • FIG. 9 details a flat pattern of distal stent 128 , which includes distal stent connector elements 134 .
  • Distal connector member connector elements 130 are configured to be coupled with distal stent connector elements 134 via coupling members (not shown) similar to those discussed with respect to the FIGS. 1 - 6 embodiments.
  • Distal stent 128 comprises one or more optional distal stent barbs 136 , one or more optional distal stent barb tuck pads 138 and one or more optional distal stent barb tuck slots 140 , each of which functions in a similar fashion to the corresponding features of embodiments discussed above.
  • Distal stent barbs 136 are oriented proximally, opposite the direction of orientation of barbs 121 , to accommodate the environment often found in the iliac arteries that can cause the bifurcated portions 114 and 115 to migrate proximally in vivo. Note that only two distal stent barbs 136 are shown in FIG. 9 for the purposes of clarity of illustration despite a larger number being depicted in the FIG. 7 embodiment of the present invention. It is understood that all embodiments of the present invention includes proximal and distal stents each of which may optionally comprise one, two, or any number of barbs.
  • the optional distal connector member 150 disposed in the FIG. 7 embodiment at or near distal end 152 of second bifurcated portion 115 , has a structure similar to that of first bifurcated portion 114 , with the exception of the absence of fill-port bridge 132 .
  • Other embodiments of the invention include bifurcated grafts in which the distal connector member 150 includes a fill-port bridge.
  • FIGS. 10 - 13 illustrate additional features of the present invention that may be used in any of the various stents and connector rings of the present invention, in any combination.
  • FIG. 10 a simplified detail of a proximal apex 93 of the second or three-crown region 92 of proximal stent 70 is shown.
  • An outer surface 170 of apex 93 takes on a circular radius of curvature as defined by circle 172 having a radius r 1 .
  • An inner surface 174 of the stent strut apex 93 takes on an elliptical shape as shown by ellipse 176 .
  • circle 172 and ellipse 176 offset as shown by reference numeral 177 ; however, they may share a common center.
  • NiTi stents used in the present invention provide for a more diffuse strain distribution in the stent and reduces the peak strains experienced during assembly and in vivo, while also allowing for a smaller delivery profile as compared to other configurations, particularly in the proximal apex 93 of the second or three-crown region 92 of proximal stent 70 .
  • the stent apex configuration of FIG. 10 may be used in any other stent or connector member apex described herein, and may be used for components comprising material other than NiTi.
  • radius r 1 of between about 0.030 and about 0.070 inch; specifically about 0.050 inch is useful, while an offset 171 of between about zero and about 0.050 inch; specifically about 0.0025 inch, is effective.
  • FIG. 11 details an alternative offset circular apex configuration.
  • a simplified detail of proximal apex 94 in the first or six-crown region 90 of proximal stent 70 is shown (without a transition region to the second or three-crown stent region as seen in, e.g., FIG. 4 for clarity of illustration).
  • An outer surface 180 of apex 94 takes on a circular radius of curvature as defined by circle 182 having a radius r 2 .
  • An inner surface 184 of apex 94 takes on a circular radius of curvature defined by circle 186 having a radius r 3
  • Radius r 2 may be equal to or greater than radius r 3 and be within the scope of the present invention.
  • the centers of circles 182 and 186 are offset from each other as indicated by reference numeral 188 in FIG. 11. This offset 188 may be equal to, greater than, or less than the width of the strut 71 in the region of apex 94
  • offset values ranging from about zero to about 0.030 inch; particular about 0.020 inch, to be effective in NiTi stents having expanded, or deployed diameters ranging from about 16 to about 26 mm.
  • radius r 2 ranges from about 0.020 to about 0.040 inch; more particularly about 0.035 inch, and in which radius r 3 ranges from about 0.005 to about 0.020 inch; in particular about 0.010 inch.
  • Optional taper or tapers may be incorporated into the struts 41 and 71 of the various stent embodiments of the present invention as well as the various proximal and distal connector members.
  • incorporating one or more tapers into the struts on both proximal and distal stents provide greater space in the tapered region to accommodate alternative features such as barbs and tuck pads. It allows for a smaller deployment profile when the component is in a radially collapsed delivery configuration.
  • the stents experience a large degree of bending strain that is often poorly or locally distributed. Tapering certain stent struts in particular locations helps to distribute this strain more evenly throughout the stent or connector member and to manage the peak strains.
  • FIGS. 12 and 13 are now introduced and discussed below.
  • FIG. 12 a simplified section of the second or three-crown region 92 of proximal stent 70 is depicted in which the stent struts 71 taper from a maximum width 190 (which may or may not equal a width of strut 71 in region of apex 93 ) to a minimum width 192 .
  • the optional taper expressed as the ratio of the maximum width 190 to the minimum width 192 , may vary widely depending on the particular region of the stent or connector member, the material used, and other factors. Taper ratios ranging from 1 to about 10 or greater are within the scope of the present invention. It is also within the scope of the present invention for the stent struts 71 to exhibit no taper.
  • a maximum strut width 190 ranging from about 0.016 to about 0.032 inch; particularly from about 0.022 and about 0.028 inch, and a minimum strut width 192 of between about 0.010 and about 0.026 inch; particularly from about 0.012 and about 0.022 inch.
  • the optional tapered strut feature described herein and shown in FIG. 12 may be used in any other stent or connector member described herein, and may be used for components comprising material other than NiTi.
  • distal stent 128 comprises a distal apex or crown 196 exhibiting a width 198 and a proximal apex or crown (with connector element 134 removed for clarity of illustration) 200 exhibiting a smaller width 202 . It is within the scope of the present invention for width 198 and width 202 to be equal.
  • an asymmetric crown in which the distal apex 200 has a smaller strut width than that of the proximal apex 196 results in a difference in the expansion force exerted between each of the proximal and distal apices.
  • the proximal apices of such a stent having this configuration will tend to exert a smaller expansion force near the graft seal zone, reducing the potential for such a stent to cause trauma to tissue in the seal zone near the cuffs (where weaker, more diseased tissue tends to reside).
  • Such a configuration also facilitates a consistent, safe and predictable deployment when the component moves from a reduced diameter delivery profile to an expanded treatment profile.
  • a taper reduces the flare exhibited by the distal apex 200 ; this in turn provides for a smaller distal stent delivery profile when the distal stent is in a reduced-diameter configuration.
  • Taper ratios (defined in the same manner above as the ratio between width 198 and width 202 ) ranging from 1 to about 10 or higher are within the scope of the present invention.
  • a width 202 ranging from about 0.010 to about 0.026 inch; specifically from about 0.012 and about 0.024 inch to be useful, and we have found a width 198 ranging from about 0.016 to about 0.032 inch; specifically from about 0.017 to about 0.028 inch to be useful.
  • Useful inflation media generally include those formed by the mixing of multiple components and that have a cure time ranging from a few minutes to tens of minutes, preferably from about three and about twenty minutes.
  • a material should be biocompatible, exhibit long-term stability (preferably on the order of at least ten years in vivo), pose as little an embolic risk as possible, and exhibit adequate mechanical properties, both pre- and post-cure, suitable for service in the graft of the present invention in vivo.
  • such a material should have a relatively low viscosity before solidification or curing to facilitate the graft cuff and channel fill process.
  • a desirable post-cure elastic modulus of such an inflation medium is from about 50 to about 400 psi—balancing the need for the filled graft to form an adequate seal in vivo while maintaining clinically relevant kink resistance of the graft.
  • the inflation media ideally should be radiopaque, both acute and chronic, although this is not absolutely necessary.
  • compositions suitable for use as an inflation medium in the present invention are described in greater detail in U.S. patent application Ser. No. 09/496,231 to Hubbell et al., filed Feb. 1, 2000 and entitled “Biomaterials Formed by Nucleophilic Addition Reaction to Conjugated Unsaturated Groups” and U.S. patent application Ser. No. 09/586,937 to Hubbell et al., filed Jun. 2, 2000 and entitled “Conjugate Addition Reactions for the Controlled Delivery of Pharmaceutically Active Compounds”. The entirety of each of these patent applications is hereby incorporated herein by reference.
  • This medium comprises:
  • PEGDA polyethylene glycol diacrylate
  • glycylglycine buffer present in a proportion ranging from about 22 to about 27 weight percent; specifically in a proportion of about 24 weight percent.
  • Radiopaque materials as previously discussed may be added to this 3-component system. We have found that adding radiopacifiers such as barium sulfate, tantalum powder, and soluble materials such as iodine compounds to the glycylglycine buffer is useful.
  • triethanolamine in phosphate-buffered saline may be used as an alternative to glycylglycine buffer as the third component described above to form an alternative curable gel suitable for use in embodiments of the present invention.
  • An alternative to these three-component systems is a gel made via polymer precipitation from biocompatible solvents.
  • suitable polymers include ethylene vinyl alcohol and cellulose acetate.
  • suitable biocompatible solvents include dimethylsulfoxide (DMSO), n-methyl pyrrolidone (NMP) and others.
  • DMSO dimethylsulfoxide
  • NMP n-methyl pyrrolidone
  • Such polymers and solvents may be used in various combinations as appropriate.
  • various siloxanes may be used as inflation gels.
  • examples include hydrophilic siloxanes and polyvinyl siloxanes (such as STAR-VPS from Danville Materials of San Ramon, Calif. and various silicone products such as those manufactured by NuSil, Inc. of Santa Barbara, Calif.).
  • gel systems useful as an inflation medium or material for the present invention include phase change systems that gel upon heating or cooling from their initial liquid or thixotropic state.
  • materials such as n-isopropyl-polyacrylimide (NIPAM), BASF F-127 pluronic polyoxyamer, and polyethylene glycol (PEG) chemistries having molecular weights ranging between about 500 and about 1,200 are suitable.
  • Effective gels may also comprise thixotropic materials that undergo sufficient shear-thinning so that they may be readily injected through a conduit such as a delivery catheter but yet still are able to become substantially gel-like at zero or low shear rates when present in the various channels and cuffs of the present invention.
  • Cure times may be tailored by adjusting the formulations, mixing protocol, and other variables according to the requirements of the clinical setting. Details of suitable delivery protocols for these materials are discussed in copending U.S. patent application Ser. No. 09/917,371 to Chobotov et al.
  • these gels may exhibit moduli of elasticity ranging from tens of psi to several hundred psi; the formulation described above exhibits moduli ranging from about 175 to about 250 psi with an elongation to failure ranging from about 30 to about 50 percent.
  • adding a fluid such as saline to the PEGDA-QT-glycylglycine formulation lowers the viscosity of the formulation and results in greater ease when injecting the formulation into the graft body section network of inflatable cuffs and channels without sacrificing the desired physical, chemical, and mechanical properties of the formulation or its clinical efficacy.
  • adding materials such as saline may also reduce the potential for the inflation material such as PEGDA-QT-glycylglycine to pose an embolic risk in case of spillage or leakage.
  • Saline concentrations as a volume percentage of the final saline/three-component formulation combination may range from zero to as high as sixty percent or more; particularly suitable are saline concentrations ranging from about twenty to about forty percent. We have found a saline volume concentration of about thirty percent to be most suitable.
  • Alternatives to saline may include biocompatible liquids, including buffers such as glycylglycine.
  • an inflation medium in which each of its components is biocompatible and soluble in blood.
  • a biocompatible inflation medium is desirable so to manage any toxicity risk in the case the inflation medium were inadvertently released into the patient's vasculature.
  • a soluble inflation medium is desirable so to manage any embolism risk if released into the vasculature.
  • Such an inflation medium should not disperse nor gel or solidify if spilled into flowing blood before curing. In the event of a spill, the normal blood flow would then rapidly disperse the components and their concentration would fall below the level required for crosslinking and formation of a solid. These components would then be eliminated by the body through standard pathways without posing an embolic risk to the patient.
  • an inflation medium example in which all of the components are soluble in blood is the combination polyethylene glycol diacrylate, a thiolated polyethyleneamine, and a buffer.
  • more than one type of inflation medium, or more than one variant of a single type of inflation medium may be used in a single graft to optimize the graft properties in the region in which it is disposed.
  • the inflation material serves as a conformable sealing medium to provide a seal against the lumen wall.
  • Desirable mechanical characteristics for the inflation medium in the proximal and distal cuffs would therefore include a low shear strength so to enable the cuff to deform around any luminal irregularities (such as calcified plaque asperities) and to conform to the luminal profile, as well as a high volumetric compressibility to allow the fill material to expand the cuffs as needed to accommodate any late lumen dilatation and maintain a seal.
  • the inflation medium serves primarily to provide structural support to the lumen within which the graft is placed and kink resistance to the graft.
  • Desirable mechanical characteristics for the inflation medium in the channel or channels therefore includes a high shear strength, to prevent inelastic deformation of a channel or channel segment due to external compression forces from the vessel or lumen (due, for example, to neointimal hyperproliferation) and low volumetric compressibility to provide stable support for adjacent channels or channel segments that may be in compressive contact with each other, thereby providing kink resistance to the graft.
  • the inflation medium be visible through the use of techniques such as fluoroscopy during the time of deployment in which the graft cuffs and channels are being filled with the inflation medium. Such visibility allows the clinician to verify that the cuffs and channels are filling correctly and to adjust the filling procedure if they are not. It also provides an opportunity to detect any leakage or otherwise undesirable flow of inflation material out of the graft so that injection may be stopped, thereby minimizing the amount of leaked inflation material.
  • the graft After the graft has been deployed into a patient, it is desirable that the graft be visible through the use of follow-up imaging techniques such as computed tomography (CT) and the like.
  • CT computed tomography
  • the inflation material at this point in time is ideally not so radiopaque that it produces a dense CT image as such an image could potentially mask clinically significant endoleaks that would be visualized by opacifying the blood with a contrast agent.
  • One solution is to use an inflation medium that becomes less radiopaque over time, such as for example by using a blend of radiopaque materials in which one or more will diffuse out of the inflation medium over time, thereby reducing the inflation medium's radiopacity.
  • a blend of a soluble contrast agent such as an iodinated aqueous solution and an insoluble contrast agent such as barium sulfate may serve this purpose.
  • the soluble contrast agent will diffuse through the graft body section pores some time after the graft has been implanted, resulting in a progressive decrease in radiopacity of the inflation material over time.
  • a fill material radiopacifier prepared from a combination of about two percent barium sulfate (by weight) and about 20 percent iodinated contrast solution (by weight) is useful in this capacity.

Abstract

This invention is a system for the treatment of body passageways; in particular, vessels with vascular disease. The system includes an endovascular graft with a low-profile delivery configuration and a deployed configuration in which it conforms to the morphology of the vessel or body passageway to be treated as well as various connector members and stents. The graft is made from an inflatable graft body section and may be bifurcated. One or more inflatable cuffs may be disposed at either end of the graft body section. At least one inflatable channel is disposed between and in fluid communication with the inflatable cuffs.

Description

    RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 10/029,559, filed Dec. 20, 2001, entitled “Advanced Endovascular Graft” by Chobotov et al. In addition, this application is related to U.S. patent application Ser. No. 10/029,570, filed Dec. 20, 2001, entitled “Method and Apparatus for Shape Forming Endovascular Graft Material” by Chobotov et al., U.S. patent application Ser. No. 10/029,584, filed Dec. 20, 2001, entitled “Endovascular Graft Joint and Method for Manufacture” by Chobotov et al., U.S. patent application Ser. No. 10/029,557, filed Dec. 20, 2001, entitled “Method and Apparatus for Manufacturing an Endovascular Graft Section”, by Chobotov et al. All of the above applications are commonly owned and were filed on even date herewith. All of the above applications are hereby incorporated herein by reference, each in its entirety.[0001]
  • BACKGROUND
  • The present invention relates to a system for the treatment of disorders of the vasculature. More specifically, the invention relates to a system for the treatment of disease or injury that potentially compromises the integrity of a flow conduit in the body. For example, an embodiment of the invention is useful in treating indications in the digestive and reproductive systems as well as indications in the cardiovascular system, including thoracic and abdominal aortic aneurysms, arterial dissections (such as those caused by traumatic injury), etc. Such cardiovascular indications often require intervention due to the severity of the sequelae, which frequently is death. [0002]
  • For indications such as abdominal aortic aneurysms, traditional open surgery is still the conventional and most widely-utilized treatment when the aneurysm's size has grown to the point that the risk of aneurysm rupture outweighs the drawbacks of surgery. Surgical repair involves replacement of the section of the vessel where the aneurysm has formed with a graft. An example of a surgical procedure is described by Cooley in Surgical Treatment of Aortic Aneurysms, 1986 (W. B. Saunders Company). [0003]
  • Despite its advantages, however, open surgery is fraught with high morbidity and mortality rates, primarily because of the invasive and complex nature of the procedure. Complications associated with surgery include, for example, the possibility of aneurysm rupture, loss of function related to extended periods of restricted blood flow to the extremities, blood loss, myocardial infarction, congestive heart failure, arrhythmia, and complications associated with the use of general anesthesia and mechanical ventilation systems. In addition, the typical patient in need of aneurysm repair is older and in poor health, facts that significantly increase the likelihood of complications. [0004]
  • Due to the risks and complexities of surgical intervention, various attempts have been made to develop alternative methods for treating such disorders. One such method that has enjoyed some degree of success is the catheter-based delivery of a bifurcated stent-graft via the femoral arteries to exclude the aneurysm from within the aorta. [0005]
  • Endovascular repair of aortic aneurysms represents a promising and attractive alternative to conventional surgical repair techniques. The risk of medical complications is significantly reduced due to the less-invasive nature of the procedure. Recovery times are significantly reduced as well, which concomitantly diminishes the length and expense of hospital stays. For example, open surgery requires an average six-day hospital stay and one or more days in the intensive care unit. In contrast, endovascular repair typically requires a two-to-three day hospital stay. Once out of the hospital, patients benefiting from endovascular repair may fully recover in two weeks while surgical patients require six to eight weeks. [0006]
  • Despite these and other significant advantages, however, endovascular-based systems have a number of shortcomings. Present bifurcated stent-grafts require relatively large delivery catheters, often up to 24 French and greater in diameter. These catheters also tend to have a high bending stiffness. Such limitations result in the need for a surgical cut-down to deliver the stent-graft and make delivery through the often narrow and irregular arteries of diseased vessels difficult and risky. Because of this, endovascular treatment of aortic aneurysmal disease is not available to many patients who could otherwise benefit from it. For instance, women statistically tend to have smaller vessels and therefore some are excluded from many current endovascular therapies simply due to this reason. There is therefore a need for an endovascular stent-graft capable of being delivered via a smaller and more flexible delivery catheter. Even greater advantages may be realized if such an endovascular stent-graft is capable of being delivered percutaneously. [0007]
  • Further, an endovascular stent-graft must withstand tremendous pulsatile forces over a substantial period of time while remaining both seated and sealed within the vessel. In order to achieve these objectives, the device, which may comprise component parts and/or materials, must remain intact. The device must resist axial migration from the site of deployment while being subjected to significant pulsatile forces, and it should have sufficient radial compliance to conform to the vessel anatomy within which it is deployed so as to prevent blood leakage between the device and the vessel wall at both its proximal, or cephalic, end as well as at its distal, or caudal end or ends (where the net force may be retrograde). Such a device should conform to the morphology of the treated vessel, without kinking or twisting, over the life of the patient. [0008]
  • SUMMARY
  • The present invention generally is directed to a system for the endovascular treatment of body passageways that includes a medical device implantable within a body lumen such as a blood vessel. Some embodiments of this invention include an endovascular graft for treating vascular disease. [0009]
  • One embodiment includes a graft with a graft body section having a proximal end and a distal end, and, disposed or affixed on at least one end, a connector member having one or more connector member connector elements. The connector member may be embedded within multiple layers of the graft body section. A stent may be coupled or affixed to the one or more connector member connector elements via one or more stent connector elements. The graft may include a proximal stent and connector member only, a distal stent and connector member only, or both proximal and distal stents and their respective connector members. [0010]
  • Both the connector member connector elements and the stent connector elements may have a proximal end and a distal end that comprise opposing shoulder portions. The graft may further have one or more coupling members, such as a wire coil, configured to couple or connect the one or more connector member connector elements to the one or more stent connector elements. [0011]
  • Both the connector members and the stents may be formed of a serpentine ring having one or more apices. One embodiment includes a graft having single stage distal and/or proximal stents in which the associated connector member may have twice as many apices as the stent. In another embodiment, the graft has two-stage distal and/or proximal stents with twice as many apices in a first region as in a second region while the associated connector member has the twice the number of apices as in the first region of the stent. For example, a useful embodiment is one in which a twelve-apex connector member is connected to a first six-apex or six-crown region of a proximal or distal stent and that stent has a second three-apex or three-crown region integral with or joined to the six-crown region. [0012]
  • In alternative embodiments, grafts that include various combinations of single and multiple-stage proximal and distal stents with their associated connector members are possible. [0013]
  • The stents may also include one or more barbs. Typically, the barbs on a proximal stent are oriented distally to engage the stent into the tissue wall in the proximal-to-distal flow field in which the graft is typically disposed. Likewise, in applications in which the graft is deployed to treat an abdominal or thoracic aortic aneurysm, the barbs on one or more distal stents are typically oriented proximally to engage the stent into the tissue wall to oppose the typically retrograde migration forces. The barbs may range in length from about 1 to about 5 mm. They will typically project radially outward from a longitudinal axis of their respective stent and form a barb radial angle from about 10 to about 45 degrees with respect to the graft proximal neck portion inlet axis when the stent is deployed in vivo. The barbs may also be laterally biased in a plane that is orthogonal to a plane in which the barb radial angle is formed to form a barb kick angle. [0014]
  • The stent or stents (proximal and/or distal) comprise struts having one or more optional barb tuck pads integral to the struts such that when the proximal stent is in a reduced profile delivery configuration, each barb is retained by the stent strut. When the endovascular graft is in a deployed configuration, the one or more barbs are released. [0015]
  • The stent or stents may also comprise optional barb tuck slots configured to receive the barbs such that each barb is retained by a slot when the stent is in a delivery configuration. In a deployed configuration, the barbs are released from their corresponding barb tuck slots. [0016]
  • In addition, the stent may comprise grooves. In a typical delivery system, some type of belts or sutures may be used to help retain the endovascular graft in its compressed delivery configuration. The grooves may accommodate these belts or sutures without increasing the small diameter delivery of the device. [0017]
  • The graft body section may also have one or more inflatable cuffs disposed on or near the graft body section proximal end, distal end, or both. The inflatable cuffs provide a sufficiently stiff structure when inflated which help to support the graft body section and provide a conformable surface to seal the graft against the interior surface of the vessel in which it is deployed. [0018]
  • The graft body section may also include one or more inflatable channels. The channel or channels typically may be disposed between and in fluid communication with either or both proximal and distal inflatable cuffs. The channel or channels enhance the graft body section stiffness upon their inflation, help to prevent kinking of the graft body section, and may also facilitate deployment of the graft within a patient's body passageway. The inflatable channel or channels can be in a longitudinal and/or linear configuration with respect to the graft body section, but alternatively may take on a helical or circumferential configuration. Other orientations such as interconnecting grids or rings may also be suitable alone or in combination with any of the other configurations. [0019]
  • During deployment of the graft, the inflatable cuff or cuffs and channel or channels may be inflated or injected with a material that may comprise one or more of a solid, fluid (gas and/or liquid), gel or other medium. According to the invention, a useful inflation medium includes the combination polyethylene glycol diacrylate, pentaerthyritol tetra 3(mercaptopropionate) and a buffer such as glycylglycine or triethanolamine in phosphate-buffered saline. Saline or another inert biocompatible liquid may be added to this three-component inflation medium in amounts up to about sixty percent of the total inflation medium volume. Radiopaque materials such as tantalum, iodinated contrast agents, barium sulfate, etc. may be added to this three-component medium, typically in the buffer, so to render the inflation medium visible under fluoroscopy. [0020]
  • In another embodiment of the invention, the graft may comprise a main body portion and a first bifurcated portion forming a continuous lumen that is configured to confine a flow of fluid therethrough. The graft may also include a second bifurcated portion in fluid communication with the main body portion. At least one inflatable cuff may be disposed at either or both a proximal end of the main body portion and a distal end of the first bifurcated portion. One or more inflatable channels may be disposed between the inflatable cuffs as previously described, and may extend over some or all of the main body portion. The cuffs and channels may be filled with an inflation medium, optionally diluted with an inert biocompatible material such as saline or other liquid, as described above. [0021]
  • In yet another embodiment of the invention, the graft may comprise a main body portion in fluid communication with a first and a second bifurcated portion forming a continuous bifurcated lumen, said lumen configured to confine a flow of fluid therethrough. At least one inflatable cuff may be disposed at or near either or both a proximal end of the main body portion and a distal end of the first and second bifurcated portions. One or more inflatable channels may be disposed between the inflatable cuffs as previously described, and may extend over some or all of the main body portion. [0022]
  • The proximal ends of the graft main body portion may have connector members comprising one or more connector elements, and a proximal stent coupled to the one or more connector elements. One or both of the first and/or second bifurcated portions may likewise have first and/or second distal connector members comprising one or more connector elements disposed on their respective distal ends, and a distal stent coupled to the first and/or second distal connector members. [0023]
  • The present invention is also a system for implanting a tubular medical device within a body lumen having a wall, including a stent for affixing the medical device to the body lumen wall and a connector member for coupling the stent to the medical device, wherein the stent and the connector member are coupled to one another by at least one set of connector elements. [0024]
  • One or more barbs may also be included in this system. In addition, one or more barb tuck pads may be included in which the one or more barbs are configured to be retained by the one or more barb tuck pads when the system is in a delivery configuration and released by the one or more barb tuck pads when the system moves to a deployed configuration. The stent may further include optional slots configured to receive the barbs when the system is in a delivery configuration and wherein the barbs are configured to be released from the slots when the system is in a deployed configuration. [0025]
  • The invention also includes an endovascular graft comprising a graft body section with a proximal end and a distal end and a proximal connector member affixed to the proximal end of the graft body section. The proximal connector member may have one or more connector elements. [0026]
  • The graft may also have a proximal stent comprising one or more distally oriented barbs and one or more proximal stent connector elements coupled to the one or more proximal connector member connector elements and a distal connector member affixed to the distal end of the graft body section. The distal connector member may include one or more connector elements. [0027]
  • The graft of this embodiment further includes a distal stent comprising one or more proximally oriented barbs and comprising one or more distal stent connector elements coupled to the one or more distal connector member connector elements, one or more inflatable cuffs disposed at or near each of the proximal and distal ends of the graft body section, and wherein the graft body section comprises an inflatable channel in fluid communication with the proximal and distal cuffs. [0028]
  • In addition, the proximal and distal connector member connector elements may each have opposing shoulder portions on their proximal and distal ends, as may the proximal and distal stent connector elements. One or more coupling members may couple the proximal connector member connector elements to the proximal stent connector elements and likewise couple the one or more distal connector member connector elements to the one or more distal stent connector elements. [0029]
  • At least one of the inflatable channel, the distal inflatable cuff, and the proximal inflatable cuff may contain an inflation medium comprising the combination polyethylene glycol diacrylate, pentaerthyritol tetra 3(mercaptopropionate), and a buffer. [0030]
  • The proximal stent barbs or distal stent barbs of this embodiment may have a length from about 1 to about 5 mm, and the graft body section may comprise ePTFE. [0031]
  • In yet still a further bifurcated embodiment of the present invention, the device includes a main body portion with a distal end and a proximal end with a connector member disposed on the proximal end. The connector member may include one or more connector elements. [0032]
  • The proximal stent of this embodiment may comprise one or more distally oriented barbs and one or more proximal stent connector elements that are coupled to the connector member connector elements. [0033]
  • This embodiment further includes a first bifurcated portion and a second bifurcated portion forming a continuous lumen with the main body portion. This lumen is configured to confine a flow of fluid therethrough. [0034]
  • A distal connector member may be disposed on distal ends of each of the first and second bifurcated portions. Each of these distal connector members includes one or more connector elements. In addition, this embodiment has one or more distal stents with at least one proximally oriented barb and comprising one or more distal stent connector elements. The distal stent connector elements are coupled to the distal connector member connector elements on one or both of the first and second bifurcated portions. [0035]
  • This embodiment also includes at least one inflatable channel extending from one or both of the first and second bifurcated portions to the main body portion, at least one inflatable cuff disposed at or near a proximal end of the main body portion in fluid communication with the at least one channel, and an inflatable cuff disposed at or near a distal end of each of the first and second bifurcated portions. [0036]
  • The proximal and distal connector member connector elements may each have opposing shoulder portions on their proximal and distal ends, as may the proximal and distal stent connector elements. One or more coupling members may couple the proximal connector member connector elements to the proximal stent connector elements and likewise couple the one or more distal connector member connector elements to the one or more distal stent connector elements. [0037]
  • At least one of the inflatable channel, the first bifurcated portion distal inflatable cuff, the second bifurcated portion distal inflatable cuff, and the proximal inflatable cuff may contain an inflation medium comprising the combination polyethylene glycol diacrylate, pentaerthyritol tetra 3(mercaptopropionate), and a buffer. [0038]
  • The proximal and/or distal stent barbs may have a length from about 1 to about 5 mm. The graft main body portion as well as the first and second bifurcated portions may comprise ePTFE. [0039]
  • These and other advantages of the invention will become more apparent from the following detailed description of the invention when taken in conjunction with the accompanying exemplary drawings.[0040]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows an endovascular graft according to an embodiment of the present invention. [0041]
  • FIGS. [0042] 1A-1B detail two angles at which a stent barb may be oriented on the graft of an embodiment of the present invention.
  • FIG. 2 shows a second endovascular graft according to an embodiment of the present invention. [0043]
  • FIG. 3 shows a flat pattern of a component of the endovascular graft of FIG. 2. [0044]
  • FIG. 4 shows a flat pattern of another component of the endovascular graft of FIG. 2. [0045]
  • FIG. 5 shows a flat pattern of a portion of the endovascular graft of FIG. 2. [0046]
  • FIG. 5A is an enlarged side view of FIG. 5 at Detail A. [0047]
  • FIG. 6 is an enlarged view of a portion of an endovascular graft having features of an embodiment of the present invention. [0048]
  • FIG. 7 shows a bifurcated endovascular graft according to embodiments of the present invention. [0049]
  • FIG. 8 shows a flat pattern of yet another component of the endovascular graft of FIG. 2. [0050]
  • FIG. 9 shows a flat pattern of another component of the endovascular graft of FIG. 2. [0051]
  • FIG. 10 shows detail of a stent apex detail that comprises offset circular and elliptical radii. [0052]
  • FIG. 11 shows detail of a stent apex detail that comprises offset circular radii. [0053]
  • FIG. 12 shows detail of a stent section comprising a tapered strut section. [0054]
  • FIG. 13 shows detail of a stent section comprising another configuration for a tapered strut section.[0055]
  • DETAILED DESCRIPTION
  • FIG. 1 shows an [0056] endovascular graft 10 in its deployed configuration. Unless otherwise stated, the term “graft” or “endovascular graft” is used herein to refer to a prosthesis capable of repairing and/or replacing diseased vessels or portions thereof, including generally tubular and bifurcated devices and any components attached or integral thereto. For purposes of illustration, the graft embodiments described below are assumed to be most useful in the endovascular treatment of abdominal aortic aneurysms (AAA). For the purposes of this application, with reference to endovascular graft devices, the term “proximal” describes the end of the graft that will be oriented towards the oncoming flow of bodily fluid, typically shows a flat pattern blood, when the device is deployed within a body passageway. The term “distal” therefore describes the graft end opposite the proximal end. Finally, while the drawings in the various figures are accurate representations of the various embodiments of the present invention, the proportions of the various components thereof are not necessarily shown to exact scale within and among or between any given figure(s).
  • [0057] Graft 10 has a proximal end 11 and a distal end 12 and includes a generally tubular structure or graft body section 13 comprised of one or more layers of fusible material, such as expanded polytetrafluoroethylene (ePTFE). A proximal inflatable cuff 16 is disposed at or near a proximal end 14 of graft body section 13 and an optional distal inflatable cuff 17 is disposed at or near a graft body section distal end 15. Graft body section 13 forms a longitudinal lumen 22 configured to confine a flow of fluid therethrough and may range in length from about 5 to about 30 cm; specifically from about 10 to about 20 cm.
  • As will be described in greater detail below, inflation of [0058] cuffs 16 and 17 will cause them to assume a generally annular shape (especially when graft body section 13 is in an unconstrained state). Inflatable cuffs 16 and 17 will generally, however, conform to the shape of the vessel within which it is deployed. When fully inflated, cuffs 16 and 17 may have an outside diameter ranging from about 10 to about 45 mm; specifically from about 16 to about 32 mm.
  • At least one [0059] inflatable channel 18 may be disposed between and in fluid communication with proximal inflatable cuff 16 and distal inflatable cuff 17. Inflatable channel 18 provides structural support to graft body section 13 when inflated to contain an inflation medium. Inflatable channel 18 further prevents kinking and twisting of the tubular structure or graft body section when it is deployed within angled or tortuous anatomies as well as during remodeling of body passageways (such as the aorta and iliac arteries) within which graft 10 is deployed. Together with proximal and distal cuffs 16 and 17, inflatable channel 18 forms a network of inflatable cuffs and channels in fluid communication with one other.
  • We have found the helical configuration of [0060] channel 18 in the FIG. 1 embodiment to be particularly effective in providing the needed kink resistance for effectively treating diseased body passageways such as AAAs, in which highly angled and tortuous anatomies are frequently found. In alternative embodiments, however, other cuff and channel configurations are possible. Inflatable channel 18 may be disposed helically as shown in FIG. 1, it may take on a more circumferential or annular rib and spine configuration as shown in the FIG. 2 embodiment, or otherwise. Similarly, the longitudinal and radial dimensions of inflatable channel 18 may vary as necessary both between different graft body sections and even within a single graft body section, depending on the indication for which graft 10 is intended to treat. Further, inflatable channel 18 may be oriented at various angles with respect to the longitudinal axis 25 of graft body section 13, and the pitch (the distance between helical or parallel windings of channel 18) may vary as necessary.
  • In the embodiment of FIG. 1, the channel pitch, or distance between each helical [0061] inflatable channel 18 winding, may range from about 2 to about 20 mm, depending on the overall size of graft body section 13 and the desired degree of kink resistance. We have found that a pitch of between about 4 and about 10 mm is effective for tubular embodiments of the present invention and a pitch of between about 3 and about 10 mm to be useful in bifurcated graft embodiments. The helix angle of each channel winding (measured with respect to a plane perpendicular to the graft body section longitudinal axis 25) may range from about 10 to about 45 degrees; more specifically, from about 20 to about 35 degrees in tubular and bifurcated graft embodiments. Finally, the width of inflatable channel 18 typically ranges from about 1 to about 8 mm; more specifically, from about 2 to about 4 mm.
  • Graft body section or [0062] tubular structure 13 and its associated components may be made from a variety of suitable materials, including ultra high molecular weight polyethylene, polyesters, and the like. As previously discussed, we have found constructing graft body section 13 primarily from one or more layers of ePTFE to be particularly useful. Details of how graft 10 may be fabricated (as well as all of the other grafts discussed herein) are more fully described in parent U.S. patent application Ser. No. 10/029,559 and in copending U.S. patent application Ser. Nos. 10/029,570, 10/029,584, and 10/029,557, each to Chobotov et al. In addition, U.S. patent application Ser. No. 09/133,978 to Chobotov, filed Feb. 9, 1998 and entitled “Endovascular Graft” and copending U.S. patent application Ser. No. 09/917,371 to Chobotov et al., filed Jul. 27, 2001 and entitled “Bifurcated Stent-Graft Delivery System and Method,” the entirety of each of which is hereby incorporated herein by reference, teach a useful endovascular stent-graft and delivery system, respectively.
  • A [0063] proximal neck portion 23 is disposed in the vicinity of graft body section proximal end 14 and serves as an additional means to help seal the deployed graft against the inside of a body passageway. Proximal neck portion 23 has an inlet axis 27 that forms an inlet axis angle α in relation to graft body section longitudinal axis 25. This angled inlet axis 27 allows the graft to better conform to the morphology of a patient's vasculature in patients who have an angled vessel morphology, such as is often the case in the neck region of abdominal aortic aneurysms. The inlet axis angle α may range in any direction with respect to longitudinal axis 25 from about zero to about 90 degrees, preferably from about 20 to about 30 degrees. Proximal neck portion 23 may be tapered or flared to a larger diameter in the proximal direction to facilitate this sealing function. Proximal neck portion 23 also serves as a means of providing a smooth fluid flow transition into graft lumen 22.
  • The network of [0064] inflatable cuffs 16, 17 and channel 18 may be inflated, most usefully in vivo, by introduction or injection of a material or medium through an injection port 33 that is in fluid communication with cuff 17 and the associated cuff/channel network. The material may comprise one or more of a solid, fluid (gas and/or liquid), gel or other medium. The material may contain a contrast medium that facilitates imaging the device while it is being deployed within a patient's body. For example, radiopaque materials containing elements such as bismuth, barium, gold, iodine, platinum, tantalum or the like may be used in particulate, liquid, powder or other suitable form as part of the inflation medium. Liquid iodinated contrast agents are a particularly suitable material to facilitate such imaging. Radiopaque markers may also be disposed on or integrally formed into or on any portion of graft 10 for the same purpose, and may be made from any combination of biocompatible radiopaque materials.
  • A [0065] connector member 24 is affixed to or integrally formed in graft body section 13, or as shown in FIG. 1, at or near graft body section proximal end 14 and proximal neck portion 23. Connector member 24 is a serpentine ring structure comprising apices 28. Connector member 24 may be made from any suitable material that permits expansion from a constrained state, most usefully a shape memory alloy having superelastic properties such as nickel titanium (NiTi). Other suitable connector member 24 materials include stainless steel, nickel-cobalt alloys such as MP35N, tantalum and its alloys, polymeric materials, composites, and the like. Connector member 24 (as well as all stents and connector members described herein) may be configured to self-expand from a radially constrained state or be configured to expand as a result of an applied force (such as from an inflated balloon), or, in the case of some shape memory materials, a temperature change.
  • The configuration of [0066] connector member 24 shown in FIG. 1 comprises eight apices 28 (put more precisely, the FIG. 1 connector member 24 comprises eight proximal apices and eight distal apices; however, unless otherwise mentioned, the term “apices” refers in this context to either the proximal or distal set of apices in a single connector member, stent, or stent portion). Another particularly useful configuration is one shown in FIGS. 2-7 in which the connector member comprises twelve apices. Any number of apices up to twenty-four or more may be used in connector member 24. In general terms, as the number of apices 28 on connector member 24 increase, connector member 24 will exhibit a greater conformability to the vessel wall when it is expanded from a radially constrained state.
  • No matter the number of apices present, one function of [0067] connector member 24 is to work in conjunction with proximal neck 23 in which it is typically embedded to help seal the deployed graft against the inside of a body passageway as previously described. It can also play a role in helping to keep graft 10 in place within the vessel wall and may also facilitate the opening of graft body section proximal end 14 during deployment.
  • Some [0068] apices 28 may also comprise a connector member connector element 30, described more fully below with respect to the embodiment of FIG. 2. In the FIG. 1 embodiment, in which connector member 24 comprises eight (proximal) apices 28, a connector element 30 is distributed on every other apex 28. We have found this configuration to be suitable for meeting the various performance requirements of the present invention. Other configurations are possible, including the twelve-apex connector member 24 shown in FIGS. 2-7 comprising six connector elements 30 distributed on every other apex 28. Other configurations in which, for example, connector elements are distributed on every apex, every third or fourth apex, or any other pattern are within the scope of the present invention.
  • [0069] Graft 10 further comprises a proximal stent 40 having a proximal end 42 and a distal end 44. Although other configurations are possible, proximal stent 40 in the FIG. 1 embodiment comprises a serpentine ring having four apices 46, or half the number of apices 28 of connector member 24. Note that proximal stent 40 in FIG. 1 takes on an optional tulip-shaped tapered profile in which the stent's diameter varies along its length. Such a profile serves to present sufficient radial force upon radial expansion of stent 40 to reliably anchor graft 10 to the vessel or lumen wall within which it is deployed while, at its tapered distal end near graft body section 13, refraining from interfering with the sealing function performed by proximal cuff 16, proximal neck portion 23, and connector member 24. This profile also accommodates any taper that may be present in the host vessel or lumen.
  • As shown in FIG. 1, [0070] proximal stent 40 is disposed generally proximal to graft body section 13 and connector member 24. Proximal stent is typically, though not necessarily, made a part of graft 10 by being affixed or connected to connector member 24 via connector elements as described in detail below. Proximal stent 40 may also be affixed or embedded directly to or in proximal neck portion 23 and/or other portions of graft body section 13. In addition, the present invention includes embodiments wherein the connector member and proximal stent are not mechanically or otherwise fastened to one another but rather unified, formed of a monolithic piece of material such as NiTi.
  • This configuration of [0071] proximal stent 40, connector member 24, proximal neck portion 23, and proximal cuff 16 helps to separate the sealing function of proximal cuff 16, which requires conformation and apposition to the vessel wall within which graft 10 is deployed without excessive radial force, from the anchoring function of proximal stent 40 (connector member 24 and proximal neck portion 23 play intermediate roles). This allows the sealing and anchoring functions each to be optimized without compromising the other. In addition, in part because proximal stent 40, connector member 24, and inflatable cuff 16 are longitudinally distributed along the graft body section longitudinal axis 25, a smaller, more flexible delivery profile ranging from about 10 to about 16 French is possible; preferably below 12 French.
  • [0072] Proximal stent 40 may be manufactured from any of the materials suitable for connector member 24. When manufactured from a shape memory alloy having superelastic properties such as NiTi, proximal stent 40 may be configured to self-expand upon release from a constrained state.
  • [0073] Proximal stent 40 further comprises proximal stent connector elements 48 that are affixed to connector member connector elements 30 via coupling members as described more fully below in relation to FIGS. 2-6. Note that in the FIG. 1 embodiment, there is one proximal stent connector element 48 for every connector member connector element 30.
  • [0074] Proximal stent 40 also comprises struts 41 and may also comprise one or more barbs 43. A barb can be any outwardly directed protuberance, typically terminating in a sharp point that is capable of at least partially penetrating a body passageway in which graft 10 is deployed (typically the intimal and medial layers of a blood vessel such as the abdominal aorta).
  • When [0075] proximal stent 40 is deployed in the abdominal aorta, for example, typically in a location proximal to the aneurysm and any diseased tissue, barbs 43 are designed to work in conjunction with the distally-oriented blood flow field in this location to penetrate tissue and prevent axial migration of graft 10. This is why barbs 43 in the FIG. 1 embodiment are oriented distally with respect to graft body section 13.
  • In alternative embodiments, depending upon the material used in the manufacture of [0076] proximal stent 40, the clinical demands and other factors, the degree to which barbs 43 help maintain the position of graft 10 within the vessel may vary. Consequently, the number, dimensions, configuration and orientation of barbs 43 may vary significantly, yet be within the scope of the present invention.
  • The length of [0077] barbs 43 in any of the embodiments of the present invention may range from about 1 to about 5 mm; more particularly, from about 2 to about 4 mm.
  • As shown in their free expanded configuration in FIG. 1 and as shown in greater detail in FIG. 1A, [0078] barbs 43 may be oriented in a distal direction and form an elevation angle β ranging from about 10 to about 45 degrees or higher with respect to a longitudinal axis 29 of strut 41, projecting generally radially outward from graft lumen 22 away from proximal neck inlet axis 27. Disposing barbs at angle β provides the necessary embedding force to anchor graft 10 into the vessel or lumen in which it is deployed. Although not shown in the figures, the barb elevation may also be described when the graft 10 is deployed in vivo in a body lumen or vessel by a second angle β′ measured relative to proximal neck inlet axis 27. This second barb elevation angle β′ will typically range from about 5 to about 45 degrees. For both barb elevation angles β and □β′, similar orientations may be found with barbs in other embodiments of the present invention.
  • It is generally desirable that [0079] barbs 43 be oriented in a position generally parallel to the axis of the lumen in which they are deployed so that they are in a position to best resist the drag loads imposed by the flow field in vivo in certain applications. To this end, we have found it useful for one or more of barbs 43 to form an optional second barb azimuth or “kick” angle γ with respect to strut longitudinal axis 29 as shown in FIG. 1B. In this view, barb 43 is laterally biased in a plane that is tangent to an outside surface 37 of strut 41 and generally orthogonal to a plane in which angle γ is formed. The term “strut outside surface 37” generally refers to that portion of the surface of strut 41 located opposite the proximal neck inlet axis 27, or that portion of strut 41 that when deployed will be in direct contact with the vessel or lumen wall. We have also found that providing lateral kick angle γ to barbs 43 contributes to greater barb stability when the barb is tucked behind an adjacent strut or tuck pad in a reduced diameter delivery configuration. In proximal stent 40, γ may range from between about 5 and about 70 degrees relative to strut axis 41. Similar orientations may be found with barbs in other embodiments of the present invention.
  • The number of barbs, the length of each barb, each of the barb angles described above, and the barb orientation may vary from barb to barb within a single stent or between multiple stents within a single graft. [0080]
  • Note that although the various barbs (and tuck pads [0081] 45 discussed below) discussed herein may be attached to or fixed on the stent struts 41, we have found it useful that, as shown in the various figures, they be integrally formed as part of the stent struts. In other words, they can be mere extensions of the struts in which no joint or other connection exists. Because there is no joint, we have found the strength of the barb/strut interface to be very high, as is the fatigue resistance of the barbs. With no mechanical connection to join the barbs to the struts, reliability of the barb/strut interface is higher. In addition, the lack of a heat-affected zone in which the mechanical properties of a welded or brazed joint may be deleteriously affected is another significant advantage to having the barbs and tuck pads be integral to the stent.
  • [0082] Struts 41 may also comprise optional integral tuck pads 45 disposed opposite each barb 43. As is the case with the barbs, the number, dimensions, configuration and orientation of barb tuck pads 45 may vary significantly.
  • During preparation of graft [0083] 10 (and therefore proximal stent 40) into its reduced diameter delivery configuration, each barb 43 is placed behind a corresponding strut 41 (and optional tuck pad 45, if present) so to thereby prevent that barb from contacting the inside of a delivery sheath or catheter during delivery of the device and from undesired contact with the inside of a vessel wall. As described in copending U.S. patent application Ser. No. 09/917,371 to Chobotov et al., a release belt disposed in one or more grooves 35 disposed on struts 41 retain proximal stent 40 in this delivery configuration.
  • Upon deployment of [0084] graft 10, and more particularly, proximal stent 40, (typically accomplished in part by release of this and other belts), the radial expansion of stent 40 results in a displacement of struts 41 so that the distance between them increases. Eventually this displacement becomes large enough so to free the barbs from behind the adjacent strut (and optional tuck pad 45, if present) and engage the wall of the lumen being treated. During experiments in which stents of the present invention having barbs described herein are released from a constrained delivery configuration to assume an expanded or deployed configuration, high speed video confirms that the barbs tend to release with a time constant that is generally an order of magnitude lower than the time constant associated with the radial expansion of the stent. In other words, during the stent deployment process, their barbs complete their deployment before the stent is fully expanded, so that the barbs may engage the vessel or lumen wall with maximum effectiveness.
  • Alternatively, and especially in the case when a different material such as stainless steel is used for [0085] proximal stent 40, an optional balloon may be used to expand stent 40 to free barbs 43 from their tuck pads 45 and to cause barbs 43 to engage tissue as desired. Even if a superelastic self-expanding proximal stent 40 is used in graft 10, such a balloon may be used to help further implant barbs 43 into their desired position to ensure proper placement of graft 10.
  • Turning now to FIG. 2, another endovascular graft having features of the present invention is illustrated. [0086] Graft 50 has a proximal end 51 and a distal end 52 and comprises a tubular structure or graft body section 53 with a proximal end 54 and distal end 55. As with the FIG. 1 embodiment, graft body section 53 forms a longitudinal lumen 73 configured to confine a flow of fluid therethrough and may range in length from about 5 to about 30 cm; specifically from about 10 to about 20 cm. Proximal inflatable cuff 56 and optional distal inflatable cuff 57 form a seal when inflated to help prevent transmission of pressure (hemodynamic pressure when the fluid is blood) to the lumen or vessel walls in the region between the proximal and distal cuffs. In addition, the cuffs help to prevent flow of fluid such as blood around the outer surface of graft body section 53.
  • [0087] Inflatable channel 58 comprises an inflatable longitudinal channel or spine in fluid communication with a series of approximately parallel inflatable circumferential channels or ribs. We have found this configuration to be particularly useful in providing effective kink resistance while allowing for rapid and relatively easy inflation of the cuffs and channels when using more viscous inflation materials. Channel 58 is in fluid communication with proximal and distal cuffs 56 and 57, forming a network of inflatable cuffs and channels in fluid communication with each other. Fill port 59 is in fluid communication with distal cuff 57, inflatable channel 58, and proximal cuff 56, adding to this network for the introduction of an inflation medium into graft body section 53. Features of the FIG. 1 embodiment not discussed herein may be present in the FIG. 2 device.
  • [0088] Graft 50 of FIG. 2 also comprises a twelve-crown or twelve-apex proximal connector member 60, a two-stage six- and three-crown proximal stent 70, distal neck portion 77, distal connector member 124, and distal stent 128. Distal connector member 124 and distal stent 128 are analogous to connector member 60 and proximal stent 70 except that the distal stent in the FIG. 2 embodiment is single-stage and its optional barbs face in the opposite, or proximal direction relative to the barbs 74 of proximal stent 70. Distal connector member 124 is affixed or attached to distal stent 128, both of which are more fully described in relation to a bifurcated version of the present invention shown in FIGS. 8 and 9, respectively. Distal connector member 124 and distal stent 128 may be manufactured from materials and according to methods that are suitable for connector member 60 and proximal stent 70. Further, distal connector member 124 may be attached to, affixed to, formed integrally with tubular structure or graft body section 53, or more typically, distal neck portion 77. Distal connector member 124 further comprises fill port bridge 132.
  • FIG. 3 shows a detailed flat pattern view of the [0089] proximal connector member 60 shown in FIG. 2. Proximal connector member 60 comprises a distal end 66 and a proximal end 64 having twelve crowns or apices 65. Alternate proximal apices 65 comprise proximal connector member connector elements 62. These connector elements 62 each in turn comprises a proximal end 61, a distal end 63, and optional ears 80 disposed near distal end 63. Ears 80 provide for increased surface area on connector elements 62 to aid in maximizing the strength of the bond between connector element and graft proximal neck portion and further comprises one or more optional apertures 82 to farther enhance such a bond as previously discussed. Opposing shoulder portions 84 may have rounded corners so to minimize their potential to snag, tear, or otherwise interfere with other components of the graft or the lumen in which it is deployed. Shoulder portions 84 also have one or more optional shoulder holes 85. These shoulder holes 85 are useful in helping to stabilize the proximal stent 70 and proximal connector member 60 device as they are coupled during assembly as discussed below in conjunction with FIG. 5A.
  • As illustrated in FIGS. [0090] 4-5 and 6-7, two-stage proximal stent 70 has a proximal end 76 and a distal end 77 with proximal stent connector elements 72. Proximal stent connector elements 72 have opposing shoulder portions 78 that may mirror opposing shoulder portions 84 of distal stent connector elements 62.
  • [0091] Proximal stent 70 comprises struts 71, any one of which may further comprise one or more barbs 74. Optional barb tuck pads 86 near each barb serve to shield barbs 74 when graft 50 is in its reduced diameter delivery configuration. Struts 71 or tuck pads 86 may also contain an optional barb tuck slot 85 to help retain barbs 74 while graft 50 (and consequently proximal stent 70) is in its delivery configuration. Upon deployment of graft 50 as previously described with respect to the FIG. 1 embodiment, barbs 74 are released from barb tuck slots 85 and are placed in their operational, or deployed configuration, as shown in FIGS. 2 and 6. When so deployed in a patient vessel, proximal stent 70 is expanded, forcing barbs 74 at least partially into the vessel wall to emplace graft 50 therein and to resist fluid flow forces that might otherwise dislodge graft 50.
  • [0092] Proximal stent 70 also may comprise one or more sets of optional grooves 87 for housing device release bands as previously discussed.
  • Unlike [0093] proximal stent 40 of FIG. 1, however, proximal stent 70 is a two-stage component having a first, or six-crown region 90 and a second, or three-crown region 92. The first, or six-crown region 90 comprises a serpentine ring having six apices 94 (i.e., six distal and six proximal apices). Likewise, the second, or three-crown region 92 comprises a serpentine ring having three apices 93, the distal apices of which connect to every other proximal apex 94 of six-crown region 90. Note that proximal stent 70 is typically made from a single piece of material such that there are no joints or connections between each stage (such as a mechanical connection or a weld, etc.). However, other configurations in which two or more stages may be so joined or connected from separate parts or stents to form a single stent are possible; likewise, single-piece stents having more than two stages are also possible.
  • [0094] Proximal stent 70 may exhibit a greater outward radial force at three-crown region 92 than in six-crown region 90. Such a design is particularly useful in a clinical setting in which it is desired that such outward radial force be applied within a healthier section of vessel, more remote from the site of disease. Proximal stent 70 may accordingly perform the anchoring function within a portion of vessel that can accommodate such radial force.
  • FIG. 5 is a flat pattern view of [0095] connector member 60 joined to proximal stent 70. For this embodiment, there is a relationship among the various apices 65, 93 and 94 of the connector member 60 and the two stages of proximal stent 70, respectively, in which there are twelve connector member apices 65, six apices 94 in the proximal stent first or six-crown region 90 and three apices 93 in the proximal stent second or three-crown region 92.
  • While the actual number of apices may vary as previously discussed, this more generally illustrates a useful convention for the present invention in which the relationship among the various apices may be described: for instance, if the number of [0096] connector member 60 apices 65 is denoted “n”, “n/2” then denotes the number of proximal stent 70 first or six-crown region 90 apices 94 and “n/4” as the number of proximal stent 70 second or three-crown region 92 apices 93. Other useful embodiments include those in which there are “n” connector member apices, “n” proximal stent first region apices, and “n/2” proximal stent second region apices. These ratios may vary as appropriate; these particular sets of ratios are merely illustrative.
  • Note also in FIG. 5 that connector [0097] member connector elements 62 are coupled to proximal stent connector elements 72 via coupling members 54.
  • FIG. 5A is a side view of proximal [0098] stent connector element 72, connector member connector element 62, and coupling member 54. Coupling member 54 is a wire or similar element wrapped to form a coil around the overlapping connector member connector element 62 and proximal stent connector element 72 to mechanically join connector member 60 to proximal stent 70. Alternatively, any other suitable joining technique, such as welding, brazing, soldering, mechanical means, adhesive, etc. may be used to join these components of the graft 50. We have found, however, that mechanical means such as coupling member 54 is most useful in that it avoids problems presented by techniques such as welding, etc., where possible heat-affected zones some distance from the joint may deleteriously affect the microstructure of the stent/connector element material, especially when that material is nickel titanium, thus having a negative impact on the joint strength, fatigue life, and ultimately the integrity of graft 50.
  • Any suitable member may be used for coupling [0099] member 54 although we have found a wire or wire-like member having a circular cross-sectional shape to be useful (although any shape may be used). Optimally, the wire coupling member 54 may be formed of a suitable metal such as nickel, stainless steel, nickel-titanium, etc. The wire may have a diameter ranging from about 0.002 to about 0.006 inch; more specifically from about 0.003 to about 0.005 inch.
  • To secure the [0100] connector elements 62 and 72 to one another, coupling member 54 may be wound around the matched connector elements one or more times. We have found that providing enough windings to present a single layer of wire in which the windings are immediately adjacent one another from shoulder 78, 84 to shoulder 78, 84 provides sufficient strength and stiffness to the joint thus created without detracting from the low delivery profile afforded by the novel design of graft 50. Thus the number of optimal windings from graft to graft will vary but typically ranges from about 6 to about 18 windings in most applications. With coupling members 54 in place, connector member connector elements 62 and proximal stent connector elements 72 are securely coupled to one another. The features and advantages of coupling member 54 discussed herein may be utilized by any of the embodiments of the present invention herein discussed.
  • FIG. 6 is a perspective view of [0101] connector member 60 joined to proximal stent 70 in this way in their expanded, or deployed configuration. Graft body section 53 and other graft components are removed for clarity of illustration. Barbs 74 are shown in their deployed state, released from optional barb tuck pads 86.
  • FIG. 7 illustrates another embodiment of the invention in the form of a bifurcated [0102] endovascular graft 100. A bifurcated device such as endovascular graft 100 may be utilized to repair a diseased lumen at or near a bifurcation within the vessel, such as, for example, in the case of an abdominal aortic aneurysm in which the aneurysm to be treated may extend into the anatomical bifurcation or even into one or both of the iliac arteries distal to the bifurcation. In the following discussion, the various features of the graft embodiments previously discussed may be used as necessary in the bifurcated graft 100 embodiment unless specifically mentioned otherwise.
  • [0103] Graft 100 comprises a first bifurcated portion 114, a second bifurcated portion 115 and main body portion 116. The size and angular orientation of the bifurcated portions 114 and 115, respectively, may vary even between portion 114 and 115—to accommodate graft delivery system requirements and various clinical demands. For instance, each bifurcated portion or leg is shown in FIG. 7 to have a different length, but this is not necessary. First and second bifurcated portions 114 and 115 are generally configured to have an outer inflated diameter that is compatible with the inner diameter of a patient's iliac arteries. First and second bifurcated portions 114 and 115 may also be formed in a curved shape to better accommodate curved and even tortuous anatomies in some applications.
  • Together, [0104] main body portion 116 and first and second bifurcated portions 114, 115 form a continuous bifurcated lumen, similar to lumens 22 and 73, which is configured to confine a flow of fluid therethrough. And although not shown in FIG. 7, graft 100 does not have to have a second bifurcated portion 115, in which case the bifurcated lumen is formed between main body portion 116 and first bifurcated portion 114.
  • First and second [0105] bifurcated portions 114 and 115 each comprises a network of inflatable cuffs and channels as discussed with respect to the FIG. 2 embodiment, including inflatable channel 113. Channel 113 comprises one or more optional inflatable longitudinal channels 110 in fluid communication with one or more approximately parallel inflatable circumferential channels 144, all of which are in fluid communication with optional distal inflatable cuffs 117 and 119.
  • As with the embodiments previously discussed, the number of inflatable [0106] circumferential channels 144 may vary with the specific configuration of the graft as adapted to a given indication. Generally, however, the number of inflatable circumferential channels 144 per bifurcated portion may range from 1 to about 30, preferably about 10 to about 20. Similarly, the dimensions, spacing, angular orientation, etc. of circumferential inflatable channels 144 may vary as well.
  • For instance, the distance between and width of each circumferential [0107] inflatable channel 144 may vary along the length of the graft or may be constant. The pitch or inter-ring distance may range from about 2 to about 20 mm; specifically, it may range from about 3 to about 10 mm. Circumferential inflatable channels 144 are each typically between about 2 and about 4 mm wide, but may be from about 1 to about 8 mm wide. Each longitudinal channel 110 is typically from about 2 to about 4 mm wide, but may vary, together or independently, to be from about 1 to about 8 mm wide.
  • In the embodiment of FIG. 7, [0108] channel 113 forms a continuous cuff and channel network extending from first bifurcated portion 114 to main body portion 116 to second bifurcated portion 115. Accordingly, inflatable channel 113 fluidly connects into a network with proximal inflatable cuff 111, secondary proximal cuff 112, circumferential inflatable channels 144, optional distal inflatable cuff 117 and optional distal inflatable cuff 119. Note that longitudinal channels 110 extend proximally along main body portion 116 to be in fluid communication with cuffs 111 and 112.
  • In alternative embodiments of the graft of FIG. 7 as well as that of FIGS. 1 and 2, numerous other inflatable channel and cuff configurations are possible. The inflatable channel for instance may be disposed longitudinally, horizontally, in a helical fashion, or otherwise. One or more additional cuffs may be disposed on either or both [0109] bifurcated portions 114 and 115 as well as main body portion 116. In other embodiments, graft 100 may have compartmentalized channels and cuffs requiring multiple sites from which they are inflated and may use multiple inflation materials to optimize properties in each region.
  • Second [0110] bifurcated portion 115 may be of a similar construction to first bifurcated portion 114. In the FIG. 7 embodiment of graft 100, second bifurcated portion 115 is of a unitary, continuous construction with first bifurcated portion 114 and main body portion 116. Alternatively, first and second bifurcated portion 114 and 115 respectively may be singly or jointly formed separately from a main body portion and may be joined to the main body portion before deployment in the body passageway or in vivo after such deployment.
  • First and second [0111] bifurcated portions 114 and 115 may be generally cylindrical in shape when deployed, and will generally conform to the shape of a vessel interior within which they are deployed. Their length as measured from main body portion 116 may range from about 1 to about 10 cm or more. The nominal inflated outside diameter of the distal ends of the first and second bifurcated portions 114 and 115 at cuffs 117 and 119 may range from about 2 to about 30 mm, preferably from about 5 to about 20 mm.
  • [0112] Main body portion 116 comprises a proximal inflatable cuff 111 and an optional secondary proximal inflatable cuff 112 in fluid communication with one or more inflatable longitudinal channels 110. As with other embodiments, proximal cuff 111 serves primarily to seal graft 100 firmly against a lumen wall. Secondary proximal inflatable cuff 112 has been found to confer additional kink resistance on graft 100, particularly in those clinical applications in which the vessel in which the graft is deployed is highly angled or tortuous. The nominal inflated outside diameter of secondary proximal inflatable cuff 112 may range from about 10 to about 45 mm, preferably from about 15 to about 30 mm, while the nominal inflated outside diameter of proximal cuff 111 may range from about 10 to about 45 mm, preferably from about 16 to about 32 mm. Main body portion 116 may range in length from about 2 to about 10 cm; preferably from about 4 to about 8 cm.
  • Endovascular [0113] graft 100 further comprises a proximal connector member 118, proximal stent 120, and proximal neck portion 146 all of which may be similar to those components discussed above in reference to FIGS. 2-6. Coupling members (not shown) may join proximal stent 120 and proximal connector member 118 as discussed with respect to the embodiments of FIGS. 1-6. Proximal connector members and proximal stents as discussed in conjunction with the FIG. 1 embodiment are also possible for use in bifurcated graft 100.
  • In bifurcated embodiments of grafts having features of the invention which also have a biased proximal end that forms an inlet axis angle, the direction of the bias or angulation can be important with regard to achieving a proper fit between the graft and the morphology of the deployment site. Generally, the angular bias of the proximal end of the graft, proximal neck portion or proximal anchor can be in any direction. Preferably, the angular bias is in a direction and of a magnitude consistent with the mean angulation of the type of lesion (e.g. abdominal aortic aneurysm) intended for treatment with the graft. [0114]
  • As with [0115] proximal stent 70 of the embodiments shown in FIGS. 2 and 4-6, proximal stent 120 comprises barbs 121 which are oriented in a distal direction for reliable anchoring against the direction of pulsatile forces in vivo when the device is implanted in the abdominal aorta, for instance, to treat an abdominal aortic aneurysm.
  • One or both [0116] bifurcated portions 114 and/or 115 may further comprise a distal connector member 124 and/or 150, a distal stent 128, and a distal neck portion 154. The embodiment of FIG. 7 has distal connector member 124 and distal stent 128 disposed at the distal ends of each of first and second bifurcated portions 114 and 115, respectively. Distal connector member 124 and distal stent 128 are shown in greater detail in FIGS. 8 and 9.
  • As discussed with respect to the FIG. 2 embodiment and as shown more clearly in FIG. 8, [0117] distal connector member 124 disposed at or near first bifurcated portion 114 comprises distal connector member connector elements 130 and an optional fill-port bridge 132. Fill-port bridge 132 serves to prevent interference by distal connector member 124 with the manufacture of graft 100 and with the injection of an inflation medium, while preserving the continuous ring structure of distal connector member 124.
  • Inflatable channels [0118] 113 (and other inflatable members of the invention) are in communication with a fill port 160 through distal inflatable cuff 117. Fill port 160 may be disposed alternatively on second bifurcated portion 115 or graft main body portion 116, and more than one fill port may be used. Fill port 160 is configured to accept a pressurized source of fluid (gas and/or liquid), particles, gel or combination thereof as previously discussed.
  • As discussed with respect to the FIG. 2 embodiment, FIG. 9 details a flat pattern of [0119] distal stent 128, which includes distal stent connector elements 134. Distal connector member connector elements 130 are configured to be coupled with distal stent connector elements 134 via coupling members (not shown) similar to those discussed with respect to the FIGS. 1-6 embodiments. Distal stent 128 comprises one or more optional distal stent barbs 136, one or more optional distal stent barb tuck pads 138 and one or more optional distal stent barb tuck slots 140, each of which functions in a similar fashion to the corresponding features of embodiments discussed above. Distal stent barbs 136 are oriented proximally, opposite the direction of orientation of barbs 121, to accommodate the environment often found in the iliac arteries that can cause the bifurcated portions 114 and 115 to migrate proximally in vivo. Note that only two distal stent barbs 136 are shown in FIG. 9 for the purposes of clarity of illustration despite a larger number being depicted in the FIG. 7 embodiment of the present invention. It is understood that all embodiments of the present invention includes proximal and distal stents each of which may optionally comprise one, two, or any number of barbs.
  • The optional [0120] distal connector member 150, disposed in the FIG. 7 embodiment at or near distal end 152 of second bifurcated portion 115, has a structure similar to that of first bifurcated portion 114, with the exception of the absence of fill-port bridge 132. Other embodiments of the invention include bifurcated grafts in which the distal connector member 150 includes a fill-port bridge.
  • FIGS. [0121] 10-13 illustrate additional features of the present invention that may be used in any of the various stents and connector rings of the present invention, in any combination.
  • Turning to FIG. 10, a simplified detail of a [0122] proximal apex 93 of the second or three-crown region 92 of proximal stent 70 is shown. An outer surface 170 of apex 93 takes on a circular radius of curvature as defined by circle 172 having a radius r1. An inner surface 174 of the stent strut apex 93 takes on an elliptical shape as shown by ellipse 176. In the configuration of FIG. 10, circle 172 and ellipse 176 offset as shown by reference numeral 177; however, they may share a common center. Radius r4 shown at one of the foci of ellipse 176; the foci are shown as separated by a distance 171 in FIG. 10.
  • We have found that for the NiTi stents used in the present invention, such a configuration provides for a more diffuse strain distribution in the stent and reduces the peak strains experienced during assembly and in vivo, while also allowing for a smaller delivery profile as compared to other configurations, particularly in the [0123] proximal apex 93 of the second or three-crown region 92 of proximal stent 70. However, the stent apex configuration of FIG. 10 may be used in any other stent or connector member apex described herein, and may be used for components comprising material other than NiTi.
  • In the example of FIG. 10 wherein [0124] proximal apex 93 of the second or three-crown region 92, we have found that for NiTi components radius r1 of between about 0.030 and about 0.070 inch; specifically about 0.050 inch is useful, while an offset 171 of between about zero and about 0.050 inch; specifically about 0.0025 inch, is effective. A radius r4 of between about 0.010 and about 0.030 inch; specifically about 0.020 inch, is useful as well.
  • FIG. 11 details an alternative offset circular apex configuration. Here, a simplified detail of proximal apex [0125] 94 in the first or six-crown region 90 of proximal stent 70 is shown (without a transition region to the second or three-crown stent region as seen in, e.g., FIG. 4 for clarity of illustration). An outer surface 180 of apex 94 takes on a circular radius of curvature as defined by circle 182 having a radius r2. An inner surface 184 of apex 94 takes on a circular radius of curvature defined by circle 186 having a radius r3 Radius r2 may be equal to or greater than radius r3 and be within the scope of the present invention. The centers of circles 182 and 186 are offset from each other as indicated by reference numeral 188 in FIG. 11. This offset 188 may be equal to, greater than, or less than the width of the strut 71 in the region of apex 94.
  • We have found that when NiTi is used for the stents and connector members of the present invention, such a configuration is effective in distributing the peak strains experienced in the stent from the apex [0126] 94 to stent strut 71 as compared to other configurations, particularly in the proximal apex 94 of the first or six-crown region 90 of proximal stent 70. However, the offset circular apex configuration of FIG. 11 may be used in any other stent or connector member apex described herein, and may be used for components comprising material other than NiTi.
  • When used in the [0127] proximal apex 94 of the proximal stent first or six-crown region 90, we have found offset values ranging from about zero to about 0.030 inch; particular about 0.020 inch, to be effective in NiTi stents having expanded, or deployed diameters ranging from about 16 to about 26 mm. We have also found effective a configuration in which radius r2 ranges from about 0.020 to about 0.040 inch; more particularly about 0.035 inch, and in which radius r3 ranges from about 0.005 to about 0.020 inch; in particular about 0.010 inch.
  • Optional taper or tapers may be incorporated into the [0128] struts 41 and 71 of the various stent embodiments of the present invention as well as the various proximal and distal connector members. In general, incorporating one or more tapers into the struts on both proximal and distal stents provide greater space in the tapered region to accommodate alternative features such as barbs and tuck pads. It allows for a smaller deployment profile when the component is in a radially collapsed delivery configuration. We have found that when configuring the various stents and connector elements of the present invention into this reduced diameter delivery profile, the stents experience a large degree of bending strain that is often poorly or locally distributed. Tapering certain stent struts in particular locations helps to distribute this strain more evenly throughout the stent or connector member and to manage the peak strains. The examples of FIGS. 12 and 13 are now introduced and discussed below.
  • In FIG. 12, a simplified section of the second or three-[0129] crown region 92 of proximal stent 70 is depicted in which the stent struts 71 taper from a maximum width 190 (which may or may not equal a width of strut 71 in region of apex 93) to a minimum width 192. The optional taper, expressed as the ratio of the maximum width 190 to the minimum width 192, may vary widely depending on the particular region of the stent or connector member, the material used, and other factors. Taper ratios ranging from 1 to about 10 or greater are within the scope of the present invention. It is also within the scope of the present invention for the stent struts 71 to exhibit no taper.
  • For example, in a [0130] proximal stent 70 three-crown region 92 made from NiTi, we have found effective a maximum strut width 190 ranging from about 0.016 to about 0.032 inch; particularly from about 0.022 and about 0.028 inch, and a minimum strut width 192 of between about 0.010 and about 0.026 inch; particularly from about 0.012 and about 0.022 inch. The optional tapered strut feature described herein and shown in FIG. 12 may be used in any other stent or connector member described herein, and may be used for components comprising material other than NiTi.
  • Turning now to FIG. 13, a simplified section of [0131] distal stent 128 is shown as an example of optional tapering that results in asymmetric crowns. In this example, distal stent 128 comprises a distal apex or crown 196 exhibiting a width 198 and a proximal apex or crown (with connector element 134 removed for clarity of illustration) 200 exhibiting a smaller width 202. It is within the scope of the present invention for width 198 and width 202 to be equal.
  • We have found that, especially for the distal stents of the present invention, an asymmetric crown in which the [0132] distal apex 200 has a smaller strut width than that of the proximal apex 196 results in a difference in the expansion force exerted between each of the proximal and distal apices. When deployed in a diseased lumen or vessel, the proximal apices of such a stent having this configuration will tend to exert a smaller expansion force near the graft seal zone, reducing the potential for such a stent to cause trauma to tissue in the seal zone near the cuffs (where weaker, more diseased tissue tends to reside). Such a configuration also facilitates a consistent, safe and predictable deployment when the component moves from a reduced diameter delivery profile to an expanded treatment profile. Finally, such a taper reduces the flare exhibited by the distal apex 200; this in turn provides for a smaller distal stent delivery profile when the distal stent is in a reduced-diameter configuration. Taper ratios (defined in the same manner above as the ratio between width 198 and width 202) ranging from 1 to about 10 or higher are within the scope of the present invention.
  • For [0133] distal stent 128 comprising NiTi, we have found that a width 202 ranging from about 0.010 to about 0.026 inch; specifically from about 0.012 and about 0.024 inch to be useful, and we have found a width 198 ranging from about 0.016 to about 0.032 inch; specifically from about 0.017 to about 0.028 inch to be useful.
  • Of course, the various types of offset radii and combinations of elliptical and circular apex radii may be used to effect these tapers and ratios so to further cause the desired behavior during assembly into a reduced-diameter delivery configuration, effective delivery and performance in vivo. [0134]
  • Useful inflation media generally include those formed by the mixing of multiple components and that have a cure time ranging from a few minutes to tens of minutes, preferably from about three and about twenty minutes. Such a material should be biocompatible, exhibit long-term stability (preferably on the order of at least ten years in vivo), pose as little an embolic risk as possible, and exhibit adequate mechanical properties, both pre- and post-cure, suitable for service in the graft of the present invention in vivo. For instance, such a material should have a relatively low viscosity before solidification or curing to facilitate the graft cuff and channel fill process. A desirable post-cure elastic modulus of such an inflation medium is from about 50 to about 400 psi—balancing the need for the filled graft to form an adequate seal in vivo while maintaining clinically relevant kink resistance of the graft. The inflation media ideally should be radiopaque, both acute and chronic, although this is not absolutely necessary. [0135]
  • Details of compositions suitable for use as an inflation medium in the present invention are described in greater detail in U.S. patent application Ser. No. 09/496,231 to Hubbell et al., filed Feb. 1, 2000 and entitled “Biomaterials Formed by Nucleophilic Addition Reaction to Conjugated Unsaturated Groups” and U.S. patent application Ser. No. 09/586,937 to Hubbell et al., filed Jun. 2, 2000 and entitled “Conjugate Addition Reactions for the Controlled Delivery of Pharmaceutically Active Compounds”. The entirety of each of these patent applications is hereby incorporated herein by reference. [0136]
  • We have found one particular three-component medium formed by the Michael addition process to be particularly useful in serving as an inflation medium for the present invention. This medium comprises: [0137]
  • (1) polyethylene glycol diacrylate (PEGDA), present in a proportion ranging from about 50 to about 55 weight percent; specifically in a proportion of about 52 weight percent, [0138]
  • (2) pentaerthyritol tetra 3(mercaptopropionate) (QT) present in a proportion ranging from about 22 to about 27 weight percent; specifically in a proportion of about 24 weight percent, and [0139]
  • (3) glycylglycine buffer present in a proportion ranging from about 22 to about 27 weight percent; specifically in a proportion of about 24 weight percent. [0140]
  • Variations of these components and other formulations as described in copending U.S. patent application Ser. Nos. 09/496,231 and 09/586,937, both to Hubbell et al., may be used as appropriate. In addition, we have found PEGDA having a molecular weight ranging from about 350 to about 850 to be useful; PEGDA having a molecular weight ranging from about 440 to about 560 are particularly useful. [0141]
  • Radiopaque materials as previously discussed may be added to this 3-component system. We have found that adding radiopacifiers such as barium sulfate, tantalum powder, and soluble materials such as iodine compounds to the glycylglycine buffer is useful. [0142]
  • We have found that triethanolamine in phosphate-buffered saline may be used as an alternative to glycylglycine buffer as the third component described above to form an alternative curable gel suitable for use in embodiments of the present invention. [0143]
  • An alternative to these three-component systems is a gel made via polymer precipitation from biocompatible solvents. Examples of such suitable polymers include ethylene vinyl alcohol and cellulose acetate. Examples of such suitable biocompatible solvents include dimethylsulfoxide (DMSO), n-methyl pyrrolidone (NMP) and others. Such polymers and solvents may be used in various combinations as appropriate. [0144]
  • Alternatively, various siloxanes may be used as inflation gels. Examples include hydrophilic siloxanes and polyvinyl siloxanes (such as STAR-VPS from Danville Materials of San Ramon, Calif. and various silicone products such as those manufactured by NuSil, Inc. of Santa Barbara, Calif.). [0145]
  • Other gel systems useful as an inflation medium or material for the present invention include phase change systems that gel upon heating or cooling from their initial liquid or thixotropic state. For example, materials such as n-isopropyl-polyacrylimide (NIPAM), BASF F-127 pluronic polyoxyamer, and polyethylene glycol (PEG) chemistries having molecular weights ranging between about 500 and about 1,200 are suitable. [0146]
  • Effective gels may also comprise thixotropic materials that undergo sufficient shear-thinning so that they may be readily injected through a conduit such as a delivery catheter but yet still are able to become substantially gel-like at zero or low shear rates when present in the various channels and cuffs of the present invention. [0147]
  • In the case of the three-component PEDGA-QT-glycylglycine formulation described above, a careful preparation and delivery protocol should be followed to ensure proper mixing, delivery, and ultimately clinical efficacy. Each of the three components is typically packaged separately in sterile containers such as syringes until the appropriate time for deploying the endovascular graft. The QT and buffer (typically glycylglycine) are first continuously and thoroughly mixed, typically between their respective syringes for approximately two minutes. PEGDA is then mixed thoroughly with the resulting two-component mixture for approximately three minutes. This resulting three-component mixture is then ready for introduction into the graft body section as it will cure into a gel having the desired properties within the next several minutes. Cure times may be tailored by adjusting the formulations, mixing protocol, and other variables according to the requirements of the clinical setting. Details of suitable delivery protocols for these materials are discussed in copending U.S. patent application Ser. No. 09/917,371 to Chobotov et al. [0148]
  • We have found the post-cure mechanical properties of these gels to be highly tailorable without significant changes to the formulation. For instance, these gels may exhibit moduli of elasticity ranging from tens of psi to several hundred psi; the formulation described above exhibits moduli ranging from about 175 to about 250 psi with an elongation to failure ranging from about 30 to about 50 percent. [0149]
  • Notably, we have found it helpful to add an inert biocompatible material to the inflation material. In particular, we have found that adding a fluid such as saline to the PEGDA-QT-glycylglycine formulation (typically after it has been mixed but before significant curing takes place) lowers the viscosity of the formulation and results in greater ease when injecting the formulation into the graft body section network of inflatable cuffs and channels without sacrificing the desired physical, chemical, and mechanical properties of the formulation or its clinical efficacy. In the appropriate volume percentages, adding materials such as saline may also reduce the potential for the inflation material such as PEGDA-QT-glycylglycine to pose an embolic risk in case of spillage or leakage. Saline concentrations as a volume percentage of the final saline/three-component formulation combination may range from zero to as high as sixty percent or more; particularly suitable are saline concentrations ranging from about twenty to about forty percent. We have found a saline volume concentration of about thirty percent to be most suitable. Alternatives to saline may include biocompatible liquids, including buffers such as glycylglycine. [0150]
  • In more general terms, it is desirable to use an inflation medium in which each of its components is biocompatible and soluble in blood. A biocompatible inflation medium is desirable so to manage any toxicity risk in the case the inflation medium were inadvertently released into the patient's vasculature. A soluble inflation medium is desirable so to manage any embolism risk if released into the vasculature. Such an inflation medium should not disperse nor gel or solidify if spilled into flowing blood before curing. In the event of a spill, the normal blood flow would then rapidly disperse the components and their concentration would fall below the level required for crosslinking and formation of a solid. These components would then be eliminated by the body through standard pathways without posing an embolic risk to the patient. Among the many possibilities of an inflation medium example in which all of the components are soluble in blood is the combination polyethylene glycol diacrylate, a thiolated polyethyleneamine, and a buffer. [0151]
  • As previously discussed, more than one type of inflation medium, or more than one variant of a single type of inflation medium may be used in a single graft to optimize the graft properties in the region in which it is disposed. [0152]
  • For example, in the proximal and distal cuffs of the various embodiments of the present invention, the inflation material serves as a conformable sealing medium to provide a seal against the lumen wall. Desirable mechanical characteristics for the inflation medium in the proximal and distal cuffs would therefore include a low shear strength so to enable the cuff to deform around any luminal irregularities (such as calcified plaque asperities) and to conform to the luminal profile, as well as a high volumetric compressibility to allow the fill material to expand the cuffs as needed to accommodate any late lumen dilatation and maintain a seal. [0153]
  • In the channel or channels, by contrast, the inflation medium serves primarily to provide structural support to the lumen within which the graft is placed and kink resistance to the graft. Desirable mechanical characteristics for the inflation medium in the channel or channels therefore includes a high shear strength, to prevent inelastic deformation of a channel or channel segment due to external compression forces from the vessel or lumen (due, for example, to neointimal hyperproliferation) and low volumetric compressibility to provide stable support for adjacent channels or channel segments that may be in compressive contact with each other, thereby providing kink resistance to the graft. [0154]
  • Given these contrasting requirements, it may be useful to have different inflation materials fill different portions of the graft, such as one inflation medium for the proximal and distal cuffs and a second in the channel or channels. [0155]
  • In the various embodiments of the present invention, it is desirable that the inflation medium be visible through the use of techniques such as fluoroscopy during the time of deployment in which the graft cuffs and channels are being filled with the inflation medium. Such visibility allows the clinician to verify that the cuffs and channels are filling correctly and to adjust the filling procedure if they are not. It also provides an opportunity to detect any leakage or otherwise undesirable flow of inflation material out of the graft so that injection may be stopped, thereby minimizing the amount of leaked inflation material. [0156]
  • After the graft has been deployed into a patient, it is desirable that the graft be visible through the use of follow-up imaging techniques such as computed tomography (CT) and the like. However, the inflation material at this point in time is ideally not so radiopaque that it produces a dense CT image as such an image could potentially mask clinically significant endoleaks that would be visualized by opacifying the blood with a contrast agent. [0157]
  • Balancing these two objectives is difficult, however, since CT techniques are much more sensitive in detecting small amounts of radiopaque matter than are fluoroscopy techniques. One solution is to use an inflation medium that becomes less radiopaque over time, such as for example by using a blend of radiopaque materials in which one or more will diffuse out of the inflation medium over time, thereby reducing the inflation medium's radiopacity. For instance, a blend of a soluble contrast agent such as an iodinated aqueous solution and an insoluble contrast agent such as barium sulfate may serve this purpose. The soluble contrast agent will diffuse through the graft body section pores some time after the graft has been implanted, resulting in a progressive decrease in radiopacity of the inflation material over time. A fill material radiopacifier prepared from a combination of about two percent barium sulfate (by weight) and about 20 percent iodinated contrast solution (by weight) is useful in this capacity. [0158]
  • While particular forms of the invention have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the invention. [0159]

Claims (33)

What is claimed is:
1. An endovascular graft comprising:
a graft body section having an inflatable cuff and wherein the inflatable cuff contains a three-component inflation medium.
2. The endovascular graft of claim 1 wherein the inflation medium comprises the combination polyethylene glycol diacrylate, pentaerthyritol tetra 3(mercaptopropionate), and a buffer.
3. The endovascular graft of claim 2 wherein the buffer comprises glycylglycine.
4. The endovascular graft of claim 2 wherein the buffer comprises triethanolamine in phosphate-buffered saline.
5. The endovascular graft of claim 2 wherein the polyethylene glycol diacrylate is present in a proportion ranging from about 50 to about 55 weight percent.
6. The endovascular graft of claim 2 wherein the polyethylene glycol diacrylate has a molecular weight ranging from about 350 to about 850.
7. The endovascular graft of claim 2 wherein the pentaerthyritol tetra 3(mercaptopropionate) is present in a proportion ranging from about 22 to about 27 weight percent.
8. The endovascular graft of claim 2 wherein the glycylglycine is present in a proportion ranging from about 22 to about 27 weight percent.
9. The endovascular graft of claim 1 wherein the inflation material is radiopaque.
10. The endovascular graft of claim 9 wherein the inflation material comprises a radiopaque material that is soluble in glycylglycine.
11. The endovascular graft of claim 9 wherein the inflation material becomes less radiopaque over time.
12. The endovascular graft of claim 11 wherein the inflation material comprises a radiopaque material comprising a blend of a soluble contrast agent and an insoluble contrast agent.
13. The endovascular graft of claim 1 wherein the soluble contrast agent comprises an iodinated aqueous solution and the insoluble contrast agent comprises barium sulfate.
14. The endovascular graft of claim 1 wherein a post-cure elastic modulus of the inflation medium is between about 175 and about 250 pounds per square inch.
15. The endovascular graft of claim 14 wherein the inflation medium exhibits a cure time between about two minutes and about ten minutes.
16. The endovascular graft of claim 1 wherein the inflation medium additionally comprises saline or other inert biocompatible material.
17. The endovascular graft of claim 16 wherein the inflation medium comprises between about 20 and about 50 percent by volume saline.
18. The endovascular graft of claim 1 wherein the inflation medium comprises polyethylene glycol diacrylate, a thiolated polyethyleneamine, and a buffer.
19. The endovascular graft of claim 1 wherein the inflation medium comprises polyethylene glycol diacrylate, a thiolated tetronic, and a buffer.
20. The endovascular graft of claim 1 wherein the graft body section comprises an inflatable channel in fluid communication with the inflatable cuff.
21. The endovascular graft of claim 20 wherein the inflatable cuff is disposed at a proximal portion of the graft body section and further comprising a second inflatable cuff disposed at a distal portion of the graft body section and wherein the second inflatable cuff is in fluid communication with the inflatable channel and inflatable cuff.
22. An endovascular graft comprising:
a main body portion having at least one inflatable cuff,
a first bifurcated portion forming a continuous lumen with the main body portion, said lumen configured to confine a flow of fluid therethrough,
at least one inflatable channel extending from the first bifurcated portion to the main body portion,
wherein the inflatable cuff is in fluid communication with the inflatable channel, and
wherein the inflatable channel and inflatable cuff contain a three-component inflation medium.
23. The endovascular graft of claim 22 wherein the inflation medium comprises the combination polyethylene glycol diacrylate, pentaerthyritol tetra 3(mercaptopropionate), and a buffer.
24. The endovascular graft of claim 22 wherein the inflation material is radiopaque.
25. The endovascular graft of claim 22 further comprising a second bifurcated portion and wherein the inflatable channel extends to the second bifurcated portion.
26. The endovascular graft of claim 25 wherein the inflatable channel extends to a distal inflatable cuff disposed at a distal portion of one or both of the first and second bifurcated portions, and wherein each of the inflatable channel, at least one inflatable cuff, and distal inflatable cuffs are in fluid communication with each other.
27. A kit for the endovascular delivery of a graft, comprising:
a graft body section having an inflatable cuff,
a three-component inflation medium, and
instructions for use.
28. The kit of claim 27 wherein the graft body section further comprises an expandable member disposed on the graft body section and extending away from a proximal portion thereof.
29. The kit of claim 27 wherein each of the three components of the inflation medium is packaged separately.
30. The kit of claim 27 wherein the graft body section further comprises an inflatable channel in fluid communication with the inflatable cuff.
31. The kit of claim 28 further comprising a second inflatable cuff disposed at a distal portion of the graft body section in fluid communication with the inflatable channel and inflatable cuff.
32. The kit of claim 27 wherein the graft body section comprises a main body portion and at least one bifurcated portion forming a continuous lumen with the main body portion, said lumen configured to confine a flow of fluid therethrough.
33. The kit of claim 27 wherein the instructions for use comprise directions for mixing each of the three components with each other in a particular sequence and for a particular amount of time prior to introducing the three-component mixture into the graft body section inflatable cuff.
US10/091,641 2001-12-20 2002-03-05 Advanced endovascular graft Abandoned US20030120338A1 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
US10/091,641 US20030120338A1 (en) 2001-12-20 2002-03-05 Advanced endovascular graft
JP2003554049A JP4331610B2 (en) 2001-12-20 2002-12-20 Advanced endovascular graft
ES09009090T ES2384133T3 (en) 2001-12-20 2002-12-20 Advanced endovascular graft
CA002468951A CA2468951A1 (en) 2001-12-20 2002-12-20 Advanced endovascular graft
AU2002360765A AU2002360765C1 (en) 2001-12-20 2002-12-20 Advanced endovascular graft
PCT/US2002/041338 WO2003053288A1 (en) 2001-12-20 2002-12-20 Advanced endovascular graft
EP02796047.5A EP1467679B1 (en) 2001-12-20 2002-12-20 Advanced endovascular graft
EP09009090A EP2135583B1 (en) 2001-12-20 2002-12-20 Advanced endovascular graft
EP10180726.1A EP2277474A3 (en) 2001-12-20 2002-12-20 Advanced endovascular graft
US10/327,711 US7147660B2 (en) 2001-12-20 2002-12-20 Advanced endovascular graft
AT09009090T ATE553721T1 (en) 2001-12-20 2002-12-20 EXTENDED ENDOVASCULAR TRANSPLANT
US11/333,595 US7766954B2 (en) 2001-12-20 2006-01-17 Advanced endovascular graft
JP2008303094A JP2009039581A (en) 2001-12-20 2008-11-27 Advanced endovascular graft
AU2009201682A AU2009201682B2 (en) 2001-12-20 2009-04-28 Advanced endovascular graft
US12/491,336 US8709065B2 (en) 2001-12-20 2009-06-25 Advanced endovascular graft
US12/566,104 US8900288B2 (en) 2001-12-20 2009-09-24 Advanced endovascular graft delivery system and method of treatment
US12/566,808 US20100016943A1 (en) 2001-12-20 2009-09-25 Method of delivering advanced endovascular graft
AU2009230748A AU2009230748B2 (en) 2001-12-20 2009-10-26 Advanced endovascular graft
JP2010041226A JP5432003B2 (en) 2001-12-20 2010-02-26 Advanced endovascular graft
US13/245,652 US20120016457A1 (en) 2001-12-20 2011-09-26 Barbed radially expandable stent with slotted struts
US13/245,661 US8167927B2 (en) 2001-12-20 2011-09-26 Barbed radially expandable stent
US13/246,643 US8241346B2 (en) 2001-12-20 2011-09-27 Endovascular graft and method of delivery
US13/246,651 US8864814B2 (en) 2001-12-20 2011-09-27 Method of delivering advanced endovascular graft and system
JP2011256571A JP2012035139A (en) 2001-12-20 2011-11-24 Advanced endovascular graft
US14/799,656 US9788934B2 (en) 2001-12-20 2015-07-15 Advanced endovascular graft
US15/686,218 US10470871B2 (en) 2001-12-20 2017-08-25 Advanced endovascular graft
US16/680,779 US11439497B2 (en) 2001-12-20 2019-11-12 Advanced endovascular graft

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/029,559 US7147661B2 (en) 2001-12-20 2001-12-20 Radially expandable stent
US10/091,641 US20030120338A1 (en) 2001-12-20 2002-03-05 Advanced endovascular graft

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US10/029,559 Continuation US7147661B2 (en) 2001-12-20 2001-12-20 Radially expandable stent
US10/029,559 Continuation-In-Part US7147661B2 (en) 2001-12-20 2001-12-20 Radially expandable stent

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/327,711 Continuation-In-Part US7147660B2 (en) 2001-12-20 2002-12-20 Advanced endovascular graft
US11/333,595 Continuation US7766954B2 (en) 2001-12-20 2006-01-17 Advanced endovascular graft

Publications (1)

Publication Number Publication Date
US20030120338A1 true US20030120338A1 (en) 2003-06-26

Family

ID=21849652

Family Applications (10)

Application Number Title Priority Date Filing Date
US10/029,559 Expired - Lifetime US7147661B2 (en) 2001-12-20 2001-12-20 Radially expandable stent
US10/091,641 Abandoned US20030120338A1 (en) 2001-12-20 2002-03-05 Advanced endovascular graft
US11/333,595 Expired - Fee Related US7766954B2 (en) 2001-12-20 2006-01-17 Advanced endovascular graft
US12/491,336 Expired - Fee Related US8709065B2 (en) 2001-12-20 2009-06-25 Advanced endovascular graft
US12/566,104 Expired - Fee Related US8900288B2 (en) 2001-12-20 2009-09-24 Advanced endovascular graft delivery system and method of treatment
US13/245,652 Abandoned US20120016457A1 (en) 2001-12-20 2011-09-26 Barbed radially expandable stent with slotted struts
US13/245,661 Expired - Lifetime US8167927B2 (en) 2001-12-20 2011-09-26 Barbed radially expandable stent
US14/799,656 Expired - Lifetime US9788934B2 (en) 2001-12-20 2015-07-15 Advanced endovascular graft
US15/686,218 Expired - Fee Related US10470871B2 (en) 2001-12-20 2017-08-25 Advanced endovascular graft
US16/680,779 Expired - Lifetime US11439497B2 (en) 2001-12-20 2019-11-12 Advanced endovascular graft

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/029,559 Expired - Lifetime US7147661B2 (en) 2001-12-20 2001-12-20 Radially expandable stent

Family Applications After (8)

Application Number Title Priority Date Filing Date
US11/333,595 Expired - Fee Related US7766954B2 (en) 2001-12-20 2006-01-17 Advanced endovascular graft
US12/491,336 Expired - Fee Related US8709065B2 (en) 2001-12-20 2009-06-25 Advanced endovascular graft
US12/566,104 Expired - Fee Related US8900288B2 (en) 2001-12-20 2009-09-24 Advanced endovascular graft delivery system and method of treatment
US13/245,652 Abandoned US20120016457A1 (en) 2001-12-20 2011-09-26 Barbed radially expandable stent with slotted struts
US13/245,661 Expired - Lifetime US8167927B2 (en) 2001-12-20 2011-09-26 Barbed radially expandable stent
US14/799,656 Expired - Lifetime US9788934B2 (en) 2001-12-20 2015-07-15 Advanced endovascular graft
US15/686,218 Expired - Fee Related US10470871B2 (en) 2001-12-20 2017-08-25 Advanced endovascular graft
US16/680,779 Expired - Lifetime US11439497B2 (en) 2001-12-20 2019-11-12 Advanced endovascular graft

Country Status (3)

Country Link
US (10) US7147661B2 (en)
JP (1) JP2012035139A (en)
AT (1) ATE553721T1 (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040073190A1 (en) * 2002-07-02 2004-04-15 The Foundry Inc. Methods and devices for treating aneurysms
US20040138734A1 (en) * 2001-04-11 2004-07-15 Trivascular, Inc. Delivery system and method for bifurcated graft
US20040176836A1 (en) * 2003-03-06 2004-09-09 Trivascular, Inc. Kink resistant endovascular graft
US20060025846A1 (en) * 2004-07-28 2006-02-02 Frederick Feller AAA low profile support structure
US20060025851A1 (en) * 2004-07-28 2006-02-02 Khan Isaac J AAA device having connected bifurcated legs
US20060149349A1 (en) * 2002-10-10 2006-07-06 Jean-Francois Garbe Device for connection between a corporeal duct and a prosthesis
US20060206197A1 (en) * 2002-12-30 2006-09-14 Hesham Morsi Endovascular balloon graft
JP2007537779A (en) * 2004-03-11 2007-12-27 トライヴァスキュラー インコーポレイテッド Modular endovascular graft
WO2008021199A1 (en) 2006-08-14 2008-02-21 Trivascular2, Inc. Dual chamber cuff structure
US20090005849A1 (en) * 2006-03-24 2009-01-01 Syed Faiyaz Ahmed Hossainy Methods and apparatuses for coating a lesion
US20090143850A1 (en) * 2007-11-30 2009-06-04 Pierre Galvagni Silveira Endoprosthesis and delivery system for its placement within a patients vessel and uses for this endoprosthesis and delivery system
US20090171454A1 (en) * 2007-12-27 2009-07-02 Cook Incorporated Coated stent and methods of manufacture
US20090171438A1 (en) * 2007-12-26 2009-07-02 Cook Incorporated Stent having less invasive ends
US20100070020A1 (en) * 2008-06-11 2010-03-18 Nanovasc, Inc. Implantable Medical Device
US20100331957A1 (en) * 2007-06-11 2010-12-30 Nanovasc, Inc. Implantable medical device
US20110196060A1 (en) * 2005-04-01 2011-08-11 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
US20110224774A1 (en) * 2007-11-30 2011-09-15 Silveira Pierre G Endoprosthesis and delivery system for delivering the endoprosthesis within a vessel of a patient
US20130023981A1 (en) * 2008-08-29 2013-01-24 William Kurt Dierking Barbed anchor
US8663309B2 (en) * 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8679572B2 (en) 2008-08-28 2014-03-25 Cook Medical Technologies, LLC Coated stent
US20160058546A1 (en) * 2002-07-22 2016-03-03 Timur P. Sarac Percutaneous endovascular apparatus for repair of aneurysms and arterial blockages
US9504568B2 (en) * 2007-02-16 2016-11-29 Medtronic, Inc. Replacement prosthetic heart valves and methods of implantation
US20170014221A1 (en) * 2015-07-19 2017-01-19 Sanford Health Bridging Stent Graft with Interlocking Features and Methods for Use
CN107569311A (en) * 2017-07-05 2018-01-12 杭州唯强医疗科技有限公司 Ring holder
US10105209B2 (en) 2001-04-11 2018-10-23 Andrew Kerr Stent/graft assembly
US10470871B2 (en) 2001-12-20 2019-11-12 Trivascular, Inc. Advanced endovascular graft
WO2020190953A1 (en) * 2019-03-19 2020-09-24 Q3 Medical Devices Limited Stent with anti-migration devices
US11207199B2 (en) 2008-06-11 2021-12-28 Q3 Medical Devices Limited Stent with anti-migration devices

Families Citing this family (216)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100318181A1 (en) * 1998-12-11 2010-12-16 Endologix, Inc. Implantable vascular graft
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US6979347B1 (en) * 2000-10-23 2005-12-27 Advanced Cardiovascular Systems, Inc. Implantable drug delivery prosthesis
US8038708B2 (en) 2001-02-05 2011-10-18 Cook Medical Technologies Llc Implantable device with remodelable material and covering material
AUPR847201A0 (en) * 2001-10-26 2001-11-15 Cook Incorporated Endoluminal graft
US20060292206A1 (en) 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
US20100016943A1 (en) 2001-12-20 2010-01-21 Trivascular2, Inc. Method of delivering advanced endovascular graft
US7828839B2 (en) * 2002-05-16 2010-11-09 Cook Incorporated Flexible barb for anchoring a prosthesis
US7044962B2 (en) * 2002-06-25 2006-05-16 Scimed Life Systems, Inc. Implantable prosthesis with displaceable skirt
US20070038288A1 (en) * 2002-07-11 2007-02-15 Whye-Kei Lye Methods and apparatuses for repairing aneurysms
US20040034407A1 (en) * 2002-08-16 2004-02-19 John Sherry Covered stents with degradable barbs
EP1542616B1 (en) 2002-09-20 2015-04-22 Endologix, Inc. Stent-graft with positioning anchor
US7481821B2 (en) 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
US20040143342A1 (en) * 2003-01-16 2004-07-22 Stack Richard S. Satiation pouches and methods of use
US20040260382A1 (en) 2003-02-12 2004-12-23 Fogarty Thomas J. Intravascular implants and methods of using the same
US7717952B2 (en) 2003-04-24 2010-05-18 Cook Incorporated Artificial prostheses with preferred geometries
DE602004023708D1 (en) * 2003-04-24 2009-12-03 Cook Inc ARTIFICIAL FLAP FLAP WITH IMPROVED FLOW BEHAVIOR
US7625399B2 (en) * 2003-04-24 2009-12-01 Cook Incorporated Intralumenally-implantable frames
US20050015110A1 (en) 2003-07-18 2005-01-20 Fogarty Thomas J. Embolization device and a method of using the same
DE10337739B4 (en) * 2003-08-12 2009-11-26 Jotec Gmbh Stent for implantation in a blood vessel, especially in the area of the aortic arch
US20050090804A1 (en) * 2003-10-22 2005-04-28 Trivascular, Inc. Endoluminal prosthesis endoleak management
US7338530B2 (en) * 2003-11-24 2008-03-04 Checkmed Systems, Inc. Stent
EP1708763A4 (en) * 2004-01-07 2011-03-23 Trivascular Inc Methods, compositions, and devices for embolizing body lumens
ATE455520T1 (en) * 2004-01-27 2010-02-15 Med Inst Inc BARB FOR ATTACHING TO A MEDICAL PROSTHESIS
US7803178B2 (en) * 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
EP2308425B2 (en) 2004-03-11 2023-10-18 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous Heart Valve Prosthesis
US7641686B2 (en) * 2004-04-23 2010-01-05 Direct Flow Medical, Inc. Percutaneous heart valve with stentless support
EP2422751A3 (en) 2004-05-05 2013-01-02 Direct Flow Medical, Inc. Unstented heart valve with formed in place support structure
US20050283226A1 (en) * 2004-06-18 2005-12-22 Scimed Life Systems, Inc. Medical devices
EP1763327B1 (en) * 2004-07-02 2018-09-12 Cook Medical Technologies LLC Balloon / self-expanding stent graft
US8048145B2 (en) 2004-07-22 2011-11-01 Endologix, Inc. Graft systems having filling structures supported by scaffolds and methods for their use
US7530988B2 (en) * 2004-07-22 2009-05-12 Nellix, Inc. Methods and systems for endovascular aneurysm treatment
WO2006015111A2 (en) * 2004-07-27 2006-02-09 University Of Southern California Percutaneously retrievable stent assembly with fluid draining capability
WO2006023871A2 (en) * 2004-08-24 2006-03-02 Vision Membrane Technologies, Inc. Foldable intraocular lens with adaptable haptics
US7588596B2 (en) * 2004-12-29 2009-09-15 Scimed Life Systems, Inc. Endoluminal prosthesis adapted to resist migration and method of deploying the same
US20060248698A1 (en) * 2005-05-05 2006-11-09 Hanson Brian J Tubular stent and methods of making the same
CA2610669A1 (en) 2005-06-07 2006-12-14 Direct Flow Medical, Inc. Stentless aortic valve replacement with high radial strength
US7666220B2 (en) 2005-07-07 2010-02-23 Nellix, Inc. System and methods for endovascular aneurysm treatment
CA2829353C (en) 2005-07-27 2016-03-15 Cook Medical Technologies Llc Stent/graft device and method for open surgical placement
US20070038292A1 (en) * 2005-08-09 2007-02-15 Moise Danielpour Bio-absorbable stent
US7731741B2 (en) * 2005-09-08 2010-06-08 Boston Scientific Scimed, Inc. Inflatable bifurcation stent
WO2007058857A2 (en) 2005-11-10 2007-05-24 Arshad Quadri Balloon-expandable, self-expanding, vascular prosthesis connecting stent
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
EP3360509B1 (en) 2006-07-31 2022-06-22 Syntheon TAVR, LLC Sealable endovascular implants
AU2013260693B2 (en) * 2006-07-31 2015-02-12 Edwards Lifesciences Cardiaq Llc Sealable endovascular implants and methods for their use
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US7935144B2 (en) 2006-10-19 2011-05-03 Direct Flow Medical, Inc. Profile reduction of valve implant
US8133213B2 (en) 2006-10-19 2012-03-13 Direct Flow Medical, Inc. Catheter guidance through a calcified aortic valve
US7655034B2 (en) * 2006-11-14 2010-02-02 Medtronic Vascular, Inc. Stent-graft with anchoring pins
EP2111190B1 (en) * 2007-01-19 2013-10-09 Medtronic, Inc. Stented heart valve devices for atrioventricular valve replacement
US20080188923A1 (en) * 2007-02-01 2008-08-07 Jack Fa-De Chu Endovascular devices to protect aneurysmal wall
US8974514B2 (en) 2007-03-13 2015-03-10 Abbott Cardiovascular Systems Inc. Intravascular stent with integrated link and ring strut
US20080228259A1 (en) * 2007-03-16 2008-09-18 Jack Fa-De Chu Endovascular devices and methods to protect aneurysmal wall
US20080294237A1 (en) * 2007-04-04 2008-11-27 Jack Fa-De Chu Inflatable devices and methods to protect aneurysmal wall
US20080255653A1 (en) * 2007-04-13 2008-10-16 Medtronic Vascular, Inc. Multiple Stent Delivery System and Method
US20080262590A1 (en) * 2007-04-19 2008-10-23 Medtronic Vascular, Inc. Delivery System for Stent-Graft
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
WO2009021181A1 (en) 2007-08-09 2009-02-12 Boston Scientific Scimed, Inc. Endoprosthesis holder
US9237959B2 (en) * 2007-08-17 2016-01-19 Cook Medical Technologies Llc Stent and barb
EP3075355A1 (en) 2007-08-23 2016-10-05 Direct Flow Medical, Inc. Translumenally implantable heart valve with formed in place support
US8066755B2 (en) * 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US20090082847A1 (en) * 2007-09-26 2009-03-26 Boston Scientific Corporation System and method of securing stent barbs
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US20090082841A1 (en) * 2007-09-26 2009-03-26 Boston Scientific Corporation Apparatus for securing stent barbs
WO2009042789A2 (en) * 2007-09-26 2009-04-02 Trivascular2, Inc. Stent deployment devices and methods
EP2194919A4 (en) * 2007-09-26 2013-05-08 Trivascular Inc Alignment stent apparatus and method
WO2009046372A2 (en) 2007-10-04 2009-04-09 Trivascular2, Inc. Modular vascular graft for low profile percutaneous delivery
US20090112237A1 (en) * 2007-10-26 2009-04-30 Cook Critical Care Incorporated Vascular conduit and delivery system for open surgical placement
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8328861B2 (en) * 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US20090149946A1 (en) * 2007-12-05 2009-06-11 Cook Incorporated Stent having at least one barb and methods of manufacture
US10022250B2 (en) 2007-12-12 2018-07-17 Intact Vascular, Inc. Deployment device for placement of multiple intraluminal surgical staples
US9603730B2 (en) 2007-12-12 2017-03-28 Intact Vascular, Inc. Endoluminal device and method
US10166127B2 (en) 2007-12-12 2019-01-01 Intact Vascular, Inc. Endoluminal device and method
US9375327B2 (en) 2007-12-12 2016-06-28 Intact Vascular, Inc. Endovascular implant
US7896911B2 (en) 2007-12-12 2011-03-01 Innovasc Llc Device and method for tacking plaque to blood vessel wall
US8128677B2 (en) 2007-12-12 2012-03-06 Intact Vascular LLC Device and method for tacking plaque to a blood vessel wall
GB2476451A (en) 2009-11-19 2011-06-29 Cook William Europ Stent Graft
EP2240119B1 (en) * 2007-12-26 2018-03-28 Cook Medical Technologies LLC Stent and method of making a stent
US9226813B2 (en) 2007-12-26 2016-01-05 Cook Medical Technologies Llc Low profile non-symmetrical stent
US9180030B2 (en) 2007-12-26 2015-11-10 Cook Medical Technologies Llc Low profile non-symmetrical stent
US8574284B2 (en) 2007-12-26 2013-11-05 Cook Medical Technologies Llc Low profile non-symmetrical bare alignment stents with graft
US7905915B2 (en) * 2007-12-27 2011-03-15 Cook Incorporated Z-stent with incorporated barbs
US20090235168A1 (en) * 2008-03-14 2009-09-17 Colin Raymond Dawson User mediated embedded help system
CN101902988A (en) 2008-04-25 2010-12-01 耐利克斯股份有限公司 The induction system of stent graft
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
CA2726596A1 (en) 2008-06-04 2009-12-10 Nellix, Inc. Sealing apparatus and methods of use
CA3201875A1 (en) 2008-06-06 2009-12-10 Edwards Lifesciences Corporation Low profile transcatheter heart valve
US8454679B2 (en) * 2008-07-10 2013-06-04 Atrial Systems, Llc Endovascular conduit device for increasing safety of cardiac lead extraction and other vascular procedures
US8454680B2 (en) * 2008-07-10 2013-06-04 Atrial Systems, Llc Endovascular conduit device with low profile occlusion members
CN102245129B (en) 2008-07-21 2015-03-18 詹妮弗·K·怀特 Repositionable endoluminal support structure and its applications
CA2749026C (en) 2008-09-29 2018-01-09 Impala, Inc. Heart valve
EP2341871B1 (en) 2008-10-01 2017-03-22 Edwards Lifesciences CardiAQ LLC Delivery system for vascular implant
JP2012523894A (en) 2009-04-15 2012-10-11 カルディアック バルブ テクノロジーズ,インコーポレーテッド Vascular implant and its placement system
US9468515B2 (en) * 2009-07-01 2016-10-18 Correx, Inc. Method and apparatus for effecting a percutaneous aortic valve bypass
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
US8690749B1 (en) 2009-11-02 2014-04-08 Anthony Nunez Wireless compressible heart pump
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US9757263B2 (en) 2009-11-18 2017-09-12 Cook Medical Technologies Llc Stent graft and introducer assembly
US20110276078A1 (en) 2009-12-30 2011-11-10 Nellix, Inc. Filling structure for a graft system and methods of use
US20110218609A1 (en) * 2010-02-10 2011-09-08 Trivascular, Inc. Fill tube manifold and delivery methods for endovascular graft
US8454682B2 (en) 2010-04-13 2013-06-04 Medtronic Vascular, Inc. Anchor pin stent-graft delivery system
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9433501B2 (en) 2010-05-19 2016-09-06 Direct Flow Medical, Inc. Inflation media for implants
US9603708B2 (en) 2010-05-19 2017-03-28 Dfm, Llc Low crossing profile delivery catheter for cardiovascular prosthetic implant
US10271970B2 (en) 2010-08-03 2019-04-30 Cook Medical Technologies Llc Blood perfusion device
US20120035706A1 (en) 2010-08-03 2012-02-09 Cook Medical Technologies Llc Blood perfusion device delivery system
EP2618784B1 (en) 2010-09-23 2016-05-25 Edwards Lifesciences CardiAQ LLC Replacement heart valves and delivery devices
US8801768B2 (en) 2011-01-21 2014-08-12 Endologix, Inc. Graft systems having semi-permeable filling structures and methods for their use
WO2012139054A1 (en) 2011-04-06 2012-10-11 Endologix, Inc. Method and system for endovascular aneurysm treatment
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US10390977B2 (en) 2011-06-03 2019-08-27 Intact Vascular, Inc. Endovascular implant
US8795357B2 (en) 2011-07-15 2014-08-05 Edwards Lifesciences Corporation Perivalvular sealing for transcatheter heart valve
JP2014525811A (en) 2011-08-12 2014-10-02 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド Apparatus and method for approximating a cross-sectional profile of a vasculature with branches
US10213329B2 (en) 2011-08-12 2019-02-26 W. L. Gore & Associates, Inc. Evertable sheath devices, systems, and methods
US9144486B2 (en) * 2011-10-14 2015-09-29 Trivascular, Inc. Fenestrated inflatable graft
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9877858B2 (en) 2011-11-14 2018-01-30 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US9782282B2 (en) 2011-11-14 2017-10-10 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
EP2606854B1 (en) * 2011-12-22 2016-10-19 Cook Medical Technologies LLC Low profile non-symmetrical stents and stent grafts
EP3733134A1 (en) 2012-01-25 2020-11-04 Intact Vascular, Inc. Endoluminal device
EP3281608B1 (en) 2012-02-10 2020-09-16 CVDevices, LLC Medical product comprising a frame and visceral pleura
US9687371B2 (en) 2012-02-14 2017-06-27 W. L. Gore & Associates, Inc. Endoprosthesis having aligned legs for ease of cannulation
US9375308B2 (en) 2012-03-13 2016-06-28 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US9993328B2 (en) 2012-04-03 2018-06-12 Trivascular, Inc. Advanced kink resistant stent graft
US8992595B2 (en) * 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) * 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9445897B2 (en) 2012-05-01 2016-09-20 Direct Flow Medical, Inc. Prosthetic implant delivery device with introducer catheter
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US9066828B2 (en) 2012-06-15 2015-06-30 Trivascular, Inc. Endovascular delivery system with flexible and torqueable hypotube
US9233015B2 (en) 2012-06-15 2016-01-12 Trivascular, Inc. Endovascular delivery system with an improved radiopaque marker scheme
US9132025B2 (en) 2012-06-15 2015-09-15 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US9681965B2 (en) 2012-07-31 2017-06-20 Cook Medical Technologies Llc Barbed anchors for attachment to endoluminal prosthesis
US9724186B2 (en) 2012-10-10 2017-08-08 Trivascular, Inc. Endovascular graft for aneurysms involving major branch vessels
EP2943153A1 (en) 2013-01-10 2015-11-18 TriVascular, Inc. Gate wire for contralateral leg access
US9655754B2 (en) 2013-01-10 2017-05-23 Trivascular, Inc. Systems and methods for guidewire crossover for bifurcated prostheses
CA2900862C (en) 2013-02-11 2017-10-03 Cook Medical Technologies Llc Expandable support frame and medical device
US9763819B1 (en) 2013-03-05 2017-09-19 W. L. Gore & Associates, Inc. Tapered sleeve
US9987155B1 (en) 2013-03-07 2018-06-05 W. L. Gore & Associates, Inc. Implantable medical devices and related delivery systems
US10583002B2 (en) 2013-03-11 2020-03-10 Neovasc Tiara Inc. Prosthetic valve with anti-pivoting mechanism
US20140277368A1 (en) * 2013-03-12 2014-09-18 Cordis Corporation Prosthesis comprising a coiled stent and method of use thereof
US11154350B2 (en) * 2013-03-13 2021-10-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter having electronic device disposed within a lumen
US10561509B2 (en) 2013-03-13 2020-02-18 DePuy Synthes Products, Inc. Braided stent with expansion ring and method of delivery
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
EP2968692B8 (en) 2013-03-14 2021-02-24 Endologix LLC Method for forming materials in situ within a medical device
US9259335B2 (en) 2013-03-15 2016-02-16 Covidien Lp Stent
US9180031B2 (en) 2013-03-15 2015-11-10 Covidien Lp Stent with varying radius between struts
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US9907684B2 (en) 2013-05-08 2018-03-06 Aneuclose Llc Method of radially-asymmetric stent expansion
US9724083B2 (en) 2013-07-26 2017-08-08 Edwards Lifesciences Cardiaq Llc Systems and methods for sealing openings in an anatomical wall
US11123205B2 (en) * 2013-09-24 2021-09-21 Trivascular, Inc. Tandem modular endograft
EP3409243B1 (en) 2014-01-09 2022-07-20 TriVascular, Inc. Endovasular delivery system
US9907641B2 (en) 2014-01-10 2018-03-06 W. L. Gore & Associates, Inc. Implantable intraluminal device
CN104906682A (en) 2014-01-24 2015-09-16 史蒂文·沙勒布瓦 Articulating balloon catheter and method for using the same
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
US10966850B2 (en) 2014-03-06 2021-04-06 W. L. Gore & Associates, Inc. Implantable medical device constraint and deployment apparatus
JP6959003B2 (en) 2014-03-10 2021-11-02 トリバスキュラー インコーポレイテッド Inflatable occlusion wire balloon for aortic applications
US9974675B2 (en) 2014-04-04 2018-05-22 W. L. Gore & Associates, Inc. Delivery and deployment systems for bifurcated stent grafts
US9833346B2 (en) 2014-04-04 2017-12-05 W. L. Gore & Associates, Inc. Deployment handle for a medical device deployment system
KR101628711B1 (en) * 2014-06-26 2016-06-09 주식회사 에스앤지바이오텍 Stent With External Flow Path
US10478324B2 (en) 2014-08-12 2019-11-19 W. L. Gore & Associates, Inc. Handle for medical device deployment
US10206796B2 (en) 2014-08-27 2019-02-19 DePuy Synthes Products, Inc. Multi-strand implant with enhanced radiopacity
WO2016065208A1 (en) 2014-10-23 2016-04-28 Trivascular, Inc. Stent graft delivery system with access conduit
JP6960334B2 (en) 2014-12-04 2021-11-05 トリバスキュラー インコーポレイテッド Internal iliac artery preservation device and method
US10166126B2 (en) * 2014-12-08 2019-01-01 Boston Scientific Scimed, Inc. Inflatable balloon stent
US9375336B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
US9433520B2 (en) 2015-01-29 2016-09-06 Intact Vascular, Inc. Delivery device and method of delivery
JP6766078B2 (en) 2015-06-01 2020-10-07 エドワーズ ライフサイエンシーズ コーポレイションEdwards Lifesciences Corporation Heart valve repair device configured for percutaneous delivery
CA2990872C (en) 2015-06-22 2022-03-22 Edwards Lifescience Cardiaq Llc Actively controllable heart valve implant and methods of controlling same
US10092400B2 (en) 2015-06-23 2018-10-09 Edwards Lifesciences Cardiaq Llc Systems and methods for anchoring and sealing a prosthetic heart valve
US20170042551A1 (en) 2015-08-13 2017-02-16 The Brain Protection Company PTY LTD Implantable damping devices for treating dementia and associated systems and methods of use
CN105167892A (en) * 2015-09-02 2015-12-23 先健科技(深圳)有限公司 Implanted medical device
CN105147424A (en) * 2015-09-25 2015-12-16 北京工业大学 Novel vascular stent
US10034785B1 (en) 2015-10-13 2018-07-31 W. L. Gore & Associates, Inc. Single site access aortic aneurysm repair method
US10993824B2 (en) 2016-01-01 2021-05-04 Intact Vascular, Inc. Delivery device and method of delivery
US10052185B2 (en) * 2016-02-12 2018-08-21 Covidien Lp Vascular device marker attachment
CN205612594U (en) * 2016-03-15 2016-10-05 北京奇伦天佑创业投资有限公司 Take ramose tectorial membrane support and implantation system thereof
CN105769383B (en) * 2016-03-18 2019-12-10 杭州唯强医疗科技有限公司 Aorta bare stent and aorta interlayer stent
US10350062B2 (en) 2016-07-21 2019-07-16 Edwards Lifesciences Corporation Replacement heart valve prosthesis
WO2018027215A1 (en) 2016-08-05 2018-02-08 W. L. Gore & Associates, Inc. Integrated medical device constraining lumen
EP3503852B1 (en) 2016-08-24 2020-06-03 W. L. Gore & Associates, Inc. Sleeves for expandable medical devices
US10076428B2 (en) 2016-08-25 2018-09-18 DePuy Synthes Products, Inc. Expansion ring for a braided stent
ES2902516T3 (en) 2016-08-26 2022-03-28 St Jude Medical Cardiology Div Inc Prosthetic heart valve with paravalvular leak mitigation features
US10292851B2 (en) 2016-09-30 2019-05-21 DePuy Synthes Products, Inc. Self-expanding device delivery apparatus with dual function bump
CN113813089A (en) * 2016-11-09 2021-12-21 波士顿科学国际有限公司 Stent anchoring system
US10905572B2 (en) 2016-11-14 2021-02-02 Covidien Lp Stent
US10449069B2 (en) 2016-11-14 2019-10-22 Covidien Lp Stent
US10258488B2 (en) 2016-11-14 2019-04-16 Covidien Lp Stent
US20200215284A9 (en) * 2016-12-22 2020-07-09 E-PROSPERITY & DEVELOPMENT CO., Ltd. Airway device
EP3582844B1 (en) 2017-02-14 2023-05-17 W. L. Gore & Associates, Inc. Implantable medical device delivery systems
USD889653S1 (en) 2017-05-15 2020-07-07 St. Jude Medical, Cardiology Division, Inc. Stent having tapered struts
USD875935S1 (en) 2017-05-15 2020-02-18 St. Jude Medical, Cardiology Division, Inc. Stent having tapered struts
USD875250S1 (en) 2017-05-15 2020-02-11 St. Jude Medical, Cardiology Division, Inc. Stent having tapered aortic struts
US11660218B2 (en) 2017-07-26 2023-05-30 Intact Vascular, Inc. Delivery device and method of delivery
US10849769B2 (en) * 2017-08-23 2020-12-01 Vesper Medical, Inc. Non-foreshortening stent
EP3694450B1 (en) 2017-10-11 2023-08-02 W. L. Gore & Associates, Inc. Implantable medical device constraint and deployment apparatus
CN111818877B (en) 2018-01-25 2023-12-22 爱德华兹生命科学公司 Delivery system for assisting in recapture and repositioning of replacement valves after deployment
US10441449B1 (en) 2018-05-30 2019-10-15 Vesper Medical, Inc. Rotary handle stent delivery system and method
AU2019204522A1 (en) 2018-07-30 2020-02-13 DePuy Synthes Products, Inc. Systems and methods of manufacturing and using an expansion ring
US10456280B1 (en) 2018-08-06 2019-10-29 DePuy Synthes Products, Inc. Systems and methods of using a braided implant
US10278848B1 (en) 2018-08-06 2019-05-07 DePuy Synthes Products, Inc. Stent delivery with expansion assisting delivery wire
US10449073B1 (en) 2018-09-18 2019-10-22 Vesper Medical, Inc. Rotary handle stent delivery system and method
CN109223250B (en) * 2018-10-12 2020-12-29 大连科万维医疗科技有限公司 Suture-free integrated branch covered stent blood vessel
US11039944B2 (en) 2018-12-27 2021-06-22 DePuy Synthes Products, Inc. Braided stent system with one or more expansion rings
DE102020101232A1 (en) 2019-01-21 2020-07-23 Advanced Angioneers UG (haftungsbeschränkt) Endoluminally implantable device
CN113853178A (en) 2019-03-20 2021-12-28 Inqb8医疗科技有限责任公司 Aortic dissection implant
US20210121180A1 (en) * 2019-10-24 2021-04-29 Atrium Medical Corporation Endovascular fixation device
EP3854349A1 (en) * 2020-01-23 2021-07-28 Kardiozis SAS Endoprosthesis and method of manufacturing an endoprosthesis
US11219541B2 (en) 2020-05-21 2022-01-11 Vesper Medical, Inc. Wheel lock for thumbwheel actuated device
WO2022076366A1 (en) * 2020-10-06 2022-04-14 Major Medical Devices Inc Systems and methods for preventing endovascular leaks
EP4321186A1 (en) 2021-03-30 2024-02-14 GRUNWALD, Sorin Devices for fistula-free hemodialysis
CN114098883B (en) * 2022-01-27 2022-06-17 上海微创心脉医疗科技(集团)股份有限公司 Support conveying device and support conveying system

Citations (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US617571A (en) * 1899-01-10 Canopy for boats
US3631854A (en) * 1969-05-19 1972-01-04 Robert Howard Fryer Inflatable medical assemblies
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4183102A (en) * 1977-09-08 1980-01-15 Jacques Guiset Inflatable prosthetic device for lining a body duct
US4187390A (en) * 1970-05-21 1980-02-05 W. L. Gore & Associates, Inc. Porous products and process therefor
US4497074A (en) * 1976-04-05 1985-02-05 Agence National De Valorisation De La Recherche (Anvar) Organ prostheses
US4562596A (en) * 1984-04-25 1986-01-07 Elliot Kornberg Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4647416A (en) * 1983-08-03 1987-03-03 Shiley Incorporated Method of preparing a vascular graft prosthesis
US4739762A (en) * 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4816028A (en) * 1987-07-01 1989-03-28 Indu Kapadia Woven vascular graft
US5100422A (en) * 1989-05-26 1992-03-31 Impra, Inc. Blood vessel patch
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US5104400A (en) * 1989-05-26 1992-04-14 Impra, Inc. Blood vessel patch
US5108424A (en) * 1984-01-30 1992-04-28 Meadox Medicals, Inc. Collagen-impregnated dacron graft
US5275622A (en) * 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
US5282847A (en) * 1991-02-28 1994-02-01 Medtronic, Inc. Prosthetic vascular grafts with a pleated structure
US5292514A (en) * 1992-06-24 1994-03-08 Minnesota Mining And Manufacturing Company Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof
US5387235A (en) * 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
US5405379A (en) * 1990-07-26 1995-04-11 Lane; Rodney J. Self expanding vascular endoprosthesis for aneurysms
US5489295A (en) * 1991-04-11 1996-02-06 Endovascular Technologies, Inc. Endovascular graft having bifurcation and apparatus and method for deploying the same
US5507770A (en) * 1994-11-23 1996-04-16 Aeroquip Corporation Intraluminal grafting stent and method for implanting same in a blood vessel
US5507769A (en) * 1994-10-18 1996-04-16 Stentco, Inc. Method and apparatus for forming an endoluminal bifurcated graft
US5591229A (en) * 1990-06-11 1997-01-07 Parodi; Juan C. Aortic graft for repairing an abdominal aortic aneurysm
US5607478A (en) * 1996-03-14 1997-03-04 Meadox Medicals Inc. Yarn wrapped PTFE tubular prosthesis
US5607468A (en) * 1994-11-04 1997-03-04 Aeroquip Corporation Method of manufacturing an intraluminal stenting graft
US5609628A (en) * 1995-04-20 1997-03-11 Keranen; Victor J. Intravascular graft and catheter
US5609624A (en) * 1993-10-08 1997-03-11 Impra, Inc. Reinforced vascular graft and method of making same
US5707378A (en) * 1994-09-02 1998-01-13 Sam S. Ahn Apparatus and method for performing aneurysm repair
US5709703A (en) * 1995-11-14 1998-01-20 Schneider (Europe) A.G. Stent delivery device and method for manufacturing same
US5709701A (en) * 1996-05-30 1998-01-20 Parodi; Juan C. Apparatus for implanting a prothesis within a body passageway
US5713917A (en) * 1995-10-30 1998-02-03 Leonhardt; Howard J. Apparatus and method for engrafting a blood vessel
US5716395A (en) * 1992-12-11 1998-02-10 W.L. Gore & Associates, Inc. Prosthetic vascular graft
US5718973A (en) * 1993-08-18 1998-02-17 W. L. Gore & Associates, Inc. Tubular intraluminal graft
US5718159A (en) * 1996-04-30 1998-02-17 Schneider (Usa) Inc. Process for manufacturing three-dimensional braided covered stent
US5720776A (en) * 1991-10-25 1998-02-24 Cook Incorporated Barb and expandable transluminal graft prosthesis for repair of aneurysm
US5723004A (en) * 1993-10-21 1998-03-03 Corvita Corporation Expandable supportive endoluminal grafts
US5733325A (en) * 1993-11-04 1998-03-31 C. R. Bard, Inc. Non-migrating vascular prosthesis and minimally invasive placement system
US5735892A (en) * 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5855598A (en) * 1993-10-21 1999-01-05 Corvita Corporation Expandable supportive branched endoluminal grafts
US5871537A (en) * 1996-02-13 1999-02-16 Scimed Life Systems, Inc. Endovascular apparatus
US5871536A (en) * 1993-11-08 1999-02-16 Lazarus; Harrison M. Intraluminal vascular graft and method
US6015431A (en) * 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US6019787A (en) * 1992-03-12 2000-02-01 Laboratoire Perouse Implant Fitting tool for use of an expansible endoprosthesis for a human or animal tubular organ
US6025044A (en) * 1993-08-18 2000-02-15 W. L. Gore & Associates, Inc. Thin-wall polytetrafluoroethylene tube
US6027811A (en) * 1993-08-18 2000-02-22 W. L. Gore & Associates, Inc. Thin-wall intraluminal graft
US6030415A (en) * 1997-01-29 2000-02-29 Endovascular Technologies, Inc. Bell-bottom modular stent-graft
US6036723A (en) * 1996-05-02 2000-03-14 B. Braun Celsa Surgically anastomosable transcutaneous vascular prothesis and set comprising the same
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US6039755A (en) * 1997-02-05 2000-03-21 Impra, Inc., A Division Of C.R. Bard, Inc. Radially expandable tubular polytetrafluoroethylene grafts and method of making same
US6042605A (en) * 1995-12-14 2000-03-28 Gore Enterprose Holdings, Inc. Kink resistant stent-graft
US6051020A (en) * 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US6053943A (en) * 1995-12-08 2000-04-25 Impra, Inc. Endoluminal graft with integral structural support and method for making same
US6183504B1 (en) * 1995-05-19 2001-02-06 Kanji Inoue Appliance to be implanted, method of collapsing the appliance to be implanted and method of using the appliance to be implanted
US6187036B1 (en) * 1998-12-11 2001-02-13 Endologix, Inc. Endoluminal vascular prosthesis
US6197049B1 (en) * 1999-02-17 2001-03-06 Endologix, Inc. Articulating bifurcation graft
US6203568B1 (en) * 1996-04-05 2001-03-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US6221102B1 (en) * 1983-12-09 2001-04-24 Endovascular Technologies, Inc. Intraluminal grafting system
US6336937B1 (en) * 1998-12-09 2002-01-08 Gore Enterprise Holdings, Inc. Multi-stage expandable stent-graft
US20020007193A1 (en) * 1998-07-01 2002-01-17 Howard Tanner Method and apparatus for the surgical repair of aneurysms
US20020007212A1 (en) * 1995-03-01 2002-01-17 Brown Brian J. Longitudinally flexible expandable stent
US6344044B1 (en) * 2000-02-11 2002-02-05 Edwards Lifesciences Corp. Apparatus and methods for delivery of intraluminal prosthesis
US6344444B1 (en) * 1997-02-12 2002-02-05 Nutrition 21 Arginine-silicate-inositol complex and use thereof
US6344054B1 (en) * 1996-09-20 2002-02-05 Juan Carlos Parodi Endoluminal prosthesis comprising stent and overlying graft cover, and system and method for deployment thereof
US20020016623A1 (en) * 1999-04-08 2002-02-07 Kula John S. Stent with variable wall thickness
US20020016627A1 (en) * 2000-01-19 2002-02-07 Scimed Life Systems, Inc. Tubular structure/stent/stent securement member
US20020016626A1 (en) * 1999-04-01 2002-02-07 Boston Scientific Corporation Intraluminal lining
US20020019665A1 (en) * 1998-09-30 2002-02-14 Mark Dehdashtian Methods and apparatus for intraluminal placement of a bifurcated intraluminal graft
US20020026231A1 (en) * 1996-07-03 2002-02-28 Donald T. Shannon Radially expandable stented tubular PTFE grafts
US6352553B1 (en) * 1995-12-14 2002-03-05 Gore Enterprise Holdings, Inc. Stent-graft deployment apparatus and method
US6355056B1 (en) * 1995-06-01 2002-03-12 Meadox Medicals, Inc. Implantable intraluminal prosthesis
US6355055B1 (en) * 1995-09-01 2002-03-12 Emory University Endovascular support device and method of use
US20020032408A1 (en) * 2000-07-14 2002-03-14 Cook Incorporated Medical device including tube having a braid and an expanded coil
US20020040237A1 (en) * 1997-01-17 2002-04-04 Meadox Medicals, Inc. ePTFE graft-stent composite device
US6368355B1 (en) * 1998-05-13 2002-04-09 Renan Uflacker Stent or graft support structure for treating bifurcated vessels having different diameter portions and methods of use and implantation
US20020042644A1 (en) * 2000-10-10 2002-04-11 Greenhalgh E. Skott Bifurcated fabric sleeve stent graft with junction region strengthening elements
US20020042645A1 (en) * 1996-07-03 2002-04-11 Shannon Donald T. Drug eluting radially expandable tubular stented grafts
US20020045933A1 (en) * 2000-09-25 2002-04-18 Jang G. David Intravascular stent apparatus
US20020045931A1 (en) * 1996-09-26 2002-04-18 David Sogard Support structure/membrane composite medical device
US20020045935A1 (en) * 2000-09-23 2002-04-18 Jang G. David Intravascular stent apparatus
US20020045934A1 (en) * 2000-09-25 2002-04-18 Jang G. David Intravascular stent apparatus
US20020049493A1 (en) * 1996-04-26 2002-04-25 Jang G. David Intravascular stent
US20020049487A1 (en) * 2000-08-30 2002-04-25 Biotronik Mess-Und Therapiegeraete Gmbh & Co Ingenieurbuero Berlin Stress-optimized stent
US20020049490A1 (en) * 2000-04-11 2002-04-25 Pollock David T. Single-piece endoprosthesis with high expansion ratios
US20030009212A1 (en) * 2001-07-06 2003-01-09 Andrew Kerr Axially-connected stent/graft assembly
US20030009211A1 (en) * 2001-07-03 2003-01-09 Dicarlo Paul Implant having improved fixation to a body lumen and method for implanting the same
US6517574B1 (en) * 2000-04-27 2003-02-11 Endovascular Technologies, Inc. System and method for endovascular aneurysm repair in conjunction with vascular stabilization
US6520984B1 (en) * 2000-04-28 2003-02-18 Cardiovasc, Inc. Stent graft assembly and method
US6533811B1 (en) * 1993-07-08 2003-03-18 Medtronic, Inc. Internal graft prosthesis and delivery system
US20030074048A1 (en) * 2001-10-16 2003-04-17 Scimed Life Systems, Inc. Tubular prosthesis for external agent delivery
US20030074050A1 (en) * 2001-07-06 2003-04-17 Andrew Kerr Stent/graft assembly
US20030074058A1 (en) * 2001-10-16 2003-04-17 Scimed Life Systems, Inc. Aortic artery aneurysm endovascular prosthesis

Family Cites Families (902)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2978787A (en) 1957-04-18 1961-04-11 Meadox Medicals Inc Synthetic vascular implants and the manufacture thereof
US3142067A (en) 1958-11-21 1964-07-28 William J Liebig Synthetic vascular implants
US3029819A (en) 1959-07-30 1962-04-17 J L Mcatee Artery graft and method of producing artery grafts
US3540431A (en) 1968-04-04 1970-11-17 Kazi Mobin Uddin Collapsible filter for fluid flowing in closed passageway
US3631845A (en) 1969-09-26 1972-01-04 Brooks Walker Spark timing control for internal-combustion engine
US3945052A (en) 1972-05-01 1976-03-23 Meadox Medicals, Inc. Synthetic vascular graft and method for manufacturing the same
US3805301A (en) 1972-07-28 1974-04-23 Meadox Medicals Inc Tubular grafts having indicia thereon
US3818511A (en) 1972-11-17 1974-06-25 Medical Prod Corp Medical prosthesis for ducts or conduits
US3991767A (en) 1973-11-02 1976-11-16 Cutter Laboratories, Inc. Tubular unit with vessel engaging cuff structure
US3900027A (en) 1974-01-02 1975-08-19 Pall Corp Process for preparing integral absorbent pad bandages and product
US3986828A (en) 1974-03-05 1976-10-19 Meadox Medicals, Inc. Polymer fabric compacting process
US3902198A (en) 1974-05-20 1975-09-02 Gore & Ass Method of replacing a body part with expanded porous polytetrafluoroethylene
US4374669A (en) 1975-05-09 1983-02-22 Mac Gregor David C Cardiovascular prosthetic devices and implants with porous systems
US4208745A (en) 1976-01-21 1980-06-24 Sumitomo Electric Industries, Ltd. Vascular prostheses composed of polytetrafluoroethylene and process for their production
DE2806030C2 (en) 1978-02-14 1984-02-02 B. Braun Melsungen Ag, 3508 Melsungen Process for the production of a tubular blood vessel prosthesis
US4214587A (en) 1979-02-12 1980-07-29 Sakura Chester Y Jr Anastomosis device and method
US4501263A (en) 1982-03-31 1985-02-26 Harbuck Stanley C Method for reducing hypertension of a liver
US4902289A (en) 1982-04-19 1990-02-20 Massachusetts Institute Of Technology Multilayer bioreplaceable blood vessel prosthesis
SE445884B (en) * 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
GB2121286B (en) 1982-06-02 1985-11-06 Ethicon Inc Improvements in synthetic vascular grafts, and methods of manufacturing such grafts
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4530113A (en) 1983-05-20 1985-07-23 Intervascular, Inc. Vascular grafts with cross-weave patterns
US4550447A (en) 1983-08-03 1985-11-05 Shiley Incorporated Vascular graft prosthesis
US4592754A (en) 1983-09-09 1986-06-03 Gupte Pradeep M Surgical prosthetic vessel graft and catheter combination and method
US4665906A (en) * 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US5749920A (en) 1983-12-09 1998-05-12 Endovascular Technologies, Inc. Multicapsule intraluminal grafting system and method
US7166125B1 (en) 1988-03-09 2007-01-23 Endovascular Technologies, Inc. Intraluminal grafting system
US5669936A (en) 1983-12-09 1997-09-23 Endovascular Technologies, Inc. Endovascular grafting system and method for use therewith
US4787899A (en) 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US4617932A (en) 1984-04-25 1986-10-21 Elliot Kornberg Device and method for performing an intraluminal abdominal aortic aneurysm repair
US4705517A (en) 1985-09-03 1987-11-10 Becton, Dickinson And Company Percutaneously deliverable intravascular occlusion prosthesis
JPH0696023B2 (en) 1986-11-10 1994-11-30 宇部日東化成株式会社 Artificial blood vessel and method for producing the same
US4793348A (en) * 1986-11-15 1988-12-27 Palmaz Julio C Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation
US5133732A (en) 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US6228116B1 (en) * 1987-12-22 2001-05-08 Walter J. Ledergerber Tissue expander
US4892539A (en) 1988-02-08 1990-01-09 D-R Medical Systems, Inc. Vascular graft
FR2627982B1 (en) 1988-03-02 1995-01-27 Artemis TUBULAR ENDOPROSTHESIS FOR ANATOMICAL CONDUITS, AND INSTRUMENT AND METHOD FOR ITS PLACEMENT
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US5226913A (en) 1988-09-01 1993-07-13 Corvita Corporation Method of making a radially expandable prosthesis
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
CA1322628C (en) * 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
SE8803686D0 (en) * 1988-10-17 1988-10-17 Alfa-Laval Separation Ab centrifugal
US5143842A (en) * 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4902423A (en) 1989-02-02 1990-02-20 W. L. Gore & Associates, Inc. Highly air permeable expanded polytetrafluoroethylene membranes and process for making them
US4957669A (en) 1989-04-06 1990-09-18 Shiley, Inc. Method for producing tubing useful as a tapered vascular graft prosthesis
US4994077A (en) 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
US6004261A (en) * 1989-04-28 1999-12-21 C. R. Bard, Inc. Formed-in-place endovascular stent and delivery system
US5100429A (en) * 1989-04-28 1992-03-31 C. R. Bard, Inc. Endovascular stent and delivery system
US5152782A (en) 1989-05-26 1992-10-06 Impra, Inc. Non-porous coated ptfe graft
US4955899A (en) 1989-05-26 1990-09-11 Impra, Inc. Longitudinally compliant vascular graft
US5609626A (en) 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
US5171262A (en) 1989-06-15 1992-12-15 Cordis Corporation Non-woven endoprosthesis
US5207695A (en) * 1989-06-19 1993-05-04 Trout Iii Hugh H Aortic graft, implantation device, and method for repairing aortic aneurysm
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
GB8927282D0 (en) 1989-12-01 1990-01-31 Univ Strathclyde Vascular surgical devices
US5052998A (en) 1990-04-04 1991-10-01 Zimmon David S Indwelling stent and method of use
US5344426A (en) 1990-04-25 1994-09-06 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5123917A (en) 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5360443A (en) 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5122154A (en) 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
US5139480A (en) 1990-08-22 1992-08-18 Biotech Laboratories, Inc. Necking stents
US5178630A (en) 1990-08-28 1993-01-12 Meadox Medicals, Inc. Ravel-resistant, self-supporting woven graft
US5234447A (en) 1990-08-28 1993-08-10 Robert L. Kaster Side-to-end vascular anastomotic staple apparatus
WO1992003107A1 (en) 1990-08-28 1992-03-05 Meadox Medicals, Inc. Self-supporting woven vascular graft
IL99296A (en) 1990-08-28 1995-12-08 Meadox Medicals Inc Self-supporting woven vascular graft and its preparation
AR246020A1 (en) 1990-10-03 1994-03-30 Hector Daniel Barone Juan Carl A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms.
CA2052981C (en) 1990-10-09 1995-08-01 Cesare Gianturco Percutaneous stent assembly
US5316543A (en) 1990-11-27 1994-05-31 Cook Incorporated Medical apparatus and methods for treating sliding hiatal hernias
US5217483A (en) 1990-11-28 1993-06-08 Numed, Inc. Intravascular radially expandable stent
US5163955A (en) 1991-01-24 1992-11-17 Autogenics Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment
US5156620A (en) 1991-02-04 1992-10-20 Pigott John P Intraluminal graft/stent and balloon catheter for insertion thereof
US5135536A (en) 1991-02-05 1992-08-04 Cordis Corporation Endovascular stent and method
US5171252A (en) 1991-02-05 1992-12-15 Friedland Thomas W Surgical fastening clip formed of a shape memory alloy, a method of making such a clip and a method of using such a clip
DE4104702C2 (en) 1991-02-15 1996-01-18 Malte Neuss Implants for organ pathways in spiral form
US5116365A (en) * 1991-02-22 1992-05-26 Cordis Corporation Stent apparatus and method for making
US5628783A (en) * 1991-04-11 1997-05-13 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
US6682557B1 (en) 1991-04-11 2004-01-27 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
US5197978B1 (en) * 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5350398A (en) 1991-05-13 1994-09-27 Dusan Pavcnik Self-expanding filter for percutaneous insertion
US5304200A (en) * 1991-05-29 1994-04-19 Cordis Corporation Welded radially expandable endoprosthesis and the like
EP0646151B1 (en) 1991-06-14 1997-11-05 W.L. Gore & Associates, Inc. Surface modified porous expanded polytetrafluoroethylene and process for making
US5314472A (en) * 1991-10-01 1994-05-24 Cook Incorporated Vascular stent
NL9101159A (en) 1991-07-03 1993-02-01 Industrial Res Bv FORMATTABLE EXPANDABLE RING, CYLINDER OR SLEEVE.
US5411550A (en) 1991-09-16 1995-05-02 Atrium Medical Corporation Implantable prosthetic device for the delivery of a bioactive material
US5443498A (en) 1991-10-01 1995-08-22 Cook Incorporated Vascular stent and method of making and implanting a vacsular stent
US5151105A (en) 1991-10-07 1992-09-29 Kwan Gett Clifford Collapsible vessel sleeve implant
US5662713A (en) 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5366504A (en) 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5290305A (en) * 1991-10-11 1994-03-01 Kanji Inoue Appliance collapsible for insertion into human organs and capable of resilient restoration
US5693084A (en) 1991-10-25 1997-12-02 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
AU669338B2 (en) * 1991-10-25 1996-06-06 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting
US5456713A (en) 1991-10-25 1995-10-10 Cook Incorporated Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting
CA2079417C (en) 1991-10-28 2003-01-07 Lilip Lau Expandable stents and method of making same
US5167614A (en) 1991-10-29 1992-12-01 Medical Engineering Corporation Prostatic stent
US5316023A (en) * 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
CA2087132A1 (en) * 1992-01-31 1993-08-01 Michael S. Williams Stent capable of attachment within a body lumen
US5683448A (en) 1992-02-21 1997-11-04 Boston Scientific Technology, Inc. Intraluminal stent and graft
US5282823A (en) * 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5571166A (en) * 1992-03-19 1996-11-05 Medtronic, Inc. Method of making an intraluminal stent
US5383927A (en) 1992-05-07 1995-01-24 Intervascular Inc. Non-thromogenic vascular prosthesis
US5562725A (en) 1992-09-14 1996-10-08 Meadox Medicals Inc. Radially self-expanding implantable intraluminal device
US5397344A (en) 1992-12-22 1995-03-14 Schering Aktiengesellschaft Methods of and apparatus for measuring uterine electrical and mechanical activity
FR2699809B1 (en) 1992-12-28 1995-02-17 Celsa Lg Device which can selectively constitute a temporary blood filter.
US5370691A (en) 1993-01-26 1994-12-06 Target Therapeutics, Inc. Intravascular inflatable stent
US5334201A (en) * 1993-03-12 1994-08-02 Cowan Kevin P Permanent stent made of a cross linkable material
NL9300500A (en) 1993-03-22 1994-10-17 Industrial Res Bv Expandable hollow sleeve for locally supporting and / or strengthening a body vessel, as well as a method for manufacturing it.
US5354310A (en) 1993-03-22 1994-10-11 Cordis Corporation Expandable temporary graft
US5843167A (en) 1993-04-22 1998-12-01 C. R. Bard, Inc. Method and apparatus for recapture of hooked endoprosthesis
AU689094B2 (en) 1993-04-22 1998-03-26 C.R. Bard Inc. Non-migrating vascular prosthesis and minimally invasive placement system therefor
DE69317548T2 (en) 1993-04-23 1998-08-13 Schneider Europ Gmbh Stent with a coating of elastic material and method for applying the coating on the stent
US5370682A (en) 1993-04-26 1994-12-06 Meadox Medicals, Inc. Solid woven tubular prosthesis
DE69412474T2 (en) * 1993-04-28 1998-12-17 Focal Inc DEVICE, PRODUCT AND USE REGARDING INTRALUMINAL PHOTOTHERMO MOLDING
US5480423A (en) * 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US5425765A (en) 1993-06-25 1995-06-20 Tiefenbrun; Jonathan Surgical bypass method
CA2125258C (en) 1993-08-05 1998-12-22 Dinah B Quiachon Multicapsule intraluminal grafting system and method
EP0958795A3 (en) 1993-08-20 2001-04-04 Kanji Inoue Appliance to be implanted and device for introducing the collapsed appliance into a catheter
US5549701A (en) 1993-09-20 1996-08-27 Mikhail; W. E. Michael Acetabular cup
US6685736B1 (en) 1993-09-30 2004-02-03 Endogad Research Pty Limited Intraluminal graft
US5782904A (en) 1993-09-30 1998-07-21 Endogad Research Pty Limited Intraluminal graft
AU8012394A (en) 1993-10-01 1995-05-01 Emory University Self-expanding intraluminal composite prosthesis
WO1995009585A1 (en) 1993-10-01 1995-04-13 Imperial College Of Science, Technology & Medicine Vascular prostheses
DE4334140C2 (en) * 1993-10-07 1996-04-18 Angiomed Ag Stent and device with stent
US5632772A (en) 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5639278A (en) 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5443497A (en) 1993-11-22 1995-08-22 The Johns Hopkins University Percutaneous prosthetic by-pass graft and method of use
US5527353A (en) 1993-12-02 1996-06-18 Meadox Medicals, Inc. Implantable tubular prosthesis
DE9319267U1 (en) 1993-12-15 1994-02-24 Vorwerk Dierk Dr Aortic endoprosthesis
US5789047A (en) 1993-12-21 1998-08-04 Japan Gore-Tex, Inc Flexible, multilayered tube
JP3403233B2 (en) * 1994-01-20 2003-05-06 テルモ株式会社 Balloon catheter
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US6165213A (en) 1994-02-09 2000-12-26 Boston Scientific Technology, Inc. System and method for assembling an endoluminal prosthesis
US6039749A (en) 1994-02-10 2000-03-21 Endovascular Systems, Inc. Method and apparatus for deploying non-circular stents and graftstent complexes
SI0821920T2 (en) * 1994-02-25 2006-08-31 Fischell Robert Stent
US5423851A (en) 1994-03-06 1995-06-13 Samuels; Shaun L. W. Method and apparatus for affixing an endoluminal device to the walls of tubular structures within the body
US5653746A (en) 1994-03-08 1997-08-05 Meadox Medicals, Inc. Radially expandable tubular prosthesis
US5449373A (en) * 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US6001123A (en) * 1994-04-01 1999-12-14 Gore Enterprise Holdings Inc. Folding self-expandable intravascular stent-graft
US6165210A (en) * 1994-04-01 2000-12-26 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
US5554181A (en) 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
US5824044A (en) 1994-05-12 1998-10-20 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system
DE4418336A1 (en) * 1994-05-26 1995-11-30 Angiomed Ag Stent for widening and holding open receptacles
DE29522101U1 (en) 1994-06-08 1999-12-09 Cardiovascular Concepts Inc Endoluminal prosthesis
US5824041A (en) 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
US5683451A (en) 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
ES2199993T3 (en) 1994-06-13 2004-03-01 Endomed, Inc. EXPANSIBLE ENDOVASCULAR GRAFT AND METHOD FOR FORMATION.
US5522881A (en) 1994-06-28 1996-06-04 Meadox Medicals, Inc. Implantable tubular prosthesis having integral cuffs
US5397355A (en) * 1994-07-19 1995-03-14 Stentco, Inc. Intraluminal stent
US5636641A (en) 1994-07-25 1997-06-10 Advanced Cardiovascular Systems, Inc. High strength member for intracorporeal use
CA2147547C (en) 1994-08-02 2006-12-19 Peter J. Schmitt Thinly woven flexible graft
US5575817A (en) 1994-08-19 1996-11-19 Martin; Eric C. Aorto femoral bifurcation graft and method of implantation
US6331188B1 (en) 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
US5527355A (en) 1994-09-02 1996-06-18 Ahn; Sam S. Apparatus and method for performing aneurysm repair
US5843170A (en) 1994-09-02 1998-12-01 Ahn; Sam Seunghae Apparatus and method for performing aneurysm repair
US5653743A (en) 1994-09-09 1997-08-05 Martin; Eric C. Hypogastric artery bifurcation graft and method of implantation
US5509899A (en) * 1994-09-22 1996-04-23 Boston Scientific Corp. Medical device with lubricious coating
US5649977A (en) * 1994-09-22 1997-07-22 Advanced Cardiovascular Systems, Inc. Metal reinforced polymer stent
CA2134997C (en) 1994-11-03 2009-06-02 Ian M. Penn Stent
CA2175720C (en) 1996-05-03 2011-11-29 Ian M. Penn Bifurcated stent and method for the manufacture and delivery of same
DE69532966T2 (en) 1994-11-09 2004-10-21 Endotex Interventional Sys Inc COMBINATION OF DELIVERY CATHETER AND IMPLANT FOR AN ANEURYSMA
AU3783195A (en) 1994-11-15 1996-05-23 Advanced Cardiovascular Systems Inc. Intraluminal stent for attaching a graft
AU3783295A (en) * 1994-11-16 1996-05-23 Advanced Cardiovascular Systems Inc. Shape memory locking mechanism for intravascular stent
US5891558A (en) 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5630829A (en) * 1994-12-09 1997-05-20 Intervascular, Inc. High hoop strength intraluminal stent
US5571079A (en) 1994-12-30 1996-11-05 Algos Pharmaceutical Corporation Wound dressing
NL9500094A (en) 1995-01-19 1996-09-02 Industrial Res Bv Y-shaped stent and method of deployment.
US5755770A (en) 1995-01-31 1998-05-26 Boston Scientific Corporatiion Endovascular aortic graft
US5575818A (en) 1995-02-14 1996-11-19 Corvita Corporation Endovascular stent with locking ring
US5683449A (en) 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
EP1163889B1 (en) * 1995-03-01 2008-05-14 Boston Scientific Scimed, Inc. Improved longitudinally flexible expandable stent
US6896696B2 (en) * 1998-11-20 2005-05-24 Scimed Life Systems, Inc. Flexible and expandable stent
CA2566929C (en) 1995-03-10 2009-04-21 Bard Peripheral Vascular, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
EP0813397A4 (en) 1995-03-10 1999-10-06 Cardiovascular Concepts Inc Tubular endoluminar prosthesis having oblique ends
US6451047B2 (en) 1995-03-10 2002-09-17 Impra, Inc. Encapsulated intraluminal stent-graft and methods of making same
US6264684B1 (en) 1995-03-10 2001-07-24 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Helically supported graft
US6124523A (en) * 1995-03-10 2000-09-26 Impra, Inc. Encapsulated stent
US5591197A (en) * 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
CA2171896C (en) * 1995-03-17 2007-05-15 Scott C. Anderson Multi-anchor stent
US5693089A (en) 1995-04-12 1997-12-02 Inoue; Kanji Method of collapsing an implantable appliance
US5641373A (en) 1995-04-17 1997-06-24 Baxter International Inc. Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft
US5667523A (en) 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
FR2733682B1 (en) 1995-05-04 1997-10-31 Dibie Alain ENDOPROSTHESIS FOR THE TREATMENT OF STENOSIS ON BIFURCATIONS OF BLOOD VESSELS AND LAYING EQUIPMENT THEREFOR
US5591228A (en) 1995-05-09 1997-01-07 Edoga; John K. Methods for treating abdominal aortic aneurysms
US5628786A (en) 1995-05-12 1997-05-13 Impra, Inc. Radially expandable vascular graft with resistance to longitudinal compression and method of making same
US6312466B1 (en) * 1995-05-22 2001-11-06 Board Of Regents, University Of Texas System Prosthesis containing a solution of polyethylene glycol
IL122202A0 (en) 1995-06-08 1998-04-05 Bard Galway Ltd Bifurcated endovascular stent
JPH096720A (en) 1995-06-15 1997-01-10 Canon Inc Method and system for transmitting information
US5725568A (en) * 1995-06-27 1998-03-10 Scimed Life Systems, Inc. Method and device for recanalizing and grafting arteries
US5554180A (en) 1995-07-07 1996-09-10 Aeroquip Corporation Intraluminal stenting graft
US5785679A (en) 1995-07-19 1998-07-28 Endotex Interventional Systems, Inc. Methods and apparatus for treating aneurysms and arterio-venous fistulas
US5697968A (en) 1995-08-10 1997-12-16 Aeroquip Corporation Check valve for intraluminal graft
US6814747B2 (en) 1995-09-08 2004-11-09 Anthony Walter Anson Surgical graft/stent system
US5769882A (en) * 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
AU6862596A (en) 1995-09-18 1997-04-09 W.L. Gore & Associates, Inc. A delivery system for intraluminal vascular grafts
US5824037A (en) 1995-10-03 1998-10-20 Medtronic, Inc. Modular intraluminal prostheses construction and methods
US6193745B1 (en) * 1995-10-03 2001-02-27 Medtronic, Inc. Modular intraluminal prosteheses construction and methods
US6099558A (en) 1995-10-10 2000-08-08 Edwards Lifesciences Corp. Intraluminal grafting of a bifuricated artery
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US5669924A (en) 1995-10-26 1997-09-23 Shaknovich; Alexander Y-shuttle stent assembly for bifurcating vessels and method of using the same
US6287315B1 (en) 1995-10-30 2001-09-11 World Medical Manufacturing Corporation Apparatus for delivering an endoluminal prosthesis
US6929659B2 (en) 1995-11-07 2005-08-16 Scimed Life Systems, Inc. Method of preventing the dislodgment of a stent-graft
US5628788A (en) * 1995-11-07 1997-05-13 Corvita Corporation Self-expanding endoluminal stent-graft
US5788626A (en) 1995-11-21 1998-08-04 Schneider (Usa) Inc Method of making a stent-graft covered with expanded polytetrafluoroethylene
US5665117A (en) 1995-11-27 1997-09-09 Rhodes; Valentine J. Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use
US6576009B2 (en) 1995-12-01 2003-06-10 Medtronic Ave, Inc. Bifurcated intraluminal prostheses construction and methods
US5824040A (en) 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
US6203569B1 (en) * 1996-01-04 2001-03-20 Bandula Wijay Flexible stent
US5843158A (en) 1996-01-05 1998-12-01 Medtronic, Inc. Limited expansion endoluminal prostheses and methods for their use
US6428571B1 (en) * 1996-01-22 2002-08-06 Scimed Life Systems, Inc. Self-sealing PTFE vascular graft and manufacturing methods
US5800512A (en) 1996-01-22 1998-09-01 Meadox Medicals, Inc. PTFE vascular graft
US6258116B1 (en) 1996-01-26 2001-07-10 Cordis Corporation Bifurcated axially flexible stent
US6017363A (en) 1997-09-22 2000-01-25 Cordis Corporation Bifurcated axially flexible stent
US5747128A (en) * 1996-01-29 1998-05-05 W. L. Gore & Associates, Inc. Radially supported polytetrafluoroethylene vascular graft
US6273912B1 (en) 1996-02-28 2001-08-14 Impra, Inc. Flanged graft for end-to-side anastomosis
CA2192520A1 (en) * 1996-03-05 1997-09-05 Ian M. Penn Expandable stent and method for delivery of same
US5843160A (en) 1996-04-01 1998-12-01 Rhodes; Valentine J. Prostheses for aneurysmal and/or occlusive disease at a bifurcation in a vessel, duct, or lumen
DE19614160A1 (en) * 1996-04-10 1997-10-16 Variomed Ag Stent for transluminal implantation in hollow organs
US20010029349A1 (en) 1996-04-12 2001-10-11 Boris Leschinsky Method and apparatus for treating aneurysms
BE1010183A3 (en) 1996-04-25 1998-02-03 Dereume Jean Pierre Georges Em Luminal endoprosthesis FOR BRANCHING CHANNELS OF A HUMAN OR ANIMAL BODY AND MANUFACTURING METHOD THEREOF.
US6770092B2 (en) 1996-05-03 2004-08-03 Medinol Ltd. Method of delivering a bifurcated stent
US6440165B1 (en) 1996-05-03 2002-08-27 Medinol, Ltd. Bifurcated stent with improved side branch aperture and method of making same
US7641685B2 (en) 1996-05-03 2010-01-05 Medinol Ltd. System and method for delivering a bifurcated stent
US6251133B1 (en) 1996-05-03 2001-06-26 Medinol Ltd. Bifurcated stent with improved side branch aperture and method of making same
UA58485C2 (en) 1996-05-03 2003-08-15 Медінол Лтд. Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants)
US20010041927A1 (en) 1996-05-17 2001-11-15 Solem Jan Otto By-pass graft
US5800514A (en) 1996-05-24 1998-09-01 Meadox Medicals, Inc. Shaped woven tubular soft-tissue prostheses and methods of manufacturing
FR2749160B1 (en) 1996-05-28 1999-05-21 Patrice Bergeron MODULAR BIFURCED VASCULAR PROSTHESIS
US7238197B2 (en) 2000-05-30 2007-07-03 Devax, Inc. Endoprosthesis deployment system for treating vascular bifurcations
FR2749500B1 (en) 1996-06-06 1998-11-20 Jacques Seguin DEVICE ALLOWING THE TREATMENT OF BODY DUCTS AT THE LEVEL OF A BIFURCATION
US7686846B2 (en) 1996-06-06 2010-03-30 Devax, Inc. Bifurcation stent and method of positioning in a body lumen
US8728143B2 (en) 1996-06-06 2014-05-20 Biosensors International Group, Ltd. Endoprosthesis deployment system for treating vascular bifurcations
CN1166346C (en) 1996-06-20 2004-09-15 瓦斯卡泰克有限公司 Prosthetic repair of body passages
US5676697A (en) 1996-07-29 1997-10-14 Cardiovascular Dynamics, Inc. Two-piece, bifurcated intraluminal graft for repair of aneurysm
US5755682A (en) 1996-08-13 1998-05-26 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
US6325819B1 (en) 1996-08-19 2001-12-04 Cook Incorporated Endovascular prosthetic device, an endovascular graft prothesis with such a device, and a method for repairing an abdominal aortic aneurysm
US6174326B1 (en) * 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production
US5755776A (en) * 1996-10-04 1998-05-26 Al-Saadon; Khalid Permanent expandable intraluminal tubular stent
US5824047A (en) 1996-10-11 1998-10-20 C. R. Bard, Inc. Vascular graft fabric
US5755778A (en) 1996-10-16 1998-05-26 Nitinol Medical Technologies, Inc. Anastomosis device
AU4896797A (en) 1996-11-04 1998-05-29 Davidson, Charles Extendible stent apparatus and method for deploying the same
US7220275B2 (en) 1996-11-04 2007-05-22 Advanced Stent Technologies, Inc. Stent with protruding branch portion for bifurcated vessels
US8211167B2 (en) 1999-12-06 2012-07-03 Boston Scientific Scimed, Inc. Method of using a catheter with attached flexible side sheath
US6692483B2 (en) 1996-11-04 2004-02-17 Advanced Stent Technologies, Inc. Catheter with attached flexible side sheath
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6599316B2 (en) 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
US7341598B2 (en) * 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US6835203B1 (en) 1996-11-04 2004-12-28 Advanced Stent Technologies, Inc. Extendible stent apparatus
US7591846B2 (en) 1996-11-04 2009-09-22 Boston Scientific Scimed, Inc. Methods for deploying stents in bifurcations
JP2002513301A (en) * 1996-11-07 2002-05-08 メドトロニック インステント,インコーポレーテッド Stent with variable flexibility
US6019788A (en) 1996-11-08 2000-02-01 Gore Enterprise Holdings, Inc. Vascular shunt graft and junction for same
US5925074A (en) 1996-12-03 1999-07-20 Atrium Medical Corporation Vascular endoprosthesis and method
US6315791B1 (en) 1996-12-03 2001-11-13 Atrium Medical Corporation Self-expanding prothesis
US6551350B1 (en) 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
US6494904B1 (en) 1996-12-27 2002-12-17 Ramus Medical Technologies Method and apparatus for forming vascular prostheses
US5733330A (en) * 1997-01-13 1998-03-31 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent
BE1010858A4 (en) 1997-01-16 1999-02-02 Medicorp R & D Benelux Sa Luminal endoprosthesis FOR BRANCHING.
US5957974A (en) 1997-01-23 1999-09-28 Schneider (Usa) Inc Stent graft with braided polymeric sleeve
US6152956A (en) 1997-01-28 2000-11-28 Pierce; George E. Prosthesis for endovascular repair of abdominal aortic aneurysms
DE19703482A1 (en) 1997-01-31 1998-08-06 Ernst Peter Prof Dr M Strecker Stent
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US6090128A (en) 1997-02-20 2000-07-18 Endologix, Inc. Bifurcated vascular graft deployment device
US6951572B1 (en) 1997-02-20 2005-10-04 Endologix, Inc. Bifurcated vascular graft and method and apparatus for deploying same
GB9703859D0 (en) 1997-02-25 1997-04-16 Plante Sylvain Expandable intravascular stent
US6048360A (en) 1997-03-18 2000-04-11 Endotex Interventional Systems, Inc. Methods of making and using coiled sheet graft for single and bifurcated lumens
US5824052A (en) 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Coiled sheet stent having helical articulation and methods of use
US6302908B1 (en) 1997-03-24 2001-10-16 Juan Carlos Parodi Arterial graft device and method of positioning the same
US5824055A (en) 1997-03-25 1998-10-20 Endotex Interventional Systems, Inc. Stent graft delivery system and methods of use
US5981826A (en) 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
US6162245A (en) 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
US6245102B1 (en) 1997-05-07 2001-06-12 Iowa-India Investments Company Ltd. Stent, stent graft and stent valve
US6143015A (en) 1997-05-19 2000-11-07 Cardio Medical Solutions, Inc. Device and method for partially occluding blood vessels using flow-through balloon
AUPO700897A0 (en) 1997-05-26 1997-06-19 William A Cook Australia Pty Ltd A method and means of deploying a graft
US5906641A (en) 1997-05-27 1999-05-25 Schneider (Usa) Inc Bifurcated stent graft
CA2424551A1 (en) 1997-05-27 1998-11-27 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
US6007575A (en) 1997-06-06 1999-12-28 Samuels; Shaun Laurence Wilkie Inflatable intraluminal stent and method for affixing same within the human body
US5746691A (en) * 1997-06-06 1998-05-05 Global Therapeutics, Inc. Method for polishing surgical stents
US6102938A (en) 1997-06-17 2000-08-15 Medtronic Inc. Endoluminal prosthetic bifurcation shunt
CA2241558A1 (en) 1997-06-24 1998-12-24 Advanced Cardiovascular Systems, Inc. Stent with reinforced struts and bimodal deployment
US6071292A (en) 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US5904713A (en) 1997-07-14 1999-05-18 Datascope Investment Corp. Invertible bifurcated stent/graft and method of deployment
EP0891751A1 (en) 1997-07-18 1999-01-20 Thomas Prof. Dr. Ischinger Vascular stent for bifurcations, sidebranches and ostial lesions and an application catheter and method for implantation
US6174330B1 (en) * 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6361544B1 (en) 1997-08-13 2002-03-26 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US7955379B2 (en) 1997-08-13 2011-06-07 Abbott Cardiovascular Systems Inc. Stent and catheter assembly and method for treating bifurcations
US6165195A (en) 1997-08-13 2000-12-26 Advanced Cardiovascylar Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6187033B1 (en) 1997-09-04 2001-02-13 Meadox Medicals, Inc. Aortic arch prosthetic graft
US6063114A (en) 1997-09-04 2000-05-16 Kensey Nash Corporation Connector system for vessels, ducts, lumens or hollow organs and methods of use
US5922022A (en) 1997-09-04 1999-07-13 Kensey Nash Corporation Bifurcated connector system for coronary bypass grafts and methods of use
US6306164B1 (en) 1997-09-05 2001-10-23 C. R. Bard, Inc. Short body endoprosthesis
US5968090A (en) 1997-09-08 1999-10-19 United States Surgical Corp. Endovascular graft and method
US6206910B1 (en) * 1997-09-11 2001-03-27 Wake Forest University Compliant intraluminal stents
US5984955A (en) 1997-09-11 1999-11-16 Wisselink; Willem System and method for endoluminal grafting of bifurcated or branched vessels
US6746476B1 (en) 1997-09-22 2004-06-08 Cordis Corporation Bifurcated axially flexible stent
AU738502B2 (en) * 1997-09-24 2001-09-20 Cook Medical Technologies Llc Radially expandable stent
US6520988B1 (en) 1997-09-24 2003-02-18 Medtronic Ave, Inc. Endolumenal prosthesis and method of use in bifurcation regions of body lumens
US6086611A (en) 1997-09-25 2000-07-11 Ave Connaught Bifurcated stent
US6042606A (en) * 1997-09-29 2000-03-28 Cook Incorporated Radially expandable non-axially contracting surgical stent
US5984956A (en) 1997-10-06 1999-11-16 Heartstent Corporation Transmyocardial implant
US5961548A (en) 1997-11-18 1999-10-05 Shmulewitz; Ascher Bifurcated two-part graft and methods of implantation
AUPP083597A0 (en) * 1997-12-10 1998-01-08 William A Cook Australia Pty Ltd Endoluminal aortic stents
DE69826110T2 (en) 1997-12-16 2005-01-20 B. Braun Celsa MEDICAL DEVICE FOR TREATING DAMAGE TO AN ANATOMICAL LINE
US6235051B1 (en) 1997-12-16 2001-05-22 Timothy P. Murphy Method of stent-graft system delivery
US6503271B2 (en) * 1998-01-09 2003-01-07 Cordis Corporation Intravascular device with improved radiopacity
US7520890B2 (en) 1998-01-26 2009-04-21 Phillips Peter W Reinforced graft and method of deployment
US6541116B2 (en) * 1998-01-30 2003-04-01 Advanced Cardiovascular Systems, Inc. Superoxide dismutase or superoxide dismutase mimic coating for an intracorporeal medical device
US6395018B1 (en) 1998-02-09 2002-05-28 Wilfrido R. Castaneda Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels
US6395019B2 (en) * 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
FR2775182B1 (en) 1998-02-25 2000-07-28 Legona Anstalt DEVICE FORMING INTRACORPOREAL ENDOLUMINAL ANDOPROTHESIS, IN PARTICULAR AORTIC ABDOMINAL
US6488701B1 (en) 1998-03-31 2002-12-03 Medtronic Ave, Inc. Stent-graft assembly with thin-walled graft component and method of manufacture
US6077296A (en) 1998-03-04 2000-06-20 Endologix, Inc. Endoluminal vascular prosthesis
US5938697A (en) 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6224609B1 (en) 1998-03-16 2001-05-01 Teramed Inc. Bifurcated prosthetic graft
US6129756A (en) 1998-03-16 2000-10-10 Teramed, Inc. Biluminal endovascular graft system
US6558415B2 (en) 1998-03-27 2003-05-06 Intratherapeutics, Inc. Stent
US6887268B2 (en) 1998-03-30 2005-05-03 Cordis Corporation Extension prosthesis for an arterial repair
US6290731B1 (en) 1998-03-30 2001-09-18 Cordis Corporation Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm
US6524336B1 (en) 1998-04-09 2003-02-25 Cook Incorporated Endovascular graft
US6436133B1 (en) 1998-04-15 2002-08-20 Joseph G. Furst Expandable graft
NL1009028C2 (en) 1998-04-28 1999-10-29 Adri Marinus Blomme Adhesives for connecting a tubular vascular prosthesis to a blood vessel in the body as well as branching means, a vascular prosthesis, a device for inserting and adhering a vascular prosthesis and a vascular prosthesis system.
US5989287A (en) 1998-05-06 1999-11-23 Av Healing Llc Vascular graft assemblies and methods for implanting same
DE69915821T2 (en) 1998-05-15 2005-03-17 Shlomo Gabbay INTRAVASCULAR IMPLANT AND METHOD OF MANUFACTURING THEREOF
US6740113B2 (en) 1998-05-29 2004-05-25 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
US6361559B1 (en) 1998-06-10 2002-03-26 Converge Medical, Inc. Thermal securing anastomosis systems
WO1999065419A1 (en) 1998-06-19 1999-12-23 Endologix, Inc. Self expanding bifurcated endovascular prosthesis
US6129738A (en) 1998-06-20 2000-10-10 Medtronic Ave, Inc. Method and apparatus for treating stenoses at bifurcated regions
US6261319B1 (en) * 1998-07-08 2001-07-17 Scimed Life Systems, Inc. Stent
US5911754A (en) 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US6159239A (en) 1998-08-14 2000-12-12 Prodesco, Inc. Woven stent/graft structure
US6770473B1 (en) 1998-08-21 2004-08-03 The Regents Of The University Of Michigan hKIS compositions and methods of use
US6117117A (en) 1998-08-24 2000-09-12 Advanced Cardiovascular Systems, Inc. Bifurcated catheter assembly
US6238432B1 (en) 1998-08-25 2001-05-29 Juan Carlos Parodi Stent graft device for treating abdominal aortic aneurysms
US6514281B1 (en) 1998-09-04 2003-02-04 Scimed Life Systems, Inc. System for delivering bifurcation stents
US6196230B1 (en) 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
US6261304B1 (en) 1998-09-10 2001-07-17 Percardia, Inc. Delivery methods for left ventricular conduit
AUPP624398A0 (en) 1998-09-29 1998-10-22 White, Geoffrey H. Expanding intraluminal device
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6273909B1 (en) 1998-10-05 2001-08-14 Teramed Inc. Endovascular graft system
US6042597A (en) * 1998-10-23 2000-03-28 Scimed Life Systems, Inc. Helical stent design
US6293967B1 (en) 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6214036B1 (en) 1998-11-09 2001-04-10 Cordis Corporation Stent which is easily recaptured and repositioned within the body
AU1085800A (en) 1998-11-11 2000-05-29 Mark Wilson Ian Webster Bifurcation stent and delivery systems
US6325820B1 (en) 1998-11-16 2001-12-04 Endotex Interventional Systems, Inc. Coiled-sheet stent-graft with exo-skeleton
US20010049554A1 (en) 1998-11-18 2001-12-06 Carlos E. Ruiz Endovascular prosthesis and method of making
US6540780B1 (en) 1998-11-23 2003-04-01 Medtronic, Inc. Porous synthetic vascular grafts with oriented ingrowth channels
US6733523B2 (en) 1998-12-11 2004-05-11 Endologix, Inc. Implantable vascular graft
DE69927055T2 (en) 1998-12-11 2006-06-29 Endologix, Inc., Irvine ENDOLUMINAL VASCULAR PROSTHESIS
US20100318181A1 (en) 1998-12-11 2010-12-16 Endologix, Inc. Implantable vascular graft
DE29822381U1 (en) 1998-12-16 1999-03-18 Fumedica Intertrade Ag Device for inserting an aortic endoprosthesis
US6363938B2 (en) 1998-12-22 2002-04-02 Angiotrax, Inc. Methods and apparatus for perfusing tissue and/or stimulating revascularization and tissue growth
US20050171594A1 (en) 1998-12-31 2005-08-04 Angiotech International Ag Stent grafts with bioactive coatings
EP1020166A1 (en) 1999-01-12 2000-07-19 Orbus Medical Technologies, Inc. Expandable intraluminal endoprosthesis
US20050060027A1 (en) 1999-01-13 2005-03-17 Advanced Stent Technologies, Inc. Catheter balloon systems and methods
US8257425B2 (en) 1999-01-13 2012-09-04 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7655030B2 (en) 2003-07-18 2010-02-02 Boston Scientific Scimed, Inc. Catheter balloon systems and methods
US6350277B1 (en) * 1999-01-15 2002-02-26 Scimed Life Systems, Inc. Stents with temporary retaining bands
ES2259996T3 (en) 1999-01-22 2006-11-01 Gore Enterprise Holdings, Inc. ENDOPROTESIS COVER.
CA2329213C (en) 1999-01-22 2005-08-09 Gore Enterprise Holdings, Inc. Low profile stent and graft combination
US6517571B1 (en) 1999-01-22 2003-02-11 Gore Enterprise Holdings, Inc. Vascular graft with improved flow surfaces
AU772868C (en) 1999-02-01 2005-08-11 Board Of Regents, The University Of Texas System Woven bifurcated and trifurcated stents and methods for making the same
US6958212B1 (en) * 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6558414B2 (en) 1999-02-02 2003-05-06 Impra, Inc. Partial encapsulation of stents using strips and bands
US6398803B1 (en) 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6187054B1 (en) 1999-02-04 2001-02-13 Endomed Inc. Method of making large diameter vascular prosteheses and a vascular prosthesis made by said method
US6162246A (en) 1999-02-16 2000-12-19 Barone; Hector Daniel Aortic graft and method of treating abdominal aortic aneurysms
US6110201A (en) 1999-02-18 2000-08-29 Venpro Bifurcated biological pulmonary valved conduit
US6200339B1 (en) 1999-02-23 2001-03-13 Datascope Investment Corp. Endovascular split-tube bifurcated graft prosthesis and an implantation method for such a prosthesis
US20030225453A1 (en) 1999-03-03 2003-12-04 Trivascular, Inc. Inflatable intraluminal graft
US8034100B2 (en) 1999-03-11 2011-10-11 Endologix, Inc. Graft deployment system
US20040167613A1 (en) 1999-03-11 2004-08-26 Ofer Yodfat Implantable stroke prevention device
IL128938A0 (en) 1999-03-11 2000-02-17 Mind Guard Ltd Implantable stroke treating device
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US6364903B2 (en) * 1999-03-19 2002-04-02 Meadox Medicals, Inc. Polymer coated stent
US6428576B1 (en) 1999-04-16 2002-08-06 Endospine, Ltd. System for repairing inter-vertebral discs
US6287335B1 (en) * 1999-04-26 2001-09-11 William J. Drasler Intravascular folded tubular endoprosthesis
IL146021A0 (en) 1999-04-26 2002-07-25 Gmp Vision Solutions Inc Shunt device and method for treating glaucoma
US6245101B1 (en) 1999-05-03 2001-06-12 William J. Drasler Intravascular hinge stent
US6585756B1 (en) 1999-05-14 2003-07-01 Ernst P. Strecker Implantable lumen prosthesis
EP1180003B1 (en) 1999-05-20 2008-01-16 Boston Scientific Limited Stent delivery system with nested stabilizer
US6290673B1 (en) 1999-05-20 2001-09-18 Conor Medsystems, Inc. Expandable medical device delivery system and method
US6884258B2 (en) 1999-06-04 2005-04-26 Advanced Stent Technologies, Inc. Bifurcation lesion stent delivery using multiple guidewires
US6648913B1 (en) 1999-06-07 2003-11-18 Scimed Life Systems, Inc. Guidewire-access modular intraluminal prosthesis with connecting section
US6652570B2 (en) 1999-07-02 2003-11-25 Scimed Life Systems, Inc. Composite vascular graft
US6364904B1 (en) * 1999-07-02 2002-04-02 Scimed Life Systems, Inc. Helically formed stent/graft assembly
US6440161B1 (en) 1999-07-07 2002-08-27 Endologix, Inc. Dual wire placement catheter
EP1113764B1 (en) 1999-07-16 2003-11-05 Med Institute, Inc. Stent adapted for tangle-free deployment
DE19934923A1 (en) 1999-07-20 2001-01-25 Biotronik Mess & Therapieg Balloon catheter
US6569193B1 (en) 1999-07-22 2003-05-27 Advanced Cardiovascular Systems, Inc. Tapered self-expanding stent
FR2797389B1 (en) 1999-08-09 2001-11-30 Novatech Inc BIFURCED AORTIC PROSTHESIS
US6293968B1 (en) 1999-09-02 2001-09-25 Syde A. Taheri Inflatable intraluminal vascular stent
US6409757B1 (en) 1999-09-15 2002-06-25 Eva Corporation Method and apparatus for supporting a graft assembly
US6312462B1 (en) * 1999-09-22 2001-11-06 Impra, Inc. Prosthesis for abdominal aortic aneurysm repair
US6270525B1 (en) 1999-09-23 2001-08-07 Cordis Corporation Precursor stent gasket for receiving bilateral grafts having controlled contralateral guidewire access
US6344056B1 (en) 1999-12-29 2002-02-05 Edwards Lifesciences Corp. Vascular grafts for bridging a vessel side branch
US6344052B1 (en) 1999-09-27 2002-02-05 World Medical Manufacturing Corporation Tubular graft with monofilament fibers
US20020123790A1 (en) 1999-09-28 2002-09-05 White Geoffrey Hamilton Enhanced engagement member for anchoring prosthetic devices in body lumen
US6383213B2 (en) 1999-10-05 2002-05-07 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6849087B1 (en) 1999-10-06 2005-02-01 Timothy A. M. Chuter Device and method for staged implantation of a graft for vascular repair
US6485513B1 (en) 1999-10-08 2002-11-26 The General Hospital Corporation Percutaneous stent graft and method for vascular bypass
WO2001026584A1 (en) 1999-10-14 2001-04-19 United Stenting, Inc. Stents with multilayered struts
US6325823B1 (en) 1999-10-29 2001-12-04 Revasc Corporation Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use
US6610087B1 (en) 1999-11-16 2003-08-26 Scimed Life Systems, Inc. Endoluminal stent having a matched stiffness region and/or a stiffness gradient and methods for providing stent kink resistance
US8579966B2 (en) * 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US20020055768A1 (en) 1999-11-24 2002-05-09 Kathy Hess Method of manufacturing a thin-layered, endovascular, polymer-covered stent device
US6280466B1 (en) 1999-12-03 2001-08-28 Teramed Inc. Endovascular graft system
US6673107B1 (en) 1999-12-06 2004-01-06 Advanced Cardiovascular Systems, Inc. Bifurcated stent and method of making
US6387120B2 (en) 1999-12-09 2002-05-14 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6254593B1 (en) 1999-12-10 2001-07-03 Advanced Cardiovascular Systems, Inc. Bifurcated stent delivery system having retractable sheath
US6428506B1 (en) 1999-12-22 2002-08-06 Advanced Cardiovascular Systems, Inc. Medical device formed of ultrahigh molecular weight polyethylene
US6663667B2 (en) 1999-12-29 2003-12-16 Edwards Lifesciences Corporation Towel graft means for enhancing tissue ingrowth in vascular grafts
US6471721B1 (en) 1999-12-30 2002-10-29 Advanced Cardiovascular Systems, Inc. Vascular stent having increased radiopacity and method for making same
US20040010308A1 (en) 2000-01-18 2004-01-15 Mindguard Ltd. Implantable composite device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation
US6409756B1 (en) 2000-01-24 2002-06-25 Edward G. Murphy Endovascular aortic graft
US6241761B1 (en) 2000-01-26 2001-06-05 Cabg Medical, Inc. Stented grafts for coupling vascular members
US6652571B1 (en) 2000-01-31 2003-11-25 Scimed Life Systems, Inc. Braided, branched, implantable device and processes for manufacture thereof
US6325822B1 (en) 2000-01-31 2001-12-04 Scimed Life Systems, Inc. Braided stent having tapered filaments
US6398807B1 (en) 2000-01-31 2002-06-04 Scimed Life Systems, Inc. Braided branching stent, method for treating a lumen therewith, and process for manufacture therefor
US6296661B1 (en) 2000-02-01 2001-10-02 Luis A. Davila Self-expanding stent-graft
WO2001056500A2 (en) 2000-02-03 2001-08-09 Cook Incorporated Implantable vascular device
US6391538B1 (en) * 2000-02-09 2002-05-21 The Children's Hospital Of Philadelphia Stabilization of implantable bioprosthetic tissue
US6423090B1 (en) 2000-02-11 2002-07-23 Advanced Cardiovascular Systems, Inc. Stent pattern with staged expansion
NL1014559C2 (en) 2000-02-11 2001-08-14 Surgical Innovations Vof Umbrella stent.
US6808534B1 (en) 2000-02-16 2004-10-26 Endovascular Technologies, Inc. Collapsible jacket guard
US20120089220A1 (en) 2000-02-18 2012-04-12 E.V.R. Endovascular Researches S.A. Microcatheter
EP1255506B1 (en) 2000-02-18 2003-09-03 E.V.R. Endovascular Researches S.A. Endolumenal device for delivering and deploying an endolumenal expandable prosthesis
DK1259192T3 (en) 2000-03-03 2004-03-29 Cook Inc Endovascular device with a stent
US6814752B1 (en) 2000-03-03 2004-11-09 Endovascular Technologies, Inc. Modular grafting system and method
US8092511B2 (en) 2000-03-03 2012-01-10 Endovascular Technologies, Inc. Modular stent-graft for endovascular repair of aortic arch aneurysms and dissections
US6319278B1 (en) 2000-03-03 2001-11-20 Stephen F. Quinn Low profile device for the treatment of vascular abnormalities
US6379382B1 (en) * 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
EP1263349B1 (en) 2000-03-14 2009-08-05 Cook Incorporated Endovascular stent graft
US6210433B1 (en) 2000-03-17 2001-04-03 LARRé JORGE CASADO Stent for treatment of lesions of bifurcated vessels
US6468301B1 (en) 2000-03-27 2002-10-22 Aga Medical Corporation Repositionable and recapturable vascular stent/graft
WO2001076675A2 (en) 2000-04-11 2001-10-18 Scimed Life Systems, Inc. Reinforced retention structures
US6517573B1 (en) 2000-04-11 2003-02-11 Endovascular Technologies, Inc. Hook for attaching to a corporeal lumen and method of manufacturing
US6942691B1 (en) 2000-04-27 2005-09-13 Timothy A. M. Chuter Modular bifurcated graft for endovascular aneurysm repair
US6451050B1 (en) 2000-04-28 2002-09-17 Cardiovasc, Inc. Stent graft and method
US7135037B1 (en) * 2000-05-01 2006-11-14 Endovascular Technologies, Inc. System and method for forming a junction between elements of a modular endovascular prosthesis
WO2001082836A2 (en) 2000-05-04 2001-11-08 Oregon Health Sciences University Endovascular stent graft
US6454796B1 (en) 2000-05-05 2002-09-24 Endovascular Technologies, Inc. Vascular graft
US7006858B2 (en) 2000-05-15 2006-02-28 Silver James H Implantable, retrievable sensors and immunosensors
US6776173B2 (en) * 2000-06-30 2004-08-17 Tokyo Electron Limited Liquid processing apparatus
US7179268B2 (en) 2000-07-31 2007-02-20 Sumit Roy Device, apparatus, and prosthesis for suturless anastomosis
WO2002015951A2 (en) 2000-08-23 2002-02-28 Thoratec Corporation Coated vascular grafts and methods of use
NO312223B1 (en) 2000-09-05 2002-04-15 Leiv Eiriksson Nyfotek As Coated expandable stent
US6986786B1 (en) 2000-09-11 2006-01-17 Scimed Life Systerms, Inc. Endovascular prostethic devices having hook and loop structures
US7101391B2 (en) 2000-09-18 2006-09-05 Inflow Dynamics Inc. Primarily niobium stent
US20020072792A1 (en) 2000-09-22 2002-06-13 Robert Burgermeister Stent with optimal strength and radiopacity characteristics
US6254632B1 (en) * 2000-09-28 2001-07-03 Advanced Cardiovascular Systems, Inc. Implantable medical device having protruding surface structures for drug delivery and cover attachment
US6730119B1 (en) 2000-10-06 2004-05-04 Board Of Regents Of The University Of Texas System Percutaneous implantation of partially covered stents in aneurysmally dilated arterial segments with subsequent embolization and obliteration of the aneurysm cavity
US6582463B1 (en) 2000-10-11 2003-06-24 Heartstent Corporation Autoanastomosis
US6908477B2 (en) 2000-10-13 2005-06-21 Rex Medical, L.P. Methods of implanting covered stents with side branch
US6663664B1 (en) * 2000-10-26 2003-12-16 Advanced Cardiovascular Systems, Inc. Self-expanding stent with time variable radial force
US6814754B2 (en) 2000-10-30 2004-11-09 Secant Medical, Llc Woven tubular graft with regions of varying flexibility
JP4583756B2 (en) 2000-10-31 2010-11-17 クック インコーポレイテッド Medical instruments
WO2002035988A2 (en) 2000-10-31 2002-05-10 Prodesco, Inc. Graft having region for biological seal formation
US6506211B1 (en) * 2000-11-13 2003-01-14 Scimed Life Systems, Inc. Stent designs
EP1335681B1 (en) 2000-11-15 2006-12-20 McMURRAY FABRICS INCORPORATED Soft-tissue tubular prostheses with seamed transitions
US6843802B1 (en) 2000-11-16 2005-01-18 Cordis Corporation Delivery apparatus for a self expanding retractable stent
US7314483B2 (en) 2000-11-16 2008-01-01 Cordis Corp. Stent graft with branch leg
US7267685B2 (en) 2000-11-16 2007-09-11 Cordis Corporation Bilateral extension prosthesis and method of delivery
AU780015B2 (en) 2000-11-16 2005-02-24 Cordis Corporation A stent graft having an improved means for attaching a stent to a graft
US6942692B2 (en) 2000-11-16 2005-09-13 Cordis Corporation Supra-renal prosthesis and renal artery bypass
US6494909B2 (en) 2000-12-01 2002-12-17 Prodesco, Inc. Endovascular valve
US6645242B1 (en) 2000-12-11 2003-11-11 Stephen F. Quinn Bifurcated side-access intravascular stent graft
GB2371346B (en) 2000-12-14 2002-12-04 Tayside Flow Technologies Ltd Improving fluid flow in tubing
US6582448B1 (en) 2000-12-21 2003-06-24 Advanced Cardiovascular Systems, Inc. Vessel occlusion device for embolic protection system
US7357794B2 (en) 2002-01-17 2008-04-15 Medtronic Vascular, Inc. Devices, systems and methods for acute or chronic delivery of substances or apparatus to extravascular treatment sites
WO2002067815A1 (en) 2001-02-26 2002-09-06 Scimed Life Systems, Inc. Bifurcated stent
AU2002250189A1 (en) 2001-02-26 2002-09-12 Scimed Life Systems, Inc. Bifurcated stent and delivery system
US7799064B2 (en) 2001-02-26 2010-09-21 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US6918925B2 (en) 2001-03-23 2005-07-19 Hassan Tehrani Branched aortic arch stent graft and method of deployment
FR2822370B1 (en) 2001-03-23 2004-03-05 Perouse Lab TUBULAR ENDOPROSTHESIS COMPRISING A DEFORMABLE RING AND REQUIRED OF INTERVENTION FOR ITS IMPLANTATION
ATE272369T1 (en) 2001-03-27 2004-08-15 Cook William Europ VESSEL TRANSPLANT FOR THE AORTA
US6676691B1 (en) 2001-03-28 2004-01-13 Ayman A. Hosny Stent delivery system
DE60216426T2 (en) 2001-03-28 2007-09-13 Cook Inc., Bloomington MODULAR STENT DOBROTHESIS
US20040215322A1 (en) 2001-07-06 2004-10-28 Andrew Kerr Stent/graft assembly
US20040138734A1 (en) 2001-04-11 2004-07-15 Trivascular, Inc. Delivery system and method for bifurcated graft
US8337540B2 (en) 2001-05-17 2012-12-25 Advanced Cardiovascular Systems, Inc. Stent for treating bifurcations and method of use
US6749628B1 (en) 2001-05-17 2004-06-15 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US20040176837A1 (en) 2001-05-17 2004-09-09 Atladottir Svava Maria Self-expanding stent and catheter assembly and method for treating bifurcations
US6818013B2 (en) 2001-06-14 2004-11-16 Cordis Corporation Intravascular stent device
AU2002316254A1 (en) 2001-06-18 2003-01-02 Eva Corporation Prosthetic graft assembly and method of use
GB0114918D0 (en) 2001-06-19 2001-08-08 Vortex Innovation Ltd Devices for repairing aneurysms
US6605110B2 (en) * 2001-06-29 2003-08-12 Advanced Cardiovascular Systems, Inc. Stent with enhanced bendability and flexibility
US7156877B2 (en) * 2001-06-29 2007-01-02 The Regents Of The University Of California Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs
US20030100945A1 (en) 2001-11-23 2003-05-29 Mindguard Ltd. Implantable intraluminal device and method of using same in treating aneurysms
WO2003015663A1 (en) 2001-08-20 2003-02-27 Sumit Roy Low-profile, endoluminal prosthesis and deployment device
US20030040803A1 (en) 2001-08-23 2003-02-27 Rioux Robert F. Maintaining an open passageway through a body lumen
ES2319621T3 (en) 2001-08-23 2009-05-11 Darrell C. Gumm ROTARY SYSTEM OF IMPLANT OF ENDOVASCULAR PROTESIS FOR ACCSO OF SIDE BRANCH AND PROTECTION.
US6796999B2 (en) * 2001-09-06 2004-09-28 Medinol Ltd. Self articulating stent
IES20010828A2 (en) 2001-09-12 2003-03-19 Medtronic Inc Medical device for intraluminal endovascular stenting
US6827737B2 (en) * 2001-09-25 2004-12-07 Scimed Life Systems, Inc. EPTFE covering for endovascular prostheses and method of manufacture
US6767359B2 (en) 2001-09-28 2004-07-27 Ethicon, Inc. Prosthesis for the repair of thoracic or abdominal aortic aneurysms and method therefor
US6808504B2 (en) 2001-10-04 2004-10-26 Percardia, Inc. Multi-lumen implant
DE60237719D1 (en) 2001-10-16 2010-10-28 Koninkl Philips Electronics Nv METHOD FOR SELECTION OF ESTERS FOR ALIGNMENT OF PROBES
AUPR847201A0 (en) 2001-10-26 2001-11-15 Cook Incorporated Endoluminal graft
US20030085952A1 (en) * 2001-11-05 2003-05-08 Williams Roger O Apparatus and method for controlling the free surface of liquid in a well plate
US7029496B2 (en) 2001-11-07 2006-04-18 Scimed Life Systems, Inc. Interlocking endoluminal device
AU2002356964A1 (en) 2001-11-14 2003-05-26 Atrium Medical Corporation Graft and method of making
US6719784B2 (en) 2001-11-21 2004-04-13 Scimed Life Systems, Inc. Counter rotational layering of ePTFE to improve mechanical properties of a prosthesis
US20110087320A1 (en) 2001-11-28 2011-04-14 Aptus Endosystems, Inc. Devices, Systems, and Methods for Prosthesis Delivery and Implantation, Including a Prosthesis Assembly
US20050149081A1 (en) 2001-11-28 2005-07-07 John Ricota Endovascular graft and graft trimmer
US7128754B2 (en) 2001-11-28 2006-10-31 Aptus Endosystems, Inc. Catheter-based fastener implantation apparatus and methods
WO2003045283A1 (en) 2001-11-28 2003-06-05 Aptus Endosystems, Inc. Endovascular aneurysm repair system
US6929661B2 (en) 2001-11-28 2005-08-16 Aptus Endosystems, Inc. Multi-lumen prosthesis systems and methods
US20050121411A1 (en) 2002-10-29 2005-06-09 Microfabrica Inc. Medical devices and EFAB methods and apparatus for producing them
US8080048B2 (en) 2001-12-03 2011-12-20 Xtent, Inc. Stent delivery for bifurcated vessels
US6770090B2 (en) 2001-12-07 2004-08-03 Scimed Life Systems, Inc. Anatomically curved graft for implantation at the aortic arch
US7318833B2 (en) 2001-12-19 2008-01-15 Nmt Medical, Inc. PFO closure device with flexible thrombogenic joint and improved dislodgement resistance
US20100016943A1 (en) * 2001-12-20 2010-01-21 Trivascular2, Inc. Method of delivering advanced endovascular graft
US7014653B2 (en) 2001-12-20 2006-03-21 Cleveland Clinic Foundation Furcated endovascular prosthesis
EP1467679B1 (en) * 2001-12-20 2015-11-04 TriVascular, Inc. Advanced endovascular graft
US7147661B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US6641606B2 (en) 2001-12-20 2003-11-04 Cleveland Clinic Foundation Delivery system and method for deploying an endovascular prosthesis
US20030130720A1 (en) 2002-01-08 2003-07-10 Depalma Donald F. Modular aneurysm repair system
US6723116B2 (en) 2002-01-14 2004-04-20 Syde A. Taheri Exclusion of ascending/descending aorta and/or aortic arch aneurysm
US6949121B1 (en) 2002-02-07 2005-09-27 Sentient Engineering & Technology, Llc Apparatus and methods for conduits and materials
US9539121B2 (en) 2002-02-07 2017-01-10 Dsm Ip Assets B.V. Apparatus and methods for conduits and materials
US7235095B2 (en) 2002-02-22 2007-06-26 Scimed Life Systems, Inc. Method and system for deploying multi-part endoluminal devices
US7708771B2 (en) 2002-02-26 2010-05-04 Endovascular Technologies, Inc. Endovascular graft device and methods for attaching components thereof
WO2003071929A2 (en) 2002-02-26 2003-09-04 Endovascular Technologies, Inc. Endovascular grafting device
EP1487380B1 (en) 2002-03-25 2008-02-27 Cook Incorporated Branched vessel prothesis
US7789903B2 (en) 2002-04-04 2010-09-07 Boston Scientific Scimed, Inc. Stent-graft with adjustable length
US7655036B2 (en) 2002-04-24 2010-02-02 Medtronic Vascular, Inc. Bifurcated endoluminal prosthetic assembly and method
US7131991B2 (en) 2002-04-24 2006-11-07 Medtronic Vascular, Inc. Endoluminal prosthetic assembly and extension method
DE10218339B4 (en) 2002-04-24 2005-04-21 Südrad GmbH Radtechnik Plate wheel made of sheet metal for motor vehicles and method for its production
US20030204249A1 (en) 2002-04-25 2003-10-30 Michel Letort Endovascular stent graft and fixation cuff
US6676699B2 (en) 2002-04-26 2004-01-13 Medtronic Ave, Inc Stent graft with integrated valve device and method
JP4624779B2 (en) 2002-05-16 2011-02-02 クック インコーポレイテッド Flexible “kaeshi” that locks the prosthesis
US20030220683A1 (en) 2002-05-22 2003-11-27 Zarouhi Minasian Endoluminal device having barb assembly and method of using same
EP1513470A2 (en) 2002-05-28 2005-03-16 The Cleveland Clinic Foundation Minimally invasive treatment system for aortic aneurysms
US7399313B2 (en) 2002-06-07 2008-07-15 Brown Peter S Endovascular graft with separable sensors
US7025778B2 (en) 2002-06-07 2006-04-11 Endovascular Technologies, Inc. Endovascular graft with pressure, temperature, flow and voltage sensors
AU2003241129A1 (en) 2002-06-13 2003-12-31 Existent, Inc. Guidewire system
US6858038B2 (en) 2002-06-21 2005-02-22 Richard R. Heuser Stent system
US6887258B2 (en) 2002-06-26 2005-05-03 Advanced Cardiovascular Systems, Inc. Embolic filtering devices for bifurcated vessels
AU2003258976B2 (en) 2002-06-28 2008-05-29 Cook Incorporated Thoracic aortic aneurysm stent graft.
US7314484B2 (en) * 2002-07-02 2008-01-01 The Foundry, Inc. Methods and devices for treating aneurysms
US6802859B1 (en) 2002-07-12 2004-10-12 Endovascular Technologies, Inc. Endovascular stent-graft with flexible bifurcation
US7122051B1 (en) 2002-07-12 2006-10-17 Endovascular Technologies, Inc. Universal length sizing and dock for modular bifurcated endovascular graft
US6761734B2 (en) 2002-07-22 2004-07-13 William S. Suhr Segmented balloon catheter for stenting bifurcation lesions
US20040034407A1 (en) 2002-08-16 2004-02-19 John Sherry Covered stents with degradable barbs
US8043365B2 (en) 2002-08-19 2011-10-25 Jeffery Thramann Methods for placement of vascular stent grafts and vascular stents
WO2004017866A1 (en) * 2002-08-20 2004-03-04 Cook Incorporated Stent graft with improved proximal end
US7550004B2 (en) 2002-08-20 2009-06-23 Cook Biotech Incorporated Endoluminal device with extracellular matrix material and methods
EP1545396B1 (en) 2002-08-23 2008-12-17 William A. Cook Australia Pty. Ltd. Composite prosthesis
AU2002951147A0 (en) 2002-09-02 2002-09-19 Cook Incorporated Branch grafting device and method
US7264631B2 (en) 2002-09-16 2007-09-04 Scimed Life Systems, Inc. Devices and methods for AAA management
US20040054403A1 (en) 2002-09-18 2004-03-18 Israel Henry M Angular orientation of a stent
EP1542616B1 (en) 2002-09-20 2015-04-22 Endologix, Inc. Stent-graft with positioning anchor
AU2003276903A1 (en) 2002-09-20 2004-05-04 Flowmedica, Inc. Method and apparatus for selective material delivery via an intra-renal catheter
US7326242B2 (en) 2002-11-05 2008-02-05 Boston Scientific Scimed, Inc. Asymmetric bifurcated crown
US6887266B2 (en) * 2002-11-14 2005-05-03 Synecor, Llc Endoprostheses and methods of manufacture
ITRM20020596A1 (en) 2002-11-27 2004-05-28 Mauro Ferrari IMPLANT VASCULAR PROSTHESIS WITH COMBINED, LAPAROSCOPIC AND ENDOVASCULAR TECHNIQUES, FOR THE TREATMENT OF ABDOMINAL AORTIC ANEURYSMS, AND OPERATIONAL EQUIPMENT FOR THE RELEASE OF A PROSTHESIS EQUIPPED WITH ANCHORING STENTS.
US7488344B2 (en) 2002-12-04 2009-02-10 William A. Cook Australia Pty. Ltd. Device and method for treating thoracic aorta
ITMO20020349A1 (en) 2002-12-06 2004-06-07 G A M A H S Srl PROSTHESIS FOR LARGE BLOOD VESSELS.
US7300460B2 (en) 2002-12-31 2007-11-27 Counter Clockwise, Inc. Bifurcated guidewire and methods of use
CA2512610C (en) 2003-01-14 2008-12-23 The Cleveland Clinic Foundation Branched vessel endoluminal device
US9125733B2 (en) 2003-01-14 2015-09-08 The Cleveland Clinic Foundation Branched vessel endoluminal device
US7169177B2 (en) 2003-01-15 2007-01-30 Boston Scientific Scimed, Inc. Bifurcated stent
US20080051866A1 (en) 2003-02-26 2008-02-28 Chao Chin Chen Drug delivery devices and methods
US7025779B2 (en) 2003-02-26 2006-04-11 Scimed Life Systems, Inc. Endoluminal device having enhanced affixation characteristics
US7314480B2 (en) 2003-02-27 2008-01-01 Boston Scientific Scimed, Inc. Rotating balloon expandable sheath bifurcation delivery
US7150758B2 (en) * 2003-03-06 2006-12-19 Boston Scientific Santa Rosa Corp. Kink resistant endovascular graft
US6984244B2 (en) 2003-03-27 2006-01-10 Endovascular Technologies, Inc. Delivery system for endoluminal implant
CA2518890C (en) 2003-04-03 2012-06-05 William A. Cook Australia Pty. Ltd. Branch stent graft deployment and method
US8083791B2 (en) 2003-04-14 2011-12-27 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US8109987B2 (en) 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7758630B2 (en) 2003-04-14 2010-07-20 Tryton Medical, Inc. Helical ostium support for treating vascular bifurcations
US7481834B2 (en) 2003-04-14 2009-01-27 Tryton Medical, Inc. Stent for placement at luminal os
US7717953B2 (en) 2004-10-13 2010-05-18 Tryton Medical, Inc. Delivery system for placement of prosthesis at luminal OS
US7972372B2 (en) 2003-04-14 2011-07-05 Tryton Medical, Inc. Kit for treating vascular bifurcations
US7731747B2 (en) 2003-04-14 2010-06-08 Tryton Medical, Inc. Vascular bifurcation prosthesis with multiple thin fronds
US20040215328A1 (en) 2003-04-25 2004-10-28 Ronan Thornton Bifurcated stent with concentric body portions
US20070032852A1 (en) 2003-04-25 2007-02-08 Medtronic Vascular, Inc. Methods and Apparatus for Treatment of Aneurysms Adjacent to Branch Arteries
US7438721B2 (en) 2003-04-25 2008-10-21 Medtronic Vascular, Inc. Universal modular stent graft assembly to accommodate flow to collateral branches
US20040215125A1 (en) 2003-04-27 2004-10-28 Brown Donald W. Bifurcated graft for dialysis
US8226700B2 (en) 2003-04-30 2012-07-24 Medtronic Vascular, Inc. Dual guide-wire medical device and method
US7604660B2 (en) 2003-05-01 2009-10-20 Merit Medical Systems, Inc. Bifurcated medical appliance delivery apparatus and method
US20060161244A1 (en) 2003-05-02 2006-07-20 Jacques Seguin Vascular graft and deployment system
US20040230289A1 (en) 2003-05-15 2004-11-18 Scimed Life Systems, Inc. Sealable attachment of endovascular stent to graft
US20040243221A1 (en) 2003-05-27 2004-12-02 Fawzi Natalie V. Endovascular graft including substructure for positioning and sealing within vasculature
JP2006526464A (en) 2003-06-05 2006-11-24 フローメディカ,インコーポレイテッド System and method for performing bilateral intervention or diagnosis in a branched body lumen
US20040254628A1 (en) 2003-06-13 2004-12-16 Patrice Nazzaro One-branch stent-graft for bifurcated lumens
US7431733B2 (en) 2003-06-27 2008-10-07 University Of South Florida Vascular prosthesis
CN1470294A (en) 2003-07-07 2004-01-28 �й���ѧԺ����Ӧ�û�ѧ�о��� Biodegradable common bile duct built-in carriage and its making method
JP2007530089A (en) 2003-07-14 2007-11-01 ユニバーシティ・オブ・リムリック Vascular graft
US8157850B2 (en) 2003-07-29 2012-04-17 Boston Scientific Scimed, Inc. Device and method for loading a luminal graft for endoluminal delivery
US6986751B2 (en) 2003-08-05 2006-01-17 Cabg Medical, Inc. Grafted network incorporating a multiple channel fluid flow connector
US6991615B2 (en) 2003-08-05 2006-01-31 Cabg Medical, Inc. Grafted network incorporating a multiple channel fluid flow connector
US8721710B2 (en) 2003-08-11 2014-05-13 Hdh Medical Ltd. Anastomosis system and method
US7628806B2 (en) 2003-08-20 2009-12-08 Boston Scientific Scimed, Inc. Stent with improved resistance to migration
US8298280B2 (en) 2003-08-21 2012-10-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US8292943B2 (en) 2003-09-03 2012-10-23 Bolton Medical, Inc. Stent graft with longitudinal support member
US20050059923A1 (en) 2003-09-17 2005-03-17 Ricardo Gamboa Fenestration with intrinsic means of selective closure incorporated to a tubular body and used in interventional cardiovascular procedures
US7559948B2 (en) 2003-09-17 2009-07-14 Ricardo Gamboa Fenestrated asymmetric intracardiac device for the completion of total cavopulmonary anastomosis through cardiac catheterization
WO2005032340A2 (en) 2003-09-29 2005-04-14 Secant Medical, Llc Integral support stent graft assembly
US20050113905A1 (en) 2003-10-10 2005-05-26 Greenberg Roy K. Endoluminal prosthesis with interconnectable modules
US7413573B2 (en) 2003-10-10 2008-08-19 William A. Cook Australia Pty. Ltd. Fenestrated stent grafts
US7425219B2 (en) 2003-10-10 2008-09-16 Arshad Quadri System and method for endoluminal grafting of bifurcated and branched vessels
EP1673039B1 (en) 2003-10-10 2008-12-03 William A. Cook Australia Pty. Ltd. Stent graft fenestration
WO2005037141A2 (en) 2003-10-14 2005-04-28 William A. Cook Australia Pty. Ltd. Introducer for an iliac side branch device
US7998186B2 (en) 2003-10-14 2011-08-16 William A. Cook Australia Pty. Ltd. Introducer for a side branch device
US20050080482A1 (en) 2003-10-14 2005-04-14 Craig Bonsignore Graft coupling apparatus and methods of using same
US7695508B2 (en) 2003-10-16 2010-04-13 Minvasys Sa Catheter system for stenting bifurcated vessels
US7641684B2 (en) 2003-10-16 2010-01-05 Minvasys, Sa Catheter system for stenting bifurcated vessels
US7144421B2 (en) 2003-11-06 2006-12-05 Carpenter Judith T Endovascular prosthesis, system and method
US9078780B2 (en) 2003-11-08 2015-07-14 Cook Medical Technologies Llc Balloon flareable branch vessel prosthesis and method
US7344557B2 (en) 2003-11-12 2008-03-18 Advanced Stent Technologies, Inc. Catheter balloon systems and methods
US7090694B1 (en) 2003-11-19 2006-08-15 Advanced Cardiovascular Systems, Inc. Portal design for stent for treating bifurcated vessels
AU2004299108B2 (en) 2003-12-17 2010-04-22 Cook Medical Technologies Llc Interconnected leg extensions for an endoluminal prostehsis
US7303758B2 (en) 2004-01-20 2007-12-04 Cordis Corporation Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury
US7854756B2 (en) 2004-01-22 2010-12-21 Boston Scientific Scimed, Inc. Medical devices
US20050177224A1 (en) 2004-02-11 2005-08-11 Fogarty Thomas J. Vascular fixation device and method
AU2005218677B2 (en) * 2004-03-02 2011-11-03 Peter William Walsh A vessel or sac wall treatment and a cardiac assist device
US7753951B2 (en) 2004-03-04 2010-07-13 Y Med, Inc. Vessel treatment devices
CA2558573A1 (en) 2004-03-11 2005-09-22 Trivascular, Inc. Modular endovascular graft
US8007528B2 (en) 2004-03-17 2011-08-30 Boston Scientific Scimed, Inc. Bifurcated stent
US8048140B2 (en) 2004-03-31 2011-11-01 Cook Medical Technologies Llc Fenestrated intraluminal stent system
US7674284B2 (en) 2004-03-31 2010-03-09 Cook Incorporated Endoluminal graft
US8500751B2 (en) 2004-03-31 2013-08-06 Merlin Md Pte Ltd Medical device
US7682381B2 (en) 2004-04-23 2010-03-23 Boston Scientific Scimed, Inc. Composite medical textile material and implantable devices made therefrom
EP2422751A3 (en) * 2004-05-05 2013-01-02 Direct Flow Medical, Inc. Unstented heart valve with formed in place support structure
US20060122692A1 (en) 2004-05-10 2006-06-08 Ran Gilad Stent valve and method of using same
EP1750619B1 (en) 2004-05-25 2013-07-24 Covidien LP Flexible vascular occluding device
US20050278013A1 (en) 2004-05-26 2005-12-15 Matthew Rust Method for endovascular bypass stent graft delivery
JP5054524B2 (en) 2004-06-08 2012-10-24 アドバンスド ステント テクノロジーズ, インコーポレイテッド Stent with protruding branch for branch pipe
US20050273154A1 (en) 2004-06-08 2005-12-08 Colone William M Bifurcated stent graft and apparatus for making same
US7727271B2 (en) 2004-06-24 2010-06-01 Boston Scientific Scimed, Inc. Implantable prosthesis having reinforced attachment sites
US7758626B2 (en) 2004-07-20 2010-07-20 Medtronic Vascular, Inc. Device and method for delivering an endovascular stent-graft having a longitudinally unsupported portion
ATE451076T1 (en) 2004-07-28 2009-12-15 Cordis Corp FLAT PROFILE SUPPORT STRUCTURE FOR ABDOMINAL AORTIC ANEURYSMA
EP1621158A1 (en) 2004-07-28 2006-02-01 Cordis Corporation Reduced profile abdominal aortic aneurysm device
EP1621161B1 (en) 2004-07-28 2009-11-18 Cordis Corporation Device having connected bifurcated legs to treat abdominal aortic aneurysm
US20060079956A1 (en) 2004-09-15 2006-04-13 Conor Medsystems, Inc. Bifurcation stent with crushable end and method for delivery of a stent to a bifurcation
US7998187B2 (en) 2004-09-21 2011-08-16 William A. Cook Australia Pty. Ltd. Stent graft connection arrangement
JP5083766B2 (en) 2004-09-21 2012-11-28 ウィリアム・エイ・クック・オーストラリア・プロプライエタリー・リミテッド Side branch stent graft
US20060089704A1 (en) 2004-10-25 2006-04-27 Myles Douglas Vascular graft and deployment system
US7699883B2 (en) 2004-10-25 2010-04-20 Myles Douglas Vascular graft and deployment system
US7147659B2 (en) 2004-10-28 2006-12-12 Cordis Neurovascular, Inc. Expandable stent having a dissolvable portion
JP5028605B2 (en) 2004-11-22 2012-09-19 国立大学法人九州大学 Biofilm formation inhibitor and therapeutic device
US9427340B2 (en) 2004-12-14 2016-08-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
WO2006065644A1 (en) 2004-12-17 2006-06-22 William A. Cook Australia Pty. Ltd. Stented side branch graft
US7588596B2 (en) 2004-12-29 2009-09-15 Scimed Life Systems, Inc. Endoluminal prosthesis adapted to resist migration and method of deploying the same
US7217283B2 (en) 2004-12-30 2007-05-15 Depuy Products, Inc. Orthopaedic implant for vascularization of the femoral head
US8128680B2 (en) 2005-01-10 2012-03-06 Taheri Laduca Llc Apparatus and method for deploying an implantable device within the body
US20070150051A1 (en) 2005-01-10 2007-06-28 Duke Fiduciary, Llc Vascular implants and methods of fabricating the same
US9101500B2 (en) 2005-01-10 2015-08-11 Trireme Medical, Inc. Stent with self-deployable portion having wings of different lengths
WO2008098255A2 (en) 2007-02-09 2008-08-14 Taheri Laduca Llc Apparatus and method for deploying an implantable device within the body
US20060155366A1 (en) 2005-01-10 2006-07-13 Laduca Robert Apparatus and method for deploying an implantable device within the body
US8287583B2 (en) 2005-01-10 2012-10-16 Taheri Laduca Llc Apparatus and method for deploying an implantable device within the body
US7306623B2 (en) 2005-01-13 2007-12-11 Medtronic Vascular, Inc. Branch vessel graft design and deployment method
EP1838242A2 (en) 2005-01-21 2007-10-03 Gen 4, LLC Modular stent graft employing bifurcated graft and leg locking stent elements
US7963989B2 (en) 2005-01-24 2011-06-21 Technology Advancement Group, Inc. Implantable prosthetic device for connection to a fluid flow pathway of a patient
US8128685B2 (en) 2005-02-01 2012-03-06 Stent Tech, Inc Bifurcated stenting appratus and method
US20060173534A1 (en) 2005-02-01 2006-08-03 Das Gladwin S Bifurcated stenting apparatus and method
JP2008532577A (en) 2005-02-08 2008-08-21 ビー−バルーン リミティド Apparatus and method for treatment of vascular bifurcation
FR2881946B1 (en) 2005-02-17 2008-01-04 Jacques Seguin DEVICE FOR THE TREATMENT OF BODILY CONDUIT AT BIFURCATION LEVEL
US7828837B2 (en) 2005-02-17 2010-11-09 Khoury Medical Devices, LLC. Vascular endograft
US20060212113A1 (en) 2005-02-24 2006-09-21 Shaolian Samuel M Externally adjustable endovascular graft implant
JP2008534046A (en) 2005-03-23 2008-08-28 ユニバーシティ・オブ・リムリック Vascular graft
US7766959B2 (en) 2005-03-25 2010-08-03 Scimed Life Systems, Inc. Variable length endovascular graft prosthesis adapted to prevent endoleaks
US7651524B2 (en) 2005-03-30 2010-01-26 Terumo Kabushiki Kaisha Flexible stent
WO2006103641A1 (en) 2005-03-30 2006-10-05 University Of Limerick A vascular graft
US7833263B2 (en) 2005-04-01 2010-11-16 Boston Scientific Scimed, Inc. Hybrid vascular graft reinforcement
AR054656A1 (en) 2005-04-03 2007-07-11 Liliana Rosa Grinfeld STENT FOR OSTIAL INJURIES AND VASCULAR FORKS
WO2006113501A1 (en) 2005-04-13 2006-10-26 The Cleveland Clinic Foundation Endoluminal prosthesis
EP2614796B1 (en) 2005-04-25 2020-04-08 Covidien LP Controlled fracture connections for stents
US20060247760A1 (en) 2005-04-29 2006-11-02 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent branch arteries
WO2006124824A1 (en) 2005-05-13 2006-11-23 Alveolus, Inc. Drainage stent and associated method
US8961586B2 (en) 2005-05-24 2015-02-24 Inspiremd Ltd. Bifurcated stent assemblies
CN2817768Y (en) 2005-05-24 2006-09-20 微创医疗器械(上海)有限公司 Tectorium stand and host cage section thereof
US8317855B2 (en) 2005-05-26 2012-11-27 Boston Scientific Scimed, Inc. Crimpable and expandable side branch cell
CA2610703C (en) 2005-06-01 2014-07-22 William A. Cook Australia Pty. Ltd. Side branch stent graft
US7485140B2 (en) 2005-06-17 2009-02-03 Boston Scientific Scimed, Inc. Bifurcation stent assembly
ATE489060T1 (en) 2005-06-29 2010-12-15 Bipin C Patadia SYSTEM FOR DEPLOYING A PROXIMALLY EXPANDED STENT
JP4887361B2 (en) 2005-07-07 2012-02-29 メッド・インスティテュート・インコーポレイテッド Branch vessel stent graft
DE102006020687A1 (en) 2005-07-19 2007-02-08 Aesculap Ag & Co. Kg Stent graft prosthesis for treating abdominal aneurisms and aneurisms of the thoracal aorta comprises a sleeve formed as a folding toroid and having a shape in the unfolded state which fits the shape of the aneurism
GB0515140D0 (en) 2005-07-22 2005-08-31 Ark Therapeutics Ltd Therapeutic device
WO2007013065A2 (en) 2005-07-25 2007-02-01 Rainbow Medical Ltd. Electrical stimulation of blood vessels
US7833259B2 (en) 2005-07-25 2010-11-16 Cook Incorporated Fenestrated endoluminal stent system
EP1922029B1 (en) 2005-08-18 2014-11-19 Cook Medical Technologies LLC Assembly of stent grafts
US20070050015A1 (en) 2005-08-25 2007-03-01 Scimed Life Systems, Inc. Endoluminal prosthesis adapted to deployment in a distorted branched body lumen and method of deploying the same
US20070055341A1 (en) 2005-08-26 2007-03-08 Vascular And Endovascular Surgical Technologies, Inc. Endograft
US20070050016A1 (en) 2005-08-29 2007-03-01 Boston Scientific Scimed, Inc. Stent with expanding side branch geometry
DE602006019753D1 (en) 2005-09-01 2011-03-03 Medtronic Vascular Inc METHOD AND APPARATUS FOR THE TREATMENT OF ANEURYSMS OF A. THORACICA
US20080208312A1 (en) 2005-09-02 2008-08-28 Medtronic Vascular, Inc. Stent Graft With Strips to Promote Localized Healing
EP1933764A2 (en) 2005-09-02 2008-06-25 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent to branch arteries
US7955374B2 (en) 2005-09-02 2011-06-07 Medtronic Vascular, Inc. Modular branch vessel stent-graft assembly
US8911491B2 (en) 2005-09-02 2014-12-16 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent branch arteries including branch artery flow lumen alignment
US9233012B2 (en) 2005-09-07 2016-01-12 RBKPark, LLC Medical stent
US7632304B2 (en) 2005-09-07 2009-12-15 Rbkpark Llc Coronary stent
US8038706B2 (en) 2005-09-08 2011-10-18 Boston Scientific Scimed, Inc. Crown stent assembly
US7731741B2 (en) 2005-09-08 2010-06-08 Boston Scientific Scimed, Inc. Inflatable bifurcation stent
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
US20070088428A1 (en) 2005-09-15 2007-04-19 Cappella, Inc. Intraluminal device with asymmetric cap portion
US20080221655A1 (en) 2005-09-21 2008-09-11 B-Balloon Ltd. Bifurcated Balloon and Stent
US7452372B2 (en) 2005-09-22 2008-11-18 Boston Scientific Scimed, Inc. Bifurcated stent
US20070067023A1 (en) 2005-09-22 2007-03-22 Boston Scientific Scimed, Inc. Tether guided stent side branch
US8231669B2 (en) 2005-09-22 2012-07-31 Boston Scientific Scimed, Inc. Tether guided stent side branch
US8343204B2 (en) 2005-10-31 2013-01-01 Cook Medical Technologies Llc Composite stent graft
US20070106375A1 (en) 2005-11-07 2007-05-10 Carlos Vonderwalde Bifurcated stent assembly
US20070112418A1 (en) 2005-11-14 2007-05-17 Boston Scientific Scimed, Inc. Stent with spiral side-branch support designs
US20070167901A1 (en) 2005-11-17 2007-07-19 Herrig Judson A Self-sealing residual compressive stress graft for dialysis
US20070123970A1 (en) 2005-11-29 2007-05-31 Boston Scientific Scimed, Inc. Bifurcation stent with overlapping crimped struts
US8435284B2 (en) 2005-12-14 2013-05-07 Boston Scientific Scimed, Inc. Telescoping bifurcated stent
US8343211B2 (en) 2005-12-14 2013-01-01 Boston Scientific Scimed, Inc. Connectors for bifurcated stent
US20070142904A1 (en) 2005-12-20 2007-06-21 Boston Scientific Scimed, Inc. Bifurcated stent with multiple locations for side branch access
US7540881B2 (en) 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
WO2007079081A1 (en) 2005-12-29 2007-07-12 Med Institute, Inc. Endoluminal device including a mechanism for proximal or distal fixation, and sealing and methods of use thereof
US20070156228A1 (en) 2006-01-03 2007-07-05 Majercak David C Prosthetic stent graft for treatment of abdominal aortic aneurysm
US20070162109A1 (en) 2006-01-11 2007-07-12 Luis Davila Intraluminal stent graft
WO2007084537A2 (en) 2006-01-18 2007-07-26 William A. Cook Australia Pty. Ltd. Self expanding stent
US20070168013A1 (en) 2006-01-19 2007-07-19 Myles Douglas Vascular graft and deployment system
US8083792B2 (en) 2006-01-24 2011-12-27 Cordis Corporation Percutaneous endoprosthesis using suprarenal fixation and barbed anchors
US20070173925A1 (en) 2006-01-25 2007-07-26 Cornova, Inc. Flexible expandable stent
US20070203572A1 (en) 2006-01-25 2007-08-30 Heuser Richard R Catheter system with stent apparatus for connecting adjacent blood vessels
US20080161901A1 (en) 2006-01-25 2008-07-03 Heuser Richard R Catheter system with stent apparatus for connecting adjacent blood vessels
EP1983933B1 (en) 2006-02-13 2013-01-23 William A. Cook Australia Pty. Ltd. Side branch stent graft construction
GB0603685D0 (en) 2006-02-23 2006-04-05 Angiomed Ag Vascular prosthesis for aneurysms, set of vascular prostheses, method for manufacturing a vascular prosthesis and method for inserting a vascular prosthesis
US20070208414A1 (en) 2006-03-06 2007-09-06 Shawn Sorenson Tapered strength rings on a bifurcated stent petal
US7833264B2 (en) 2006-03-06 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent
US20070208419A1 (en) 2006-03-06 2007-09-06 Boston Scientific Scimed, Inc. Bifurcation stent with uniform side branch projection
US20070208415A1 (en) 2006-03-06 2007-09-06 Kevin Grotheim Bifurcated stent with controlled drug delivery
US8298278B2 (en) 2006-03-07 2012-10-30 Boston Scientific Scimed, Inc. Bifurcated stent with improvement securement
US8167929B2 (en) 2006-03-09 2012-05-01 Abbott Laboratories System and method for delivering a stent to a bifurcated vessel
US8257419B2 (en) 2006-03-10 2012-09-04 Cordis Corporation Apparatus for treating a bifurcated region of a conduit
US7955380B2 (en) 2006-03-17 2011-06-07 Medtronic Vascular, Inc. Prosthesis fixation apparatus and methods
US20070225798A1 (en) 2006-03-23 2007-09-27 Daniel Gregorich Side branch stent
US20070225797A1 (en) 2006-03-24 2007-09-27 Medtronic Vascular, Inc. Prosthesis With Adjustable Opening for Side Branch Access
CA2646055C (en) 2006-03-29 2014-08-12 Cook Incorporated Iliac leg extension stent graft
US7481836B2 (en) 2006-03-30 2009-01-27 Medtronic Vascular, Inc. Prosthesis with coupling zone and methods
US9757260B2 (en) 2006-03-30 2017-09-12 Medtronic Vascular, Inc. Prosthesis with guide lumen
US7591848B2 (en) 2006-04-06 2009-09-22 Medtronic Vascular, Inc. Riveted stent valve for percutaneous use
US7955365B2 (en) * 2006-04-07 2011-06-07 Medtronic Vascular, Inc. Closed loop catheter photopolymerization system and method of treating a vascular condition
US20070244547A1 (en) 2006-04-18 2007-10-18 Medtronic Vascular, Inc., A Delaware Corporation Device and Method for Controlling the Positioning of a Stent Graft Fenestration
US7678141B2 (en) 2006-04-18 2010-03-16 Medtronic Vascular, Inc. Stent graft having a flexible, articulable, and axially compressible branch graft
US20080027533A1 (en) 2006-04-19 2008-01-31 Abbott Laboratories Dedicated bifurcation stent apparatus and method
US9707113B2 (en) 2006-04-19 2017-07-18 Cook Medical Technologies Llc Twin bifurcated stent graft
US20070260304A1 (en) 2006-05-02 2007-11-08 Daniel Gregorich Bifurcated stent with minimally circumferentially projected side branch
US7744643B2 (en) 2006-05-04 2010-06-29 Boston Scientific Scimed, Inc. Displaceable stent side branch structure
WO2007146021A2 (en) 2006-06-06 2007-12-21 Cook Incorporated Stent with a crush-resistant zone
EP2051673A2 (en) 2006-06-23 2009-04-29 Boston Scientific Limited Bifurcated stent with twisted hinges
US7824438B2 (en) 2006-07-06 2010-11-02 Robert Kipperman Method for placement of a stent assembly in a bifurcated vessel
US8066753B2 (en) 2006-07-06 2011-11-29 Robert Kipperman Specialized catheter and method for placement in a bifurcated vessel
US8029558B2 (en) 2006-07-07 2011-10-04 Abbott Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
EP2040642B8 (en) 2006-07-11 2013-01-09 Gabriele Iannelli Vascular prosthesis
US8202310B2 (en) 2006-07-14 2012-06-19 Cordis Corporation AAA repair device with aneurysm sac access port
US20080058925A1 (en) 2006-08-02 2008-03-06 Gordon Cohen Bifurcated flow device for cardio-pulmonary assist or support and associated methods
US8216297B2 (en) 2006-08-14 2012-07-10 Trivascular, Inc. Dual chamber cuff structure
AU2007284362C1 (en) 2006-08-18 2012-08-23 Cook Incorporated Stent graft
JP5392655B2 (en) 2006-08-18 2014-01-22 クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニー Stent grafting system
US9044350B2 (en) 2006-08-21 2015-06-02 Boston Scientific Scimed, Inc. Alignment sheath apparatus and method
US20080065200A1 (en) 2006-09-07 2008-03-13 Trireme Medical, Inc. Bifurcated prostheses having differential drug coatings
US8216267B2 (en) 2006-09-12 2012-07-10 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
JP5074502B2 (en) 2006-09-25 2012-11-14 アレキサンダー・ヴィラー Self-expanding stent system for bifurcated damage
US7951191B2 (en) 2006-10-10 2011-05-31 Boston Scientific Scimed, Inc. Bifurcated stent with entire circumferential petal
US20100324664A1 (en) 2006-10-18 2010-12-23 Asher Holzer Bifurcated Stent Assemblies
US8257431B2 (en) 2006-11-01 2012-09-04 Boston Scientific Scimed, Inc. Multi-furcated ePTFE grafts and stent-graft prostheses and methods of making the same
US8206429B2 (en) 2006-11-02 2012-06-26 Boston Scientific Scimed, Inc. Adjustable bifurcation catheter incorporating electroactive polymer and methods of making and using the same
US8167930B2 (en) 2006-11-07 2012-05-01 William A. Cook Australia Pty. Ltd. Stent graft for treatment of emergency rupture of a vessel
AU2007317777B2 (en) 2006-11-07 2012-08-02 Cook Incorporated Fenestrations for stent graft arrangements and stent graft including the same
US20090099648A1 (en) 2006-11-09 2009-04-16 Chun Ho Yu Modular stent graft and delivery system
US20080114444A1 (en) 2006-11-09 2008-05-15 Chun Ho Yu Modular stent graft and delivery system
US7615072B2 (en) 2006-11-14 2009-11-10 Medtronic Vascular, Inc. Endoluminal prosthesis
US7655034B2 (en) 2006-11-14 2010-02-02 Medtronic Vascular, Inc. Stent-graft with anchoring pins
US7842082B2 (en) 2006-11-16 2010-11-30 Boston Scientific Scimed, Inc. Bifurcated stent
US20080177377A1 (en) 2006-11-16 2008-07-24 Boston Scientific Scimed, Inc. Bifurcation Stent Design with Over Expansion Capability
JP2010510021A (en) 2006-11-21 2010-04-02 ザ メディカル リサーチ, インフラストラクチャー, アンド ヘルス サーヴィシーズ ファンド オブ ザ テル アヴィヴ メディカル センター Bifurcated stent graft for aortic aneurysm repair
US20080133000A1 (en) 2006-12-01 2008-06-05 Medtronic Vascular, Inc. Bifurcated Stent With Variable Length Branches
US20080147174A1 (en) 2006-12-11 2008-06-19 Trireme Medical, Inc. Apparatus and method of using markers to position stents in bifurcations
US8216298B2 (en) 2007-01-05 2012-07-10 Medtronic Vascular, Inc. Branch vessel graft method and delivery system
US7959668B2 (en) 2007-01-16 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent
BRPI0807260A2 (en) 2007-02-09 2014-06-10 Taheri Laduca Llc "IMPLANTABLE STENT AND METHOD OF MANUFACTURING A TUBULAR GRAFT"
GB0703379D0 (en) 2007-02-21 2007-03-28 Angiomed Ag Stent with radiopaque marker
US8118862B2 (en) 2007-02-22 2012-02-21 Mohsin Saeed Apparatus and method for implantation of bifurcated endovascular prosthesis
US8821567B2 (en) 2007-02-22 2014-09-02 Mohsin Saeed Apparatus and method for implantation of a bifurcated endovascular prosthesis
ES2624595T3 (en) 2007-03-05 2017-07-17 Endospan Ltd Bifurcated, supportive, expandable endoluminal grafts with multiple components and methods for use
US20080228255A1 (en) 2007-03-13 2008-09-18 Medtronic Vascular, Inc. Positionable Stent-Graft Delivery System and Method
US8118861B2 (en) 2007-03-28 2012-02-21 Boston Scientific Scimed, Inc. Bifurcation stent and balloon assemblies
US8715336B2 (en) 2007-04-19 2014-05-06 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent to branch arteries
SE531374C2 (en) 2007-05-14 2009-03-17 Graftcraft I Goeteborg Ab New vascular prosthesis
US20080294235A1 (en) 2007-05-24 2008-11-27 Inverthis Ltd. Bypass graft device and delivery system and method
GB2450085B (en) 2007-06-08 2009-10-28 Univ Hospitals Of Leicester Nh Collapsible stent
US8048147B2 (en) 2007-06-27 2011-11-01 Aga Medical Corporation Branched stent/graft and method of fabrication
US8057531B2 (en) 2007-06-29 2011-11-15 Abbott Cardiovascular Systems Inc. Stent having circumferentially deformable struts
US20090012601A1 (en) 2007-07-05 2009-01-08 Abbott Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US7637940B2 (en) 2007-07-06 2009-12-29 Boston Scientific Scimed, Inc. Stent with bioabsorbable membrane
US7632305B2 (en) 2007-07-06 2009-12-15 Boston Scientific Scimed, Inc. Biodegradable connectors
US20090043376A1 (en) 2007-08-08 2009-02-12 Hamer Rochelle M Endoluminal Prosthetic Conduit Systems and Method of Coupling
US8747455B2 (en) 2007-08-08 2014-06-10 The Cleveland Clinic Foundation Branched stent graft system
US8333795B2 (en) 2007-08-27 2012-12-18 Boston Scientific Scimed, Inc. Bulging balloon for bifurcation catheter assembly and methods
US7959669B2 (en) 2007-09-12 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent with open ended side branch support
US8906081B2 (en) 2007-09-13 2014-12-09 W. L. Gore & Associates, Inc. Stented vascular graft
US20090093873A1 (en) 2007-09-28 2009-04-09 The Cleveland Clinic Foundation Vascular graft and method of use
WO2009046372A2 (en) 2007-10-04 2009-04-09 Trivascular2, Inc. Modular vascular graft for low profile percutaneous delivery
US9414842B2 (en) 2007-10-12 2016-08-16 St. Jude Medical, Cardiology Division, Inc. Multi-component vascular device
US9107741B2 (en) 2007-11-01 2015-08-18 Cook Medical Technologies Llc Flexible stent graft
EP2210248B1 (en) 2007-11-13 2016-04-20 Cook Medical Technologies LLC Intraluminal bypass prosthesis
WO2009062264A1 (en) 2007-11-15 2009-05-22 Endogad Research Pty Limited Hybrid intraluminal device
US20090132019A1 (en) 2007-11-15 2009-05-21 Medtronic Vascular, Inc. Bifurcate Stent Delivery Catheter
US8540758B2 (en) 2007-11-27 2013-09-24 Vimal I. Nanavati Bifurcation stent and delivery system
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
BRPI0704464A2 (en) 2007-11-30 2009-07-28 Melchiades Da Cunha Neto endoprosthesis, delivery system within a patient's vessel and uses of said delivery system and said endoprosthesis
DE102007063265A1 (en) 2007-12-17 2009-06-18 Aesculap Ag Woven textile vascular prosthesis
WO2009082718A1 (en) 2007-12-21 2009-07-02 Feinstein Ara J Devices, systems, and methods for repair of vascular defects
US20090164001A1 (en) 2007-12-21 2009-06-25 Biggs David P Socket For Fenestrated Tubular Prosthesis
US8277501B2 (en) 2007-12-21 2012-10-02 Boston Scientific Scimed, Inc. Bi-stable bifurcated stent petal geometry
US8728145B2 (en) 2008-12-11 2014-05-20 Cook Medical Technologies Llc Low profile non-symmetrical stents and stent-grafts
US8574284B2 (en) 2007-12-26 2013-11-05 Cook Medical Technologies Llc Low profile non-symmetrical bare alignment stents with graft
US8021413B2 (en) 2007-12-27 2011-09-20 Cook Medical Technologies Llc Low profile medical device
US8834552B2 (en) 2007-12-27 2014-09-16 Cook Medical Technologies Llc Stent graft having floating yarns
US10646363B2 (en) 2007-12-27 2020-05-12 Cook Medical Technologies Llc Endovascular device delivery system
US20090171451A1 (en) 2007-12-27 2009-07-02 Cook Incorporated Implantable device having composite weave
EP2242456A2 (en) 2007-12-31 2010-10-27 Boston Scientific Scimed, Inc. Bifurcation stent delivery system and methods
US8303650B2 (en) 2008-01-10 2012-11-06 Telesis Research, Llc Biodegradable self-expanding drug-eluting prosthesis
US8317857B2 (en) 2008-01-10 2012-11-27 Telesis Research, Llc Biodegradable self-expanding prosthesis
GB0803302D0 (en) 2008-02-22 2008-04-02 Barts & London Nhs Trust Blood vessel prosthesis and delivery apparatus
WO2009105699A1 (en) 2008-02-22 2009-08-27 Endologix, Inc. Design and method of placement of a graft or graft system
US20090234440A1 (en) 2008-03-13 2009-09-17 Cardiometrix, Inc. Vascular anchor positioning system and method
US20090234436A1 (en) 2008-03-13 2009-09-17 Cardiometrix, Inc. Vascular anchor tethering system and method
US7833265B2 (en) 2008-03-13 2010-11-16 Pacesetter, Inc. Vascular anchoring system and method
US7846200B2 (en) 2008-03-13 2010-12-07 Pacesetter, Inc. Vascular anchoring system and method
US7892278B2 (en) 2008-03-13 2011-02-22 Pacesetter, Inc. Vascular anchoring system and method
US20090234439A1 (en) 2008-03-13 2009-09-17 Cardiometrix, Inc. Vascular anchoring system and method
US7901450B2 (en) 2008-03-13 2011-03-08 Pacesetter, Inc. Vascular anchoring system and method
US20090240318A1 (en) 2008-03-19 2009-09-24 Boston Scientific Scimed, Inc. Stent expansion column, strut and connector slit design
US8252048B2 (en) 2008-03-19 2012-08-28 Boston Scientific Scimed, Inc. Drug eluting stent and method of making the same
US8974518B2 (en) 2008-03-25 2015-03-10 Medtronic Vascular, Inc. Eversible branch stent-graft and deployment method
US20090259285A1 (en) 2008-04-10 2009-10-15 Medtronic Vascular, Inc. Bifurcated Delivery System
US20090259296A1 (en) 2008-04-10 2009-10-15 Medtronic Vascular, Inc. Gate Cannulation Apparatus and Methods
US7806923B2 (en) 2008-04-11 2010-10-05 Medtronic Vascular, Inc. Side branch stent having a proximal split ring
US8236040B2 (en) 2008-04-11 2012-08-07 Endologix, Inc. Bifurcated graft deployment systems and methods
US20090259299A1 (en) 2008-04-14 2009-10-15 Medtronic Vascular, Inc. Side Branch Stent Having a Proximal Flexible Material Section
US7655037B2 (en) 2008-04-17 2010-02-02 Cordis Corporation Combination barb restraint and stent attachment deployment mechanism
US20090264985A1 (en) 2008-04-17 2009-10-22 Medtronic Vascular, Inc. Branch Vessel Suture Stent System and Method
US8128686B2 (en) 2008-04-18 2012-03-06 Cook Medical Technologies Llc Branched vessel prosthesis
US20100305686A1 (en) 2008-05-15 2010-12-02 Cragg Andrew H Low-profile modular abdominal aortic aneurysm graft
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
CA2726452A1 (en) 2008-06-04 2009-12-30 Nellix, Inc. Docking apparatus and methods of use
US8292900B2 (en) 2008-06-10 2012-10-23 Boston Scientific Scimed, Inc. Side branch wiring assist sheath and methods
US8398697B2 (en) 2008-06-13 2013-03-19 Boston Scientific Scimed, Inc. Bifurcation catheter assembly with distally mounted side balloon and methods
US20100040663A1 (en) 2008-06-16 2010-02-18 Cytograft Tissue Engineering, Inc. Arterial Implants
US20090326643A1 (en) 2008-06-27 2009-12-31 Boston Scientific Scimed, Inc. Balloon folding apparatus and method
US8187313B2 (en) 2008-08-01 2012-05-29 Boston Scientific Scimed, Inc. Bifurcation catheter assembly side catheter branch construction and methods
US9005274B2 (en) 2008-08-04 2015-04-14 Stentys Sas Method for treating a body lumen
US20100049307A1 (en) 2008-08-25 2010-02-25 Aga Medical Corporation Stent graft having extended landing area and method for using the same
WO2010024879A1 (en) 2008-08-26 2010-03-04 William A. Cook Australia Pty. Ltd. Thoracic aorta stent graft with access region
WO2010024867A1 (en) 2008-08-27 2010-03-04 Cleveland Clinic Foundation Stent graft fixation coupling
US8394139B2 (en) 2008-08-29 2013-03-12 Cook Medical Technologies Llc Barbed anchors for wire stent
EP2331011B1 (en) 2008-08-29 2015-01-14 Cook Medical Technologies LLC Prosthesis with moveable fenestration
US20100063578A1 (en) 2008-09-05 2010-03-11 Aga Medical Corporation Bifurcated medical device for treating a target site and associated method
US20100114301A1 (en) 2008-10-31 2010-05-06 Vioptix, Inc. Vessel Right Sizer
US20100137973A1 (en) 2008-12-02 2010-06-03 Boston Scientific Scimed, Inc. Layered Bifurcation Stent
CN101836911A (en) 2009-03-18 2010-09-22 微创医疗器械(上海)有限公司 Collateral filmed stent
US8052741B2 (en) 2009-03-23 2011-11-08 Medtronic Vascular, Inc. Branch vessel prosthesis with a roll-up sealing assembly
EP2416734A1 (en) 2009-04-02 2012-02-15 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Stent graft fenestration
US9427302B2 (en) 2009-04-09 2016-08-30 Medtronic Vascular, Inc. Stent having a C-shaped body section for use in a bifurcation
US20100268318A1 (en) 2009-04-16 2010-10-21 Medtronic Vascular, Inc. Prosthesis for Antegrade Deployment
US8540764B2 (en) 2009-04-17 2013-09-24 Medtronic Vascular, Inc. Mobile external coupling for branch vessel connection
US20110054586A1 (en) 2009-04-28 2011-03-03 Endologix, Inc. Apparatus and method of placement of a graft or graft system
KR101073035B1 (en) 2009-05-13 2011-10-12 연세대학교 산학협력단 H Side-branch Stent
EP2434984B1 (en) 2009-05-30 2016-02-17 Deutsche Institute für Textil- und Faserforschung Denkendorf Stiftung des öffentlichen Rechts Medical device
US20100318170A1 (en) 2009-06-15 2010-12-16 Richard Newhauser Proximal catheter flap for managing wire twist
US9327058B2 (en) 2009-07-07 2016-05-03 Cook Medical Technologies Llc Hydrogel enhanced medical devices
JP5588511B2 (en) 2009-07-27 2014-09-10 エンドロジックス、インク Stent graft
BR112012000762B8 (en) 2009-07-31 2021-06-22 Jotec Gmbh catheter, having loaded an endoluminal prosthesis in it, implementation system for implementing an endoluminal prosthesis and endoluminal prosthesis
WO2011031364A1 (en) 2009-09-14 2011-03-17 Circulite, Inc Endovascular anastomotic connector device, delivery system, and methods of delivery and use
US20110077730A1 (en) 2009-09-30 2011-03-31 Fenster Michael S Bifurcated balloon stent
US20110087318A1 (en) 2009-10-09 2011-04-14 Daugherty John R Bifurcated highly conformable medical device branch access
EP2387374B1 (en) 2009-10-13 2016-03-16 Cook Medical Technologies LLC Paraplegia prevention stent graft
US20120310324A1 (en) 2009-11-04 2012-12-06 Endospan Ltd. Treatment of a main body lumen in the vicinity of a branching body lumen
KR101137896B1 (en) 2009-11-12 2012-05-02 연세대학교 산학협력단 Stent for protection of a side-branch vessel at branch lesions
WO2011068915A1 (en) 2009-12-01 2011-06-09 Altura Medical, Inc. Modular endograft devices and associated systems and methods
CA2782513A1 (en) 2009-12-02 2011-06-09 Endospan Ltd. Endovascular fenestrated stent-grafting
US8475513B2 (en) 2009-12-02 2013-07-02 Nedunchezian Sithian Stent graft apparatus and method
US20110208289A1 (en) 2010-02-25 2011-08-25 Endospan Ltd. Flexible Stent-Grafts
US20110218617A1 (en) 2010-03-02 2011-09-08 Endologix, Inc. Endoluminal vascular prosthesis
EP2549959A4 (en) 2010-03-22 2016-12-14 Scitech Produtos Medicos Ltda Endoprosthesis and delivery system for delivering the endoprosthesis within a vessel of a patient
WO2011119883A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
US20110251664A1 (en) 2010-04-08 2011-10-13 Medtronic Vascular, Inc. Short Legged Bifurcated Stent Graft Distal Capture Element and Method
US20120046733A1 (en) 2010-04-14 2012-02-23 Randolf Von Oepen Method of delivering a medical device across a valve
US8292951B2 (en) 2010-04-29 2012-10-23 Medtronic Vascular, Inc. Tethered pop up branch structure stent graft and method
US8337546B2 (en) 2010-04-29 2012-12-25 Medtronic Vascular, Inc. Mobile external coupling for branch vessel connection
US8333800B2 (en) 2010-04-29 2012-12-18 Medtronic Vascular, Inc. Mobile external coupling with internal sealing cuff for branch vessel connection
US20110313504A1 (en) 2010-06-02 2011-12-22 Golding Arthur L Device and method to prevent or treat outflow vein stenosis of an arteriovenous fistula constructed with a synthetic vascular graft
AU2010202544B1 (en) 2010-06-18 2010-08-26 Cook Incorporated Side branch stent graft
US8337542B2 (en) 2010-07-14 2012-12-25 Cook Medical Technologies Llc Delivery system for simultaneous deployment of intraluminal device
CA2748206C (en) 2010-08-21 2015-06-23 Blayne A. Roeder Prosthesis having pivoting fenestration
WO2012037558A1 (en) 2010-09-17 2012-03-22 Bioconnect Systems Implantable graft connector
US20120123526A1 (en) 2010-11-11 2012-05-17 Po-Jen Ko Thoracic aortic stent structure
US8753386B2 (en) 2010-11-15 2014-06-17 W. L. Gore & Associates, Inc. Stent-graft having facing side branch portals
US8535371B2 (en) 2010-11-15 2013-09-17 Endovascular Development AB Method of positioning a tubular element in a blood vessel of a person
US20120130475A1 (en) 2010-11-16 2012-05-24 Shaw Edward E Sleeves for expandable medical devices
US9566149B2 (en) 2010-11-16 2017-02-14 W. L. Gore & Associates, Inc. Devices and methods for in situ fenestration of a stent-graft at the site of a branch vessel
US20120136431A1 (en) 2010-11-29 2012-05-31 Wei-Hui Chen Stent Graft System
CN103237526B (en) 2010-12-06 2015-12-02 科维蒂恩有限合伙公司 Vascular remodeling device
US9198787B2 (en) 2010-12-31 2015-12-01 Cook Medical Technologies Llc Conformable prosthesis delivery system and method for deployment thereof
US20120203329A1 (en) 2011-02-07 2012-08-09 Heuser Richard R Bifurcated stent and method of use
US9839542B2 (en) 2011-04-19 2017-12-12 Medtronic Ardian Luxembourg S.A.R.L. Mobile external coupling for branch vessel connection
US20120271410A1 (en) 2011-04-19 2012-10-25 Myles Douglas Branch endograft delivery
US9993328B2 (en) * 2012-04-03 2018-06-12 Trivascular, Inc. Advanced kink resistant stent graft

Patent Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US617571A (en) * 1899-01-10 Canopy for boats
US3631854A (en) * 1969-05-19 1972-01-04 Robert Howard Fryer Inflatable medical assemblies
US4187390A (en) * 1970-05-21 1980-02-05 W. L. Gore & Associates, Inc. Porous products and process therefor
US4497074A (en) * 1976-04-05 1985-02-05 Agence National De Valorisation De La Recherche (Anvar) Organ prostheses
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4183102A (en) * 1977-09-08 1980-01-15 Jacques Guiset Inflatable prosthetic device for lining a body duct
US4647416A (en) * 1983-08-03 1987-03-03 Shiley Incorporated Method of preparing a vascular graft prosthesis
US6221102B1 (en) * 1983-12-09 2001-04-24 Endovascular Technologies, Inc. Intraluminal grafting system
US6017364A (en) * 1983-12-09 2000-01-25 Endovascular Technologies, Inc. Intraluminal repair device and catheter
US5397345A (en) * 1983-12-09 1995-03-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US5275622A (en) * 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
US5108424A (en) * 1984-01-30 1992-04-28 Meadox Medicals, Inc. Collagen-impregnated dacron graft
US4562596A (en) * 1984-04-25 1986-01-07 Elliot Kornberg Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4739762B1 (en) * 1985-11-07 1998-10-27 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4739762A (en) * 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US4816028A (en) * 1987-07-01 1989-03-28 Indu Kapadia Woven vascular graft
US5100422A (en) * 1989-05-26 1992-03-31 Impra, Inc. Blood vessel patch
US5104400A (en) * 1989-05-26 1992-04-14 Impra, Inc. Blood vessel patch
US5591229A (en) * 1990-06-11 1997-01-07 Parodi; Juan C. Aortic graft for repairing an abdominal aortic aneurysm
US5405379A (en) * 1990-07-26 1995-04-11 Lane; Rodney J. Self expanding vascular endoprosthesis for aneurysms
US5282847A (en) * 1991-02-28 1994-02-01 Medtronic, Inc. Prosthetic vascular grafts with a pleated structure
US5489295A (en) * 1991-04-11 1996-02-06 Endovascular Technologies, Inc. Endovascular graft having bifurcation and apparatus and method for deploying the same
US6210435B1 (en) * 1991-04-11 2001-04-03 Endovascular Technologies, Inc. Endovascular graft having bifurcation and apparatus and method for deploying the same
US5609625A (en) * 1991-04-11 1997-03-11 Endovascular Technologies, Inc. Endovascular graft having bifurcation and apparatus and method for deploying the same
US5387235A (en) * 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
US5720776A (en) * 1991-10-25 1998-02-24 Cook Incorporated Barb and expandable transluminal graft prosthesis for repair of aneurysm
US6019787A (en) * 1992-03-12 2000-02-01 Laboratoire Perouse Implant Fitting tool for use of an expansible endoprosthesis for a human or animal tubular organ
US5292514A (en) * 1992-06-24 1994-03-08 Minnesota Mining And Manufacturing Company Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof
US5716395A (en) * 1992-12-11 1998-02-10 W.L. Gore & Associates, Inc. Prosthetic vascular graft
US6533811B1 (en) * 1993-07-08 2003-03-18 Medtronic, Inc. Internal graft prosthesis and delivery system
US6027811A (en) * 1993-08-18 2000-02-22 W. L. Gore & Associates, Inc. Thin-wall intraluminal graft
US5735892A (en) * 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5718973A (en) * 1993-08-18 1998-02-17 W. L. Gore & Associates, Inc. Tubular intraluminal graft
US6025044A (en) * 1993-08-18 2000-02-15 W. L. Gore & Associates, Inc. Thin-wall polytetrafluoroethylene tube
US5609624A (en) * 1993-10-08 1997-03-11 Impra, Inc. Reinforced vascular graft and method of making same
US5723004A (en) * 1993-10-21 1998-03-03 Corvita Corporation Expandable supportive endoluminal grafts
US5855598A (en) * 1993-10-21 1999-01-05 Corvita Corporation Expandable supportive branched endoluminal grafts
US5733325A (en) * 1993-11-04 1998-03-31 C. R. Bard, Inc. Non-migrating vascular prosthesis and minimally invasive placement system
US5871536A (en) * 1993-11-08 1999-02-16 Lazarus; Harrison M. Intraluminal vascular graft and method
US6051020A (en) * 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US5707378A (en) * 1994-09-02 1998-01-13 Sam S. Ahn Apparatus and method for performing aneurysm repair
US20020040236A1 (en) * 1994-09-08 2002-04-04 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US5507769A (en) * 1994-10-18 1996-04-16 Stentco, Inc. Method and apparatus for forming an endoluminal bifurcated graft
US5607468A (en) * 1994-11-04 1997-03-04 Aeroquip Corporation Method of manufacturing an intraluminal stenting graft
US5507770A (en) * 1994-11-23 1996-04-16 Aeroquip Corporation Intraluminal grafting stent and method for implanting same in a blood vessel
US20020007212A1 (en) * 1995-03-01 2002-01-17 Brown Brian J. Longitudinally flexible expandable stent
US5609628A (en) * 1995-04-20 1997-03-11 Keranen; Victor J. Intravascular graft and catheter
US6183504B1 (en) * 1995-05-19 2001-02-06 Kanji Inoue Appliance to be implanted, method of collapsing the appliance to be implanted and method of using the appliance to be implanted
US6355056B1 (en) * 1995-06-01 2002-03-12 Meadox Medicals, Inc. Implantable intraluminal prosthesis
US6355055B1 (en) * 1995-09-01 2002-03-12 Emory University Endovascular support device and method of use
US5713917A (en) * 1995-10-30 1998-02-03 Leonhardt; Howard J. Apparatus and method for engrafting a blood vessel
US5709703A (en) * 1995-11-14 1998-01-20 Schneider (Europe) A.G. Stent delivery device and method for manufacturing same
US6053943A (en) * 1995-12-08 2000-04-25 Impra, Inc. Endoluminal graft with integral structural support and method for making same
US6042605A (en) * 1995-12-14 2000-03-28 Gore Enterprose Holdings, Inc. Kink resistant stent-graft
US6352553B1 (en) * 1995-12-14 2002-03-05 Gore Enterprise Holdings, Inc. Stent-graft deployment apparatus and method
US20020002397A1 (en) * 1995-12-14 2002-01-03 Martin Gerald Ray Kink resistant stent-graft
US5871537A (en) * 1996-02-13 1999-02-16 Scimed Life Systems, Inc. Endovascular apparatus
US5607478A (en) * 1996-03-14 1997-03-04 Meadox Medicals Inc. Yarn wrapped PTFE tubular prosthesis
US6203568B1 (en) * 1996-04-05 2001-03-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US20020049493A1 (en) * 1996-04-26 2002-04-25 Jang G. David Intravascular stent
US5718159A (en) * 1996-04-30 1998-02-17 Schneider (Usa) Inc. Process for manufacturing three-dimensional braided covered stent
US6036723A (en) * 1996-05-02 2000-03-14 B. Braun Celsa Surgically anastomosable transcutaneous vascular prothesis and set comprising the same
US5709701A (en) * 1996-05-30 1998-01-20 Parodi; Juan C. Apparatus for implanting a prothesis within a body passageway
US20020026231A1 (en) * 1996-07-03 2002-02-28 Donald T. Shannon Radially expandable stented tubular PTFE grafts
US20020042645A1 (en) * 1996-07-03 2002-04-11 Shannon Donald T. Drug eluting radially expandable tubular stented grafts
US6344054B1 (en) * 1996-09-20 2002-02-05 Juan Carlos Parodi Endoluminal prosthesis comprising stent and overlying graft cover, and system and method for deployment thereof
US20020045931A1 (en) * 1996-09-26 2002-04-18 David Sogard Support structure/membrane composite medical device
US6015431A (en) * 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US20020040237A1 (en) * 1997-01-17 2002-04-04 Meadox Medicals, Inc. ePTFE graft-stent composite device
US6030415A (en) * 1997-01-29 2000-02-29 Endovascular Technologies, Inc. Bell-bottom modular stent-graft
US6039755A (en) * 1997-02-05 2000-03-21 Impra, Inc., A Division Of C.R. Bard, Inc. Radially expandable tubular polytetrafluoroethylene grafts and method of making same
US6344444B1 (en) * 1997-02-12 2002-02-05 Nutrition 21 Arginine-silicate-inositol complex and use thereof
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US6368355B1 (en) * 1998-05-13 2002-04-09 Renan Uflacker Stent or graft support structure for treating bifurcated vessels having different diameter portions and methods of use and implantation
US20020007193A1 (en) * 1998-07-01 2002-01-17 Howard Tanner Method and apparatus for the surgical repair of aneurysms
US20020019665A1 (en) * 1998-09-30 2002-02-14 Mark Dehdashtian Methods and apparatus for intraluminal placement of a bifurcated intraluminal graft
US6336937B1 (en) * 1998-12-09 2002-01-08 Gore Enterprise Holdings, Inc. Multi-stage expandable stent-graft
US6187036B1 (en) * 1998-12-11 2001-02-13 Endologix, Inc. Endoluminal vascular prosthesis
US6197049B1 (en) * 1999-02-17 2001-03-06 Endologix, Inc. Articulating bifurcation graft
US20020016626A1 (en) * 1999-04-01 2002-02-07 Boston Scientific Corporation Intraluminal lining
US20020016623A1 (en) * 1999-04-08 2002-02-07 Kula John S. Stent with variable wall thickness
US20020016627A1 (en) * 2000-01-19 2002-02-07 Scimed Life Systems, Inc. Tubular structure/stent/stent securement member
US6344044B1 (en) * 2000-02-11 2002-02-05 Edwards Lifesciences Corp. Apparatus and methods for delivery of intraluminal prosthesis
US20020049490A1 (en) * 2000-04-11 2002-04-25 Pollock David T. Single-piece endoprosthesis with high expansion ratios
US6517574B1 (en) * 2000-04-27 2003-02-11 Endovascular Technologies, Inc. System and method for endovascular aneurysm repair in conjunction with vascular stabilization
US6520984B1 (en) * 2000-04-28 2003-02-18 Cardiovasc, Inc. Stent graft assembly and method
US20020032408A1 (en) * 2000-07-14 2002-03-14 Cook Incorporated Medical device including tube having a braid and an expanded coil
US20020049487A1 (en) * 2000-08-30 2002-04-25 Biotronik Mess-Und Therapiegeraete Gmbh & Co Ingenieurbuero Berlin Stress-optimized stent
US20020045935A1 (en) * 2000-09-23 2002-04-18 Jang G. David Intravascular stent apparatus
US20020045934A1 (en) * 2000-09-25 2002-04-18 Jang G. David Intravascular stent apparatus
US20020045933A1 (en) * 2000-09-25 2002-04-18 Jang G. David Intravascular stent apparatus
US20020042644A1 (en) * 2000-10-10 2002-04-11 Greenhalgh E. Skott Bifurcated fabric sleeve stent graft with junction region strengthening elements
US20030009211A1 (en) * 2001-07-03 2003-01-09 Dicarlo Paul Implant having improved fixation to a body lumen and method for implanting the same
US20030009212A1 (en) * 2001-07-06 2003-01-09 Andrew Kerr Axially-connected stent/graft assembly
US20030074050A1 (en) * 2001-07-06 2003-04-17 Andrew Kerr Stent/graft assembly
US20030074048A1 (en) * 2001-10-16 2003-04-17 Scimed Life Systems, Inc. Tubular prosthesis for external agent delivery
US20030074058A1 (en) * 2001-10-16 2003-04-17 Scimed Life Systems, Inc. Aortic artery aneurysm endovascular prosthesis

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10945829B1 (en) 2001-04-11 2021-03-16 Andrew Kerr Stent/graft assembly
US20040138734A1 (en) * 2001-04-11 2004-07-15 Trivascular, Inc. Delivery system and method for bifurcated graft
US10105209B2 (en) 2001-04-11 2018-10-23 Andrew Kerr Stent/graft assembly
US10905542B2 (en) 2001-04-11 2021-02-02 Andrew Kerr Stent/graft assembly
US10470871B2 (en) 2001-12-20 2019-11-12 Trivascular, Inc. Advanced endovascular graft
US11439497B2 (en) 2001-12-20 2022-09-13 Trivascular, Inc. Advanced endovascular graft
US20040073190A1 (en) * 2002-07-02 2004-04-15 The Foundry Inc. Methods and devices for treating aneurysms
US7314484B2 (en) * 2002-07-02 2008-01-01 The Foundry, Inc. Methods and devices for treating aneurysms
US9956070B2 (en) * 2002-07-22 2018-05-01 Tmt Systems Percutaneous endovascular apparatus for repair of aneurysms and arterial blockages
US20160058546A1 (en) * 2002-07-22 2016-03-03 Timur P. Sarac Percutaneous endovascular apparatus for repair of aneurysms and arterial blockages
US11890181B2 (en) 2002-07-22 2024-02-06 Tmt Systems, Inc. Percutaneous endovascular apparatus for repair of aneurysms and arterial blockages
US20060149349A1 (en) * 2002-10-10 2006-07-06 Jean-Francois Garbe Device for connection between a corporeal duct and a prosthesis
US7828834B2 (en) * 2002-10-10 2010-11-09 Protomed Device for connection between a corporeal duct and a prosthesis
US7468072B2 (en) 2002-12-30 2008-12-23 Hesham Morsi Endovascular balloon graft
US20060206197A1 (en) * 2002-12-30 2006-09-14 Hesham Morsi Endovascular balloon graft
US7150758B2 (en) * 2003-03-06 2006-12-19 Boston Scientific Santa Rosa Corp. Kink resistant endovascular graft
US20040176836A1 (en) * 2003-03-06 2004-09-09 Trivascular, Inc. Kink resistant endovascular graft
WO2004080338A3 (en) * 2003-03-06 2005-03-31 Trivascular Inc Kink resistant endovascular graft
JP2007537779A (en) * 2004-03-11 2007-12-27 トライヴァスキュラー インコーポレイテッド Modular endovascular graft
JP4852033B2 (en) * 2004-03-11 2012-01-11 トリバスキュラー インコーポレイテッド Modular endovascular graft
US20060025846A1 (en) * 2004-07-28 2006-02-02 Frederick Feller AAA low profile support structure
JP2006034970A (en) * 2004-07-28 2006-02-09 Cordis Corp Abdominal aortic aneurysm device having connected bifurcated legs
US20060025851A1 (en) * 2004-07-28 2006-02-02 Khan Isaac J AAA device having connected bifurcated legs
US7175657B2 (en) * 2004-07-28 2007-02-13 Cordis Corporation AAA device having connected bifurcated legs
US7344562B2 (en) * 2004-07-28 2008-03-18 Cordis Corporation AAA low profile support structure
US20110196060A1 (en) * 2005-04-01 2011-08-11 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
US11298444B2 (en) 2005-04-01 2022-04-12 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
US9308301B2 (en) 2005-04-01 2016-04-12 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
US20090005849A1 (en) * 2006-03-24 2009-01-01 Syed Faiyaz Ahmed Hossainy Methods and apparatuses for coating a lesion
US8518105B2 (en) 2006-03-24 2013-08-27 Abbott Cardiovascular System Inc. Methods and apparatuses for coating a lesion
US20080058920A1 (en) * 2006-08-14 2008-03-06 Boston Scientific Scimed, Inc. Dual chamber cuff structure
US8216297B2 (en) 2006-08-14 2012-07-10 Trivascular, Inc. Dual chamber cuff structure
WO2008021199A1 (en) 2006-08-14 2008-02-21 Trivascular2, Inc. Dual chamber cuff structure
US9504568B2 (en) * 2007-02-16 2016-11-29 Medtronic, Inc. Replacement prosthetic heart valves and methods of implantation
US20100331957A1 (en) * 2007-06-11 2010-12-30 Nanovasc, Inc. Implantable medical device
US8663309B2 (en) * 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US20110224774A1 (en) * 2007-11-30 2011-09-15 Silveira Pierre G Endoprosthesis and delivery system for delivering the endoprosthesis within a vessel of a patient
US20090143850A1 (en) * 2007-11-30 2009-06-04 Pierre Galvagni Silveira Endoprosthesis and delivery system for its placement within a patients vessel and uses for this endoprosthesis and delivery system
US8608792B2 (en) 2007-11-30 2013-12-17 Scitech Produtos Medicos Ltda Endoprosthesis and delivery system for delivering the endoprosthesis within a vessel of a patient
US9370437B2 (en) * 2007-12-26 2016-06-21 Cook Medical Technologies Llc Stent having less invasive ends
US20090171438A1 (en) * 2007-12-26 2009-07-02 Cook Incorporated Stent having less invasive ends
US20090171454A1 (en) * 2007-12-27 2009-07-02 Cook Incorporated Coated stent and methods of manufacture
US11207199B2 (en) 2008-06-11 2021-12-28 Q3 Medical Devices Limited Stent with anti-migration devices
US20100070020A1 (en) * 2008-06-11 2010-03-18 Nanovasc, Inc. Implantable Medical Device
US8679572B2 (en) 2008-08-28 2014-03-25 Cook Medical Technologies, LLC Coated stent
US20130023981A1 (en) * 2008-08-29 2013-01-24 William Kurt Dierking Barbed anchor
US8696739B2 (en) * 2008-08-29 2014-04-15 Cook Medical Technologies Llc Barbed anchor
US20170014221A1 (en) * 2015-07-19 2017-01-19 Sanford Health Bridging Stent Graft with Interlocking Features and Methods for Use
CN107569311A (en) * 2017-07-05 2018-01-12 杭州唯强医疗科技有限公司 Ring holder
WO2020190953A1 (en) * 2019-03-19 2020-09-24 Q3 Medical Devices Limited Stent with anti-migration devices

Also Published As

Publication number Publication date
US20090264984A1 (en) 2009-10-22
US20060178732A1 (en) 2006-08-10
JP2012035139A (en) 2012-02-23
US8709065B2 (en) 2014-04-29
US20030120331A1 (en) 2003-06-26
ATE553721T1 (en) 2012-05-15
US8900288B2 (en) 2014-12-02
US8167927B2 (en) 2012-05-01
US20170348087A1 (en) 2017-12-07
US20120016457A1 (en) 2012-01-19
US20120029625A1 (en) 2012-02-02
US7147661B2 (en) 2006-12-12
US7766954B2 (en) 2010-08-03
US11439497B2 (en) 2022-09-13
US10470871B2 (en) 2019-11-12
US20200078162A1 (en) 2020-03-12
US20100016942A1 (en) 2010-01-21
US9788934B2 (en) 2017-10-17
US20160022410A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
US11439497B2 (en) Advanced endovascular graft
US7147660B2 (en) Advanced endovascular graft
US8864814B2 (en) Method of delivering advanced endovascular graft and system
JP4464972B2 (en) Interconnected leg extensions for endoluminal prostheses
EP1691881A2 (en) Endoluminal prosthesis endoleak management

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOSTON SCIENTIFIC CORPORATION, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TRIVASCULAR, INC.;REEL/FRAME:015409/0438

Effective date: 20041124

AS Assignment

Owner name: TRIVASCULAR, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHOBOTOV, MICHAEL V.;WHIRLEY, ROBERT G.;REEL/FRAME:015963/0862;SIGNING DATES FROM 20041208 TO 20050103

AS Assignment

Owner name: BOSTON SCIENTIFIC SANTA ROSA CORP., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:TRIVASCULAR, INC.;REEL/FRAME:016782/0315

Effective date: 20051101

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: TRIVASCULAR, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BOSTON SCIENTIFIC CORPORATION;REEL/FRAME:025365/0673

Effective date: 20100913

AS Assignment

Owner name: DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNORS:ENDOLOGIX, INC.;NELLIX, INC.;TRIVASCULAR, INC.;REEL/FRAME:046772/0933

Effective date: 20180809

Owner name: DEERFIELD ELGX REVOLVER, LLC, AS AGENT, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNORS:ENDOLOGIX, INC.;NELLIX, INC.;TRIVASCULAR, INC.;REEL/FRAME:046762/0169

Effective date: 20180809

Owner name: DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT,

Free format text: SECURITY INTEREST;ASSIGNORS:ENDOLOGIX, INC.;NELLIX, INC.;TRIVASCULAR, INC.;REEL/FRAME:046772/0933

Effective date: 20180809

AS Assignment

Owner name: DEERFIELD PRIVATE DESIGN FUND IV, L.P., NEW YORK

Free format text: SECURITY INTEREST;ASSIGNORS:ENDOLOGIX LLC (F/K/A ENDOLOGIX, INC.);NELLIX, INC.;TRIVASCULAR TECHNOLOGIES, INC.;AND OTHERS;REEL/FRAME:053971/0052

Effective date: 20201001

Owner name: ENDOLOGIX LLC, CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:ENDOLOGIX, INC.;REEL/FRAME:053971/0135

Effective date: 20201001